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As células estaminais são células indiferenciadas que se conseguem replicar e 
originar células especializadas e funcionais, através de processos de diferenciação celular.  
Existem vários tipos de células estaminais, originárias de tecidos embrionários e adultos, 
caracterizadas por possuirem potenciais de diferenciação diferentes.  As células 
estaminais neurais (NSC) têm a capacidade de originar os principais tipos de células 
neurais, incluindo neurónios e células da glia (astrócitos e oligodendrócitos). Em cada 
divisão celular, as NSC podem seguir destinos celulares diferentes, nomeadamente 
continuar o processo proliferativo, ou iniciar o processo de diferenciação.  Esta tomada de 
decisão é regulada por vários fatores intrínsecos e extrínsecos.  Além disso, os 
mecanismos regulatórios envolvem também sinais de sobrevivência e de morte celular, 
sendo que o destino de proliferação, diferenciação ou morte depende do balanço e da 
conjugação dos múltiplos fatores. 
Estudos recentes sugerem que fatores associados ao processo apoptótico podem 
também modular a proliferação e a diferenciação das NSC.  De facto, o nosso grupo 
demonstrou já que as caspases, proteases de cisteína que desempenham um papel central 
no processo apoptótico, bem como a proteína p53, supressora de tumores, aceleram a 
diferenciação neural.  Por outro lado, também demonstrámos o envolvimento de vários 
miRNAs associados à apoptose na diferenciação neural e clarificámos o papel do 
miRNA-34a durante este processo.  Curiosamente, as variações na expressão e atividade 
de proteínas e miRNAs relacionados com a apoptose não se encontram associadas a um 
aumento de morte celular, o que sugere que estes fatores desempenham novas funções na 
regulação da diferenciação das NSC, independentemente do seu papel proapoptotico.  
Assim, propusémo-nos identificar e caracterizar novos fatores, associados à apoptose, 
com capacidade de regular o potencial de proliferação e diferenciação das NSC e, 
também, modular estes processos recorrendo a novos reguladores de vias apoptóticas. 
Avaliámos, inicialmente, a capacidade de dois derivados de naftoquinona 
sintéticos regularem a apoptose em diferentes modelos celulares.  De facto, compostos 
com uma estrutura de quinona são comuns na natureza e apresentam actividades 
anticancerígenas, antibacterianas, antimaláricas e fungicidas.  Dois compostos com o 
potencial de inibir proteases de cisteína foram concebidos e sintetizados: nafto[2,3-
d]isoxazole-4,9-diona-3-carboxilatos 1a e 1b.  O potencial antiapoptótico dos compostos 
1a e 1b foi avaliado e comparado com o da naftoquinona 4, um composto estruturalmente 
mais simples.  Culturas primárias de hepatócitos de rato foram incubadas com os 
derivados de naftoquinona sintetizados e, posteriormente, tratadas com camptotecina, um 
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estímulo tóxico proapoptótico que induz danos no DNA.  Os nossos resultados 
demonstraram que os derivados de naftoquinona 1a e 1b conferem uma proteção anti-
apoptótica eficaz nestas condições, ao contrário da naftoquinona 4.  Tanto o composto 1a, 
como o composto 1b, aumentaram significativamente a viabilidade celular e reduziram a 
fragmentação nuclear, a ativação da caspase-3, -8 e -9 e a libertação de citocromo c, 
provocadas pelo tratamento com camptotecina.  Além disso, ambos os compostos 
aumentaram a expressão da Bcl-XL, uma proteína pró-apoptótica da família da Bcl-2 que 
modula a via mitocondrial da apoptose.  Avaliámos a extensão das propriedades anti-
apoptóticas destes compostos a outros modelos, por recurso a linhas celulares e estímulos 
apoptóticos diversos.  Obtivémos efeitos protetores semelhantes em hepatócitos primários 
de rato e em células HuH-7 de hepatoma humano expostas a TGF-β1, uma citocina pró-
apoptótica.  Verificámos ainda que as propriedades antiapoptóticas dos derivados de 
naftoquinona 1a e 1b não se restringem a células do fígado, uma vez que ambos os 
compostos se revelaram eficazes na proteção de células de feocromocitoma de rato 
(PC12) tratadas com rotenona, um inibidor da cadeia respiratória mitocondrial.  Estes 
resultados sugeriram que os nafto[2,3-d]isoxazole-4,9-diona-3-carboxilatos 1a e 1b são 
agentes citoprotetores eficazes e potenciais moduladores de vias apoptóticas. 
De seguida, investigámos a função de proteínas associadas à apoptose na 
regulação do potencial de proliferação e diferenciação das NSC.  Uma vez que tínhamos 
confirmado anteriormente o efeito das caspases na diferenciação neural, investigámos 
agora outra família de proteases de cisteína, as calpaínas.  As calpaínas dependem de 
cálcio para a sua ativação e já foram associadas a vários processos celulares, incluindo a 
apoptose, a migração e o ciclo celular.  Também já foram implicadas em processos de 
diferenciação em diversos modelos celulares, mas o seu impacto na diferenciação neural é 
ainda pouco conhecido.  Assim, começámos por inibir estas proteases em NSC de ratinho.  
Tratámos as NSC com calpeptina, um inibidor químico de calpaínas, ou, em alternativa, 
sobrexpressámos a calpastatina, um inibidor endógeno específico para as calpaínas.  
Verificámos que esta inibição resultou em redução de proliferação e indução de 
diferenciação das NSC.  Este efeito foi acompanhado por alterações significativas na 
expressão de proteínas do ciclo celular.  Experiências com inibidores de canais de cálcio 
presentes no retículo endoplasmático sugeriram que as calpaínas são ativadas por fluxos 
de cálcio nas NSC.  De seguida, focámos o nosso estudo nas calpaínas mais estudadas e, 
também, mais abundantes no cérebro, as calpaínas 1 e 2.  Curiosamente, observámos que 
estas duas isoformas são reguladas de modo díspar durante a diferenciação das NSC.  A 
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análise da expressão das duas proteínas indicou que a calpaína 1 é mais expressa nas 
NSC, decrescendo os seus níveis de expressão durante a diferenciação.  Por outro lado, os 
níveis de calpaína 2 aumentaram ao longo da diferenciação celular.  De facto, a redução 
da expressão de cada uma destas proteínas, recorrendo à tecnologia de silenciamento com 
siRNAs, resultou em efeitos radicalmente diferentes.  O silenciamento da calpaína 1 
acelerou o processo de diferenciação neural, marcado pelo aumento de expressão de 
marcadores neuronais e gliais, respectivamente β-III tubulina e GFAP.  O silenciamento 
da calpaína 2, contudo, traduziu-se numa diminuição de expressão da proteína GFAP.  
Estes resultados sugerem que a calpaína 1 poderá ter um papel na manutenção da 
proliferação das NSC, reprimindo a diferenciação, e que a calpaína 2 poderá estar mais 
envolvida na diferenciação de células da glia. 
Por fim, avaliámos o efeito dos derivados de naftoquinona, previamente descritos, 
na regulação do destino celular das NSC.  De facto, os compostos 1a e 1b apresentavam 
características promissoras, uma vez que foram sintetizados enquanto inibidores de 
proteases de cisteína, para além de que os resultados anteriores mostraram que as 
caspases e as calpaínas são potenciais moduladores do destino celular.  Experiências 
preliminares sugeriram que, mais uma vez, os compostos 1a e 1b apresentavam 
propriedades semelhantes, pelo que apenas um dos compostos foi utilizado neste estudo.  
Verificámos que o tratamento com 1a resultou numa alteração do potencial de 
diferenciação das NSC, favorecendo a gliogénese em detrimento da neurogénese.  
Contudo, a modulação da atividade de caspases e calpaínas, através da adição de 
inibidores químicos, não reproduziu este efeito, o que indica que o papel do 1a nas NSC é 
independente da modulação destas proteases.  Uma vez que as naftoquinonas são 
moléculas electrofílicas e pro-oxidantes, avaliámos também a produção de espécies 
reactivas de oxigénio (ROS) nas NSC após tratamento com 1a.  Os resultados 
demonstraram que o derivado de naftoquinona promove um aumento de ROS nestas 
células, associado a um aumento de expressão e à translocação nuclear de proteínas de 
resposta antioxidante, como Nrf2 e Sirt1.  A alteração do estado redox das NSC poderá 
ser um dos principais mecanismos pelos quais o composto 1a modula a diferenciação das 
NSC.  De facto, a adição de antioxidantes reverteu, ainda que parcialmente, a alteração no 
potencial de diferenciação das NSC induzida pelo derivado de naftoquinona, reduzindo a 
geração de ROS e a translocação nuclear das proteínas Nrf2 e Sirt1.  Assim, estes estudos 
revelaram uma nova função do derivado de naftoquinona 1a na modulação do destino 
celular das NSC, sublinhando a importância do ambiente redox neste processo. 
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Em conclusão, estes estudos contribuem para uma visão integrada dos processos 
de proliferação, diferenciação e apoptose, bem como do seu papel no destino das células, 
que poderá revelar-se útil no desenvolvimento de estratégias terapêuticas com células 
estaminais neurais. 
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 Neural stem cell (NSC) fate decision is controlled by both intrinsic and extrinsic 
factors.  Mounting evidence supports the hypothesis that apoptosis-associated factors 
modulate NSC proliferation and differentiation.  Therefore, we set to identify and 
characterize new apoptosis-associated factors regulating NSC fate decision, and to 
modulate related pathways using novel regulators of apoptosis.  
We started by evaluating the ability of synthetic naphthoquinone derivatives 
naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylates 1a and 1b to prevent cell death in 
different cellular models.  Notably, under apoptogen stimulation, both 1a and 1b 
increased cell viability, promoted up-regulation of Bcl-XL, and reduced nuclear 
fragmentation, caspase-3, -8 and -9 activation, and cytochrome c release.  These results 
indicate that 1a and 1b may act as efficient modulators of apoptotic pathways. 
We next investigated the potential NSC modulatory properties of calpains, a 
family of cysteine proteases largely associated with apoptosis.  Our results showed that 
inhibition of calpains, possibly regulated by calcium, favored NSC differentiation and 
elicited changes in cell cycle-related proteins.  We found higher calpain 1 expression in 
self-renewing NSC, while calpain 2 levels increased throughout differentiation.  Specific 
silencing of each calpain suggested that calpain 1 plays a role in repressing differentiation 
and maintaining a proliferative NSC pool, while calpain 2 may be involved in glial 
differentiation. 
Finally, we evaluated whether naphthoquinone derivatives could modulate NSC 
proliferation and differentiation potential.  Interestingly, treatment of differentiating NSC 
with 1a elicited a shift from neuronal to glial differentiation, not through modulation of 
apoptosis-associated cysteine proteases, but rather through reactive oxygen species 
production.  This was associated with activation of the antioxidant-response proteins Nrf2 
and Sirt1 and partly reduced by subsequent antioxidant treatment, suggesting that 1a 
modulates NSC fate through alteration of the intracellular redox environment. 
In conclusion, these studies contribute to an integrated view of neural 
differentiation, proliferation and apoptosis pathways in cell fate decision and may prove 
useful in the development of stem cell-based therapeutic strategies.  
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1. Apoptosis 
The term apoptosis was first used by Kerr et al. in 1972 to describe an active, 
programmed mechanism of “controlled cell deletion” (Kerr et al., 1972).  The word 
derives from the Greek, and stands for the “falling off” of petals from flowers or 
leaves from trees, an eloquent metaphor of the physiological and homeostatic nature 
of apoptosis.  Indeed, apoptosis can be seen as the complementary process to cell 
division in living organisms.  It balances cell numbers, eliminating unnecessary cells 
during embryonic development, as part of a turnover process in proliferating tissues, 
and in pathological situations, preventing malformations and cancer when activated in 
aberrant cells.  Given its importance, deregulation of apoptosis can have dramatic 
consequences (Ellis et al., 1991).  Examples in opposite sides of the spectrum include 
cellular degeneration, with excessive activation of cell death pathways, and 
uncontrolled proliferation of cancer cells, where cell death is under-activated (Lowe 
and Lin, 2000; Vila and Przedborski, 2003).  Apoptosis was initially characterized 
and distinguished from other forms of cell death by a number of morphological 
features, including rounding up and shrinkage of the cell, loss of contact to 
neighboring cells and to the extracellular matrix, plasma membrane blebbing, 
condensation of chromatin, fragmentation of the nucleus and, finally, disintegration 
into apoptotic bodies, membrane-bound vesicles containing the entire contents of the 
cell, including intact organelles (Hacker, 2000).  Although these features are still 
broadly used in the scientific community to access and classify apoptotic cell death, 
there have been a number of efforts towards switching from a morphological to a 
molecular definition of cell death modes (Kroemer et al., 2005; Galluzzi et al., 2009; 
Kroemer et al., 2009; Galluzzi et al., 2012b).	  	  
1.1. Signaling pathways 
Although apoptosis and programmed cell death are still often used as 
synonyms, the latest revision from the Nomenclature Committee on Cell Death 
(NCCD) distinguishes 13 distinct regulated cell death modes, including extrinsic 
apoptosis by death receptors, extrinsic apoptosis by dependence receptors, caspase-
dependent intrinsic apoptosis and caspase-independent intrinsic apoptosis (Galluzzi et 
al., 2012b).  
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1.1.1. Extrinsic apoptosis 
Extrinsic apoptosis is mediated by extracellular ligands that are sensed by 
specific transmembrane receptors responsible for propagating the signal 
intracellularly (Fig. 1.1A).  These include death receptors, which transduce death 
signals upon ligand binding, and dependence receptors, which induce apoptosis in the 
absence of the cognate ligand and otherwise support cell survival (Mehlen and 
Bredesen, 2011).  Extrinsic apoptosis always requires the activation of caspases, 
cysteine proteases responsible for the initiation and propagation of the death signal 
(Galluzzi et al., 2012b).  
 
 
Figure 1.1.  Intrinsic and extrinsic pathways of apoptosis.  (A) The extrinsic pathway can 
be activated upon FAS ligand (FASL) binding to FAS, which leads to the recruitment of 
FAS-associated protein with a death domain (FADD), cellular inhibitor of apoptosis proteins 
(cIAPs), c-FLIPs and pro-caspase-8 (or -10).  These form the death-inducing signaling 
complex (DISC), where caspase-8 (and -10) is activated.  Caspase-8 can directly cleave and 
activate caspase-3 (in type I cells) or activate the intrinsic pathway by cleaving the BH3-only 
protein BID (in type II cells), leading to mitochondrial outer membrane permeabilization 
(MOMP).  Alternatively, the extrinsic pathway may be activated via dependence receptors, 
which induce apoptosis in the absence of their ligand (NETRIN-1).  The deleted in colorectal 
carcinoma (DCC) mediates the assembly of a DRAL- and TUCAN-containing caspase-9 
activating platform. UNC5B, in turn, dephosphorylates and activates death-associated protein 
kinase 1 (DAPK1), which can directly cleave caspases or favor MOMP.  (B) The intrinsic 
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pathway can be activated by several intracellular stress signals, which converge at the 
mitochondria and lead to MOMP.  This leads to the release of several mitochondrial 
intermembrane space (IMS) proteins into the cytosol, including cytochrome c (CYTC), direct 
IAP-binding protein with low pI (DIABLO), high temperature requirement protein A2 
(HTRA2), apoptosis-inducing factor (AIF) and endonuclease G (ENDOG). In the cytoplasm, 
CYTC, apoptosis protease-activating factor 1 (APAF1) and dATP form the apoptosome and 
activate caspase-9, which then activates caspase-3.  DIABLO and HTRA2 sequester and/or 
degrade inhibitor of apoptosis proteins (IAPs), facilitating caspase activation.  AIF and 
ENDOG mediate caspase-independent apoptosis by mediating DNA fragmentation at the 
nucleus.  HTRA2 also contributes to caspase-independent apoptosis by cleaving several 
cellular substrates, including cytoskeletal proteins.  IM, mitochondrial inner membrane; OM, 
mitochondrial outer membrane; PTPC, permeability transition pore complex; tBID, truncated 
BID.  Adapted from Galluzzi et al. 2012b. 
 
Caspases comprise a large family of proteins that were traditionally divided 
into two main functional groups, including pro-apoptotic caspases (caspase-2, -3, -6, -
7, -8, -9 and caspase-10, which is present in humans but not in mice) and pro-
inflammatory caspases (caspase-1; caspase-4 and -5 in humans and their functional 
orthologs in mice, caspase-11 and -12) (Li and Yuan, 2008; Salvesen and Ashkenazi, 
2011).  Caspase-14 is involved in keratinocyte differentiation and plays no known 
role in apoptosis or inflammation (Denecker et al., 2008).  This classification, 
however, is becoming gradually outdated, as additional functions for each caspase are 
uncovered.  Caspases can be additionally classified according to their position in the 
signaling cascade into initiator (caspase-1, -2, -4, -5, -8, -9, -10, -11 and -12) and 
effector caspases (caspase-3, -6 and -7), which differ in prodomain length and mode 
of activation (Li and Yuan, 2008).  Initiator caspases contain protein-protein 
interaction motifs in the prodomain that are important for interaction with upstream 
adapter molecules and subsequent activation.  Effector caspases have short 
prodomains and rely on truncation for activation.  They are usually cleaved by 
initiator caspases and can then proceed to cleave multiple cellular substrates.  
Caspases typically recognize and cleave specific motifs in their substrates, including 
the P1-P1’ peptide bond of a peptide of sequence P4-P3-P2-P1-P1’, where the P1 
residue is Asp, the P1’ residue is small and uncharged, and P4-P3-P2 residues are 
complementary for interactions with the catalytic groove (Pop and Salvesen, 2009).  
The number of proteins reportedly cleaved by caspases continues to increase, with 
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almost 1000 human proteins identified, representing nearly 5% of the genome 
(Crawford and Wells, 2011). 
Upon ligand binding, death receptors at the membrane can activate caspases 
within seconds, killing the cell in the following hours (reviewed in Ashkenazi and 
Dixit, 1998; Elmore, 2007).  Death receptors belong to the tumor necrosis factor 
receptor (TNFR) gene superfamily, sharing cysteine-rich extracellular domains.  They 
contain a cytoplasmic sequence of about 80 aminoacids termed the “death domain” 
(DD), which is important for oligomerization and interaction with cytoplasmic 
adapter proteins also containing DDs.  Death receptor ligands also share common 
structures and belong to the TNF gene superfamily.  Known ligand/receptor pairs 
include the Fas ligand and its receptor (FasL/FasR), TNF-α/TNFR1, lymphotoxin-
α/TNFR1, Apo3L/DR3, Apo2L/DR4 and Apo2L/DR5.  Activation of apoptosis by 
death receptors can be illustrated with the FasL/FasR model.  Binding of FasL (also 
known as CD95L) to FasR (also known as CD95) leads to receptor oligomerization 
and binding to the DD-containing adaptor Fas-associated death domain (FADD). 
Receptor-bound FADD then binds procaspase-8 and c-FLIP through shared death 
effector domain (DED) regions, forming a functional complex named death inducing 
signaling complex (DISC) (Lavrik and Krammer, 2012).  Procaspase-8 is activated at 
the DISC into functional caspase-8 that proceeds to cleave and activate caspase-3 and 
-7.  Whereas this process is sufficient for triggering the executioner phase of the 
apoptotic program in the so-called type I cells (like lymphocytes), type II cells (like 
hepatocytes and pancreatic β cells) additionally require activation of the 
mitochondrial pathway of apoptosis.  Here, caspase-8 cleaves the pro-apoptotic Bcl-2 
family member Bid (Kantari and Walczak, 2011).  Truncated Bid (tBid) then 
translocates to the mitochondria, inducing mitochondrial outer membrane 
permeabilisation (MOMP), followed by caspase-9 activation, which in turn activates 
caspase-3 and -7, eliciting cell death.  TNF-α binding to TNFR1 followed by 
induction of apoptosis also depends on the formation of DISC, also known as 
Complex II, and caspase-8 activation.  However, depending on cell type and context, 
TNRF activation can lead to the recruitment of a different subset of proteins, namely 
TNFR1-associated death domain protein (TRADD), TNFR-associated factor 2 
(TRAF2), inhibitor of apoptosis protein (IAP) 1 (cIAP1), cIAP2 and receptor-
interacting protein 1 (RIP1), which form the Complex I and mediate cell survival 
(Cabal-Hierro and Lazo, 2012).  Membrane-bound Complex I triggers several cellular 
General	  Introduction	  
7 
pathways and leads to the activation of the transcription factors nuclear factor κB 
(NF-κB) and activator protein 1 (AP-1).  NF-κB is a generic name for Rel family 
dimeric transcription factors that are regulated via shuttling from the cytoplasm to the 
nucleus in response to cell stimulation (Karin and Lin, 2002).  At Complex I, RIP is 
polyubiquitinated and mediates the activation of inhibitor of NF-κB (IκB) kinase 
(IKK) (Cabal-Hierro and Lazo, 2012).  IκBα, which inhibits NF-κB by retaining it in 
the cytoplasm, is then phosphorylated by IKK, which promotes its proteasomal 
degradation.  Thus, following TNFR-mediated IKK activation, NF-κB is free to 
translocate to the nucleus, where it induces the transcription of antiapoptotic and 
antioxidant genes, such as cIAP1, cIAP2, cFLIP, TRAF1, TRAF2, A20, FBX10, Bcl-
XL, A1, MnSOD and ferritin heavy chain (Baldwin, 2012).  Interestingly, while 
proteolytically inactive caspases promote NF-κB activity, active caspases inhibit it by 
cleaving and inactivating IKK and by cleaving IκBα, turning it into a stable super-
repressor. 
Dependence receptors are far less studied but have already been implicated in 
diverse processes, such as development, oncogenesis, and neurodegeneration (Mehlen 
and Bredesen, 2011).  They are bifunctional, transducing survival signals through 
signaling pathways, such as the mitogen-activated protein kinase (MAPK) or the 
phosphoinositide 3-kinase (PI3K) in the presence of the cognate ligands and 
activating apoptosis or subapoptotic events in their absence.  Most dependence 
receptors interact with caspases and some can assemble a complex that activates 
caspase-9. 
Integrating these complex pathways, the NCCD established that extrinsic 
apoptosis proceeds through one of these three signaling cascades: (i) death receptor 
signaling and activation of the caspase-8 or -10/caspase-3 cascade; (ii) death receptor 
signaling and activation of the caspase-8/tBid/MOMP/caspase-9/caspase-3 pathway; 
or (iii) ligand deprivation-induced dependence receptor signaling followed by (direct 
or MOMP-dependent) activation of the caspase-9/caspase-3 cascade (Galluzzi et al., 
2012b). 
 
1.1.2. Intrinsic apoptosis 
Intrinsic apoptosis, also known as the mitochondrial pathway of apoptosis, is 
activated by a plethora of intracellular signals that converge at the mitochondria, 
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where pro- and antiapoptotic factors antagonize each other to decide cell fate.  
Intrinsic apoptosis is, by definition, mediated by MOMP and is characterized by: (i) 
generalized and irreversible mitochondrial transmembrane potential dissipation; (ii) 
release of proteins from the mitochondrial intermembrane space into the cytosol (and 
their possible relocalization to other subcellular compartments); and (iii) respiratory 
chain inhibition (Galluzzi et al., 2012b). Unlike in extrinsic apoptosis, caspase 
activation is not always a strict requirement for intrinsic apoptosis, although caspases 
accelerate the process and contribute to the typical apoptotic morphology. As caspase 
activity is required in some, but not all, instances of developmental cell death, the 
NCCD proposes to differentiate between caspase-dependent and caspase-independent 
intrinsic apoptosis (Fig. 1.1B) (Galluzzi et al., 2012b). 
Mitochondrial outer membrane integrity is controlled by members of the Bcl-2 
protein family, which can be either pro- or antiapoptotic and share Bcl-2 homology 
(BH) regions that mediate protein-protein interactions (Youle and Strasser, 2008).  
Antiapoptotic members have all four BH regions (BH1, BH2, BH3 and BH4) and 
contain transmembrane domains that mediate their insertion into the outer membranes 
of mitochondria and into the endoplasmic reticulum (ER) (Kelly and Strasser, 2011).  
These include Bcl-2, Bcl-w, Bcl-XL, Mcl-1, and A1.  Proapoptotic members, which 
may also contain transmembrane domains, include multi-domain proteins with up to 
four BH domains (Bax, Bak, Bok, Bcl-XS, Bcl-gL and Bfk), and the so-called BH3-
only proteins (Bad, Bik, Bid, Hrk, Bim, Puma, Noxa and Bmf).  While a few of the 
proapoptotic proteins are capable of directly inducing MOMP by homo-
oligomerisation into proteolipid pores within the outer mitochondrial membrane (Bax 
and Bak), most promote apoptosis indirectly by engaging other Bcl-2 family proteins 
(Youle and Strasser, 2008).  There is still much debate around these specific 
interactions and their relative contributions to MOMP, and several models have been 
proposed.  Recently, a unified model has been described, compatible with and 
incorporating components from previous models (Llambi et al., 2011).  This model 
defines two modes in which antiapoptotic proteins prevent apoptosis: by sequestering 
BH3-only direct-activator proteins (MODE 1) or the active effectors Bax and Bak 
(MODE 2).  Alternatively, MOMP can result from the opening of the permeability 
transition pore (PTP), a multiprotein complex at contact sites of the inner with the 
outer mitochondrial membrane (Brenner and Grimm, 2006). 
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As a result of MOMP, several intermembrane space proteins are released from 
the mitochondria into the cytosol.  These include proapoptotic cytochrome c (Cyt c), 
second mitochondria-derived activator of caspase / direct IAP binding protein with a 
low pI (Smac/DIABLO) and Omi stress-regulated endoprotease / high temperature 
requirement protein A2 (Omi/HtrA2), which act through caspase activation; and the 
caspase independent apoptosis-inducing factor (AIF) and endonuclease G (EndoG) 
(reviewed in Kroemer et al., 2007).  Cyt c, together with dATP and apoptosis 
protease-activating factor 1 (Apaf-1), participates in the formation of a multiprotein 
complex named apoptosome.  The apoptosome, in turn, is a platform for the 
proteolytic activation of caspase-9, which can then cleave the effector caspases and 
drive the cell death process.  Another level of regulation is provided by IAP family 
members, which promote survival signaling pathways and interfere with the 
activation of caspases (Fulda and Vucic, 2012).  Smac/DIABLO and Omi/HtrA2, in 
turn, can sequester and/or degrade IAPs, thereby facilitating caspase activation.  AIF 
and EndoG do not interact with caspases and instead translocate to the nucleus to 
promote DNA fragmentation and chromatin condensation.  Several other molecules 
are implicated in the complex network of regulation of apoptosis.  We will next 
discuss the role of calpains, another family of cysteine proteases, in this process. 
 
1.2. Calpains and their involvement in apoptosis 
A neutral proteinase corresponding to calpain was first isolated from the 
soluble fraction of rat brain and described by Guroff in 1964 (Guroff, 1964).  Since 
then, hundreds of calpains and related molecules were identified in different species, 
encompassing almost all eukaryotes and also a few prokaryotes.  Fifteen human 
calpain genes have been identified and designated CAPN1, -2-16 (except -4) 
(Sorimachi et al., 2011).  Two genes encode calpain regulatory small subunits, 
CAPNS1 and -2, while another encodes calpastatin (CAST), an endogenous specific 
inhibitor of calpain.  Calpains are cysteine proteases characterized by their 
dependence on calcium (Ca2+) and by the presence of a calpain-like protease domain 
(CysPc) (reviewed in Goll et al., 2003; Ono and Sorimachi, 2012).  They represent the 
oldest branch of the papain superfamily of cysteine proteases and can be classified 
according to their structure into classical and non-classical, and according to their 
expression profile into ubiquitous or tissue-specific. 
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Calpain 1 and calpain 2 are by far the most studied and are often referred to as 
“ubiquitous,” “conventional,” or “typical” calpains (Goll et al., 2003).  They have also 
been known as µ-calpain and m-calpain for a long time because of their requirement 
for micromolar or millimolar Ca2+ concentrations for in vitro activation.  The 
functional proteases are heterodimers composed of a large catalytic ~ 80 kDa subunit 
(CAPN1 or CAPN2) and a common small regulatory subunit (CAPNS1) of about 28 
kDa.  CAPN1 and CAPN2 are divided into four regions: an N-terminal anchor helix 
region, the CysPc protease domain, the C2 domain-like domain (C2L), and penta-EF-
hand domains (PEF(L)) (Ono and Sorimachi, 2012).  CAPNS1 contains an N-terminal 
Gly-rich (GR) domain and a penta-EF-hand domain (PEF(S)).  EF-hand motifs and 
C2 domains can bind and be regulated by Ca2+ (Yanez et al., 2012). 
Ca2+ is a highly versatile intracellular signal that controls and influences a 
wide range of cellular processes, such as energy metabolism, gene expression, 
proliferation and cell death (Laude and Simpson, 2009).  Calcium signals are 
regulated in space, time and amplitude, and cytosolic free calcium concentrations are 
generally kept low (~ 100 nM), contrasting with the 1 mM concentration found in the 
extracellular fluid.  To maintain these low concentrations, cells extrude calcium 
through pumps and exchangers at the plasma membrane or sequester it into 
intracellular organelles, the ER being the main internal store.  Ca2+ can enter the 
cytosol in response to many different stimuli through plasma membrane channels, 
including many types of voltage-operated channels, receptor-operated channels and 
second-messenger-operated channels.  It can also be released from internal stores 
through Ca2+ and second messenger-controlled channels, including Inositol-1,4,5-
trisphophate receptors (IP3Rs) and ryanodine receptors  (Berridge et al., 2003).  This 
allows the generation of controlled calcium signals that can be variable in amplitude, 
frequency and duration, and restricted to small microdomains or global across the cell 
(Laude and Simpson, 2009). 
As the available intracellular Ca2+ concentrations are much lower that those 
required for calpain activation in vitro, there must be other mechanisms apart from 
Ca2+ binding alone that contribute to calpain activation.  Indeed, calcium requirements 
can be reduced by several mechanisms, including interaction with membrane 
phospholipids and autolysis of the calpain protein (Storr et al., 2011).  
Phosphorylation of different calpain residues by protein kinase Cι (Xu and Deng, 
2006), MAPK (Zadran et al., 2010b) and protein kinase A (Shiraha et al., 2002) has 
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also been reported, leading either to calpain activation or to a reduction of its activity.  
In addition, calpain activity is regulated by the specific endogenous inhibitor 
calpastatin, an intrinsically unstructured protein which is capable of reversibly 
binding and inhibiting four molecules of Ca2+-bound calpain (Hanna et al., 2008).  
After activation, calpains cleave proteins at a limited number of sites and produce 
large, often catalytically active polypeptide fragments, indicating that calpains play 
regulatory or signaling, rather than digestive, functions in the cell (Goll et al., 2003).  
Interestingly, unlike caspases, calpain subsite specificity does not seem to depend on 
specific amino acid sequences, but rather on the conformation of the polypeptide 
chain. 
There are many known calpain functions, including remodeling of cytoskeletal 
attachments to the plasma membrane, with implications for cell fusion and motility, 
control of cell cycle progression, proteolytic modification of molecules involved in 
signal transduction pathways, regulation of gene expression, involvement in long-
term potentiation and substrate degradation in apoptotic pathways (Goll et al., 2003).  
Consequently, deregulation of calpain activity has been implicated in several 
pathologic conditions, the so-called calpainopathies, including type 2 diabetes, 
cataracts, Duchenne’s muscular dystrophy, limb-girdle muscular dystrophy type 2A, 
Parkinson’s disease, Alzheimer’s disease, rheumatoid arthritis, ischemia, stroke and 
brain trauma, various platelet syndromes, hypertension, liver dysfunction, and some 
types of cancer (Zatz and Starling, 2005). 
Curiously, depending on cellular context, the nature of apoptotic stimuli and 
the level of protein expression and localization, calpains can participate in either pro-
survival or pro-apoptotic pathways (Fig. 1.2) (Storr et al., 2011).  As pro-survivors, 
calpains have been shown to cleave wild-type p53 (Kubbutat and Vousden, 1997), 
preventing it from inducing apoptosis; activate NF-кB by cleaving its inhibitor IкBα 
(Scholzke et al., 2003); interfere with the interaction between protein phosphatase 2A 
(PP2A) and AKT to prevent forkhead box O (FOXO)-mediated cell death (Bertoli et 
al., 2009); and cleave caspase-9, rendering it inactive and unable to activate caspase-3 
through the apoptosome (Chua et al., 2000).  On the other hand, calpains have been 
shown to promote the activation of p53 after DNA damage, promoting neuronal death 
(Sedarous et al., 2003).  They can additionally activate other substrates involved in 
apoptosis promotion, including Cdk5, Apaf-1, Jun, c-Jun N-terminal kinase (JNK), 
Fos and calcineurin inhibitor (cain) (Storr et al., 2011).   
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Figure 1.2. Calpain signaling pathways in survival and apoptosis.  Calpain activity can 
mediate both pro-survival and apoptotic pathways.  (A) In pro-survival signaling, calpains 
lead to p53 stabilization and nuclear factor-κB (NF-κB) activation through degradation of 
inhibitors of NF-κB (IκB).  They can also modulate forkhead box O (FOXO) transcription 
factor activity through protein phosphatase 2A (PP2A) and drive cell cycle progression by 
modulating cell cycle proteins such as cyclin E and p27KIP1.  Following endoplasmic 
reticulum (ER) stress, calpains can cleave caspase-12, eliciting apoptosis.  (B) Calpains can 
mediate both intrinsic and extrinsic pathways of apoptosis by cleaving several proteins, which 
can either lead to their activation or inactivation.  AIF, apoptosis-inducing factor; Cyto c, 
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cytochrome c; IKK, IκB kinase; PIP2, phosphatidylinositol-4,5-bisphosphate; PIP3, 
phosphatidylinositol-3,4,5-trisphosphate. Adapted from Storr et al. 2011. 
 
Interestingly, calpains have been shown to cleave and activate caspases as 
well. Calpain-induced cleavage of caspase-7 originates two products more reactive 
than those originated following caspase-3 mediated cleavage (Gafni et al., 2009). ER-
localized caspase-12 is also cleaved by calpains, resulting in cell death (Nakagawa 
and Yuan, 2000).  Caspases, on the other hand, can also activate calpains in a positive 
feedback loop through cleavage of their inhibitor, calpastatin (Wang et al., 1998).  
Calpains can additionally promote apoptosis through cleavage of Bcl-2 family 
proteins.  Cleavage of the antiapoptotic Bfl-1 and Bcl-XL turns them into proapoptotic 
factors (Nakagawa and Yuan, 2000; Valero et al., 2012), while calpain-induced 
cleavage of Bax turns it into a more potent inducer of apoptosis (Toyota et al., 2003). 
Interestingly, it has been shown that following DNA damage, poly(ADP-ribose) 
polymerase 1 (PARP1) activates mitochondrial calpains by inducing alterations in 
mitochondrial Ca2+ homeostasis (Vosler et al., 2009).  Activated calpains can induce 
caspase-independent apoptosis, as they cleave and release AIF from the mitochondria 
following MOMP, by decreasing its association with lipids (Polster et al., 2005). 
 
1.3.  Reactive oxygen species and their role in apoptosis 
Oxygen is paradoxically necessary for aerobic life and toxic to all life forms 
through the production of reactive oxygen species (ROS) (Mates et al., 2012).  Due to 
high chemical reactivity, ROS can lead to lipid peroxidation, massive protein 
oxidation and degradation and DNA sequence changes, including mutations, 
deletions, gene amplification and rearrangements (Mates et al., 2012).  ROS may be 
generated endogenously as products of normal metabolism or following xenobiotic 
exposure.  Intracellular sources include proteins at the plasma membrane, lipid 
metabolism within peroxisomes, several cytosolic enzymes and, most importantly, 
mitochondria (Balaban et al., 2005).  Indeed, mitochondria generate ~ 90% of cellular 
ROS as a consequence of oxidative phosphorylation.  It is estimated that ~ 0.2% of 
the oxygen consumed by mitochondria leads to ROS generation, mainly at sites I and 
III of the respiratory chain (Balaban et al., 2005). 
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Although ROS have been considered as harmful agents that cause oxidative 
damage in pathologies and aging, the current notion is that ROS integrate complex 
signaling pathways and play several important biological roles as second messengers 
(Murphy et al., 2011; Finkel, 2012).  The benefits of antioxidants have become 
popular knowledge, probably following Harman’s Free Radical Theory of Aging, 
which proposes that aging results from a decline of cellular functions due to an 
accumulation of cellular damages caused by metabolism-resultant ROS (Harman, 
1956).  However, current evidence defies this model, as several longevity-promoting 
interventions depend on increased levels of ROS, which exert signaling functions to 
increase stress resistance and longevity, and are impaired by antioxidant supplements 
(Ristow and Schmeisser, 2011).  Taken together, control of redox state appears to be 
an important requirement for cell homeostasis.  In this regard, oxidative stress only 
occurs when ROS overwhelm the cellular antioxidant defense system (Ray et al., 
2012).  It has been proposed that ROS-releasing organelles may function as stress 
sensors, where the intensity and duration of ROS release dictates the cellular outcome 
in response to the quality and severity of the perceived stress (Finkel, 2012).  In this 
perspective, low intensity ROS release would control metabolic adaptation, as 
happens under excess nutrient or low oxygen conditions, moderate ROS intensity 
following danger signals might regulate inflammation, and increased ROS levels 
would activate cell death inducing pathways, such as apoptotic and autophagic cell 
death (Fig. 1.3). 
 
 
Figure 1.3.  Different ROS levels elicit variable cellular outcomes.  Low levels of 
intracellular reactive oxygen species (ROS) are required for normal cellular processes, such 
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as proliferation and differentiation.  Higher levels induce adaptive programs and lead to the 
upregulation of antioxidant genes.  At even higher levels, senescence and apoptosis may be 
activated. ROS also irreversibly damage cellular components independently of their signaling 
properties, but only when at high levels. Adapted from Hamanaka and Chandel, 2010. 
 
ROS interact with proteins through oxidation of cysteine (Cys) residues, 
which contain highly sensitive thiol (−SH) moieties in their side chains (Miki and 
Funato, 2012).  The thiol is oxidized to sulfenyl (−SOH), which in turn can form 
disulfide bonds with another thiol.  Although, these reactions are reversible by various 
cellular antioxidants, the sulfenyl can be further oxidized into sulfinyl (−SO2H) and 
sulfonyl (−SO3H), highly peroxidized moieties that cannot be reduced under normal 
intracellular conditions.  Cellular antioxidants or free radical scavengers include 
superoxide dismutase (SOD), catalase, glutathione peroxidase (GPX), thioredoxin 
(Trx) reductase, nitric oxide synthase (NOS), heme oxygenase-1 (HO1), eosinophil 
peroxidase (EPO) and metallothionein; and also non-enzymatic antioxidants, such as 
vitamins C, E and A, β-carotene, polyamines, melatonin, nicotinamide adenine 
dinucleotide phosphate (NADPH), adenosine, urate, coenzyme Q-10, polyphenols, 
flavonoids, phytoestrogens, glutathione (GSH), cysteine, homocysteine, taurine, 
methionine, S-adenosyl-L-methionine, nitroxides and selenium (Mates, 2000).  
Several redox systems participate in cell signaling and modulation of cell 
function.  These include the GSH, Trx and pyridine nucleotide redox systems (Circu 
and Aw, 2010).  Pyridine nucleotides are present in the cell as oxidized and reduced 
nicotinamide adenine dinucleotides in their unphosphorylated (NAD+ and NADH) 
and phosphorylated (NADP+ and NADPH) forms (Nakamura et al., 2012).  The 
reduced forms not only serve as electron donors to produce ATP but also regulate the 
cellular redox status by reducing oxidized GSH or Trx.  Among their functions in 
energy production, regulation of metabolism and maintenance of the cellular redox 
status, pyridine nucleotides regulate sirtuins.  In fact, proteins of the sirtuin family, 
comprising Sirt1-7 in mammals, use NAD+ as a cofactor and therefore function as 
sensors of the cellular energy levels and redox status.  Sirtuins, which are best known 
for their roles in metabolism and lifespan/healthspan extension, act in different 
cellular compartments, from the cytosol, to the nucleus or the mitochondria, where 
they deacetylate proteins, including histones and transcriptional regulators 
(Houtkooper et al., 2012).  p53 was the first described non-histone target for Sirt1, 
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which, after DNA damage or oxidative stress, deacetylates and represses p53, 
preventing it from inducing apoptosis.  Sirt3, majorly found at the mitochondria, 
protects cells from oxidative stress by activating SOD2 and by deacetylating isocitrate 
dehydrogenase 2 (IDH2) (Someya et al., 2010).  
At the transcriptional level, a battery of antioxidant genes is under the 
regulation of an enhancer named antioxidant responsive element (ARE), allowing a 
quick cellular response to oxidative conditions.  These genes include glutathione S-
transferase, NADPH quinone oxidoreductase-1, HO1 and ferritin H (Ray et al., 2012).  
ARE activation under oxidative stress conditions primarily involves nuclear factor 
E2-related factor 2 (Nrf2), a member of bZIP transcription factors that is expressed in 
a variety of tissues (Kang et al., 2005).  Under basal conditions, Nrf2 is sequestered in 
the cytoplasm by its inhibitor, Kelch-like ECH-associated protein-1 (Keap1), which 
binds actin (Baird and Dinkova-Kostova, 2011).  Nrf2 is continuously ubiquitinated 
and degraded at the proteasome through interaction with the cullin-3 E3-ubiquitin 
ligase (Cul3) mediated by Keap1.  Keap1 contains reactive Cys that function as redox 
sensors and mediate its dissociation from Nrf2 upon oxidation by ROS.  Therefore, in 
oxidative conditions, Nrf2 is stabilized and translocates to the nucleus, where it 
dimerizes with members of the small Maf family and binds ARE, activating 
transcription of cytoprotective genes. 
When ROS levels are too elevated for the cell to cope with, apoptosis may be 
activated.  Apoptosis signal-regulated kinase 1 (ASK1) participates in MAPK 
cascades, activating the JNK and p38 pathways and leading to apoptosis (Ray et al., 
2012).  Reduced Trx, in turn, binds and inhibits ASK1.  However, when Trx is 
oxidized by ROS, it releases ASK1, allowing its oligomerization, 
autophosphorylation and subsequent activation.  In addition to this mechanism, ROS 
may also induce sustained activation of these signaling pathways through inhibition of 
protein tyrosine phosphatases by reversible oxidation of their catalytic-site Cys (Miki 
and Funato, 2012). For example, following TNF-α stimulation, ROS are actively 
generated and oxidize MAPK phosphatases, which negatively regulate JNK (Kamata 
et al., 2005).  Activation of Fas also leads to ROS generation, which mediate 
ubiquitination and proteasomal degradation of the antiapoptotic FLIP, thereby 
inducing apoptosis (Wang et al., 2008b).  ROS have also been shown to directly 
induce the extrinsic pathway of apoptosis by promoting death receptor clustering and 
formation of lipid-raft derived signaling platforms (Circu and Aw, 2010). 
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Apoptosis induction by several agents has been associated with ROS 
production, loss of mitochondrial membrane polarization and subsequent changes in 
permeability leading to Cyt c release (Ryter et al., 2007).  Indeed, ROS have a well-
established role in oxidizing components of the PTP, namely voltage-dependent anion 
channel (VDAC), adenine nucleotide translocase (ANT) and cyclophilin D, hence 
impacting mitochondrial anion fluxes (Circu and Aw, 2010).  In addition, it has been 
shown that Cyt c-catalyzed oxidation of cardiolipin, a mitochondria-specific 
phospholipid, is essential for MOMP and for the subsequent release of pro-apoptotic 
factors into the cytosol (Kagan et al., 2005).  Loss of Cyt c, in turn, leads to a further 
ROS increase due to disruption of the electron transport chain, thus amplifying the 
apoptotic cascade (Chen and Lesnefsky, 2006).  In addition, it has been suggested that 
the redox status of Cyt c may influence apoptosis, as only the oxidized form of the 
protein can induce caspase activation via the apoptosome (Brown and Borutaite, 
2008).  Another feed-forward loop happens at the level of mitochondrial DNA 
(mtDNA) stability.  Since mtDNA encodes 13 polypeptides of the respiratory chain, 
mtDNA damage may compromise the integrity of the respiratory chain, leading to 
further ROS generation and ultimately triggering apoptosis (Circu and Aw, 2010).   
Caspases are also prone to oxidation of their catalytic site Cys.  Accordingly, 
oxidation-mediated inactivation of caspase-3, -8 and -9 has already been reported 
(Borutaite and Brown, 2001; Barbouti et al., 2007).  On the other hand, it has been 
demonstrated that oxidative modifications of caspase-9 by ROS promote intra-
mitochondrial autoprocessing of caspase-9 (Katoh et al., 2004) and its interaction with 
Apaf-1 through disulfide formation, facilitating apoptosome formation and caspase-9 
activation (Zuo et al., 2009).   
ROS have additionally been shown to induce apoptosis by upregulating 
proapoptotic and downregulating antiapoptotic Bcl-2 family protein levels, mediating 
their levels of phosphorylation and ubiquitination (Li et al., 2004).  There are many 
other examples of ROS interplay with apoptotic pathways.  It is interesting to note 
that ROS do not seem to lead to cell demise by modifying and destroying cellular 
components at random, as initially assumed, but rather through specific targeting and 
modulation of key components of several regulatory pathways. 
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1.4. Modulation of apoptosis by naphthoquinones 
Quinones are bioactive compounds that comprise conjugated carbonyl groups 
in six-membered rings (Kumagai et al., 2012).  They are highly reactive molecules 
and have been assigned inflammatory, anti-inflammatory, and anticancer properties, 
among others.  Quinones interact with biological systems through two reactions: as 
electron transfer agents, promoting the reduction of oxygen to ROS; and as 
electrophiles, forming covalent bonds with nucleophilic groups in biological 
molecules, such as the thiol groups in Cys residues (Fig. 1.4).  Naphthoquinones are a 
subclass of quinones that are widespread in nature, occurring naturally in plants, fungi 
and bacteria (Medentsev and Akimenko, 1998; Shearer and Newman, 2008; Huang et 
al., 2010), often used in traditional medicine.  They can also be generated in humans 
through the metabolism of naphthalene (Cho et al., 2006). 
 
 
Figure 1.4.  Quinones form covalent bonds with biological molecules and generate ROS.  
Redox cycling and alkylation, the transfer of an alkyl group to another molecule, are two 
important properties of quinones.  They promote the generation of reactive oxygen species 
(ROS) and the formation of covalent bonds with cellular nucleophiles, such as cysteine 
residues in proteins.  Adapted from Bolton et al. 2010. 
 
Naphthoquinones have been shown to modulate several signaling pathways, 
eliciting different cellular outcomes.  The ability of naphthoquinone derivatives to 
modulate apoptosis and proliferation has been extensively described, mostly focusing 
on their anticancer properties (Kumagai et al., 2012).  Although most studies only 
report the general cellular effects of these compounds, such as induction of apoptosis, 
inhibition of proliferation and protection from toxic agents, some of them provide 
additional insight into the specific mechanisms through which these outcomes are 
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achieved.  Several naphthoquinone derivatives have been shown to suppress NF-κB 
survival signaling, possibly through modification of Cys residues of IKK and IκB, 
potentiating apoptosis (Choi et al., 2003; Sandur et al., 2006; Cheng et al., 2009; 
Harikumar et al., 2009; Andujar et al., 2010).  Others, as β-lapachone, have been 
shown to induce E2F1 in cancer cells, activating the S-phase-checkpoint and inducing 
apoptosis (Li et al., 2003b).  The naphthoquinone derivative plumbagin was also 
shown to lead to cancer cell apoptosis, partly through ROS mediated ASK1 and JNK 
activation (Wang et al., 2008a), and also through induction of the protein tyrosine 
phosphatase SHP-1, which leads to inhibition of the pro-survival signal transducer 
and activator of transcription 3 (Stat3) pathway (Sandur et al., 2010).  On the other 
hand, there are also examples of naphthoquinone-mediated inhibition of apoptosis.  In 
fact, sub-toxic doses of plumbagin protect neurons from oxidative and metabolic 
insults through activation of Nrf2 and induction of the expression of Nrf2/ARE 
dependent genes, such as HO1 and Trx (Sandur et al., 2010; Son et al., 2010).  The 
same pathway is activated by 1,4-naphthoquinone, which can protect lymphocytes 
against radiation-induced apoptosis, even when added to cells post-irradiation (Khan 
et al., 2011).  In addition, it has been shown that 1,4-naphthoquinone is capable of 
inactivating caspase-3 and its Caenorhabditis elegans equivalent, CED-3, by 
oxidizing the active site Cys residue, thus inhibiting apoptosis (Kokel et al., 2006).  In 
light of this controversial evidence, one can expect the overall effects of a specific 
naphthoquinone to depend on its particular chemical characteristics, cellular 
availability and overall context. 
 
2. Neural Stem Cells 
Stem cells are uncommitted cells that have the ability to proliferate and self 
renew, and give rise to differentiated progeny.  These cells became prominent because 
of their unique potential for regenerative medicine, ever since the first successful 
transplantation of hematopoietic stem cells into patients receiving radiation and 
chemotherapy in the 1950’s (Thomas et al., 1957).  Stem cells can be found in 
different tissues, both in the embryo and adult organisms, and may also differ in their 
differentiation potential.  According to their plasticity, stem cells can be defined as 
totipotent, when they give rise to all cells types of an organism, including 
extraembryonary tissues; pluripotent, when they are able to differentiate into cells of 
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the three germ layers (ectoderm, mesoderm and endoderm); and multipotent, when 
they only originate different cell types of a particular lineage. 
Given the expansion of the stem cell field and the difficulty to extensively 
characterize cell populations, there has been some controversy regarding the proper 
ways to define these cells (Tajbakhsh, 2009).  In this regard, the broader term 
“progenitor” is often used when there is doubt about a cell’s true nature.  Unlike stem 
cells, which have a seemingly unlimited self-renewal capacity and can generate 
multiple mature cells types, progenitors are proliferative cells with a limited self-
renewal capacity and a more restricted differentiation potential, often being unipotent 
(Seaberg and van der Kooy, 2003). 
Neural stem cells (NSC) are multipotent cells that have the ability to 
differentiate into the three major cell types of the mammalian central nervous system 
including neurons, astrocytes and oligodendrocytes (Reynolds and Weiss, 1996).  
NSC have been isolated from many regions of embryonic and adult nervous systems, 
where neurogenesis has been shown to occur (Fig. 2.1) (Gage, 2000; Alvarez-Buylla 
and Garcia-Verdugo, 2002; Christie and Cameron, 2006; Pignatelli and Belluzzi, 
2010).  However, the true nature of these cells still remains a question of debate, as it 
is argued that in vitro culturing and other extrinsic interventions may alter their 
properties (Conti and Cattaneo, 2010).  Indeed, regional and temporal specificity is an 
intrinsic property of stem cells, which do not self-renew indefinitely in normal 
conditions in the body, making some authors argue that truly pluripotent NSC do not 
exist in vivo (Grabel, 2012).  Further studies on the ontogeny of NCS are needed to 
clarify these issues and allow progression in the field (Tropepe and Turksen, 2012).  
 
 
Figure 2.1.  Developmental stages and corresponding in vitro NSC populations.  
Depicted are different stem, progenitor and neural stem cell (NSC) populations that can be 
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obtained in vitro according with their in vivo developmental stages.  ESCs, embryonic stem 
cells; NEPs, neuroepithelial progenitors; R-NSCs, rosette-type NEPs; It-hESNSC, human 
ESC-derived NSC; RG, radial glia. Adapted from Conti and Cattaneo, 2010 
 
2.1. NSC in the developing CNS 
During gastrulation, the three primary germ layers are formed: ectoderm, 
mesoderm and endoderm.  The outer ectoderm is then subdivided into neural and non-
neural ectoderm (Stern, 2005). In mice, at embryonic day 7.5 (E7.5), the 
neuroectoderm forms the neural plate, which is composed by a layer of 
neuroepithelial (NE) cells expressing neural specific markers such as members of the 
Sox gene family (Mizuseki et al., 1998; Conti and Cattaneo, 2010).  The 
neuroepithelium is pseudostratified because NE cells display interkinetic nuclear 
migration.  During this process, nuclei migrate up and down the apical-basal axis 
throughout the cell cycle, which results in a layered look (Del Bene, 2011).  NE cells 
contact both apical (ventricular) and basal (pial) surfaces and are highly polarized 
along their apical-basal axis, which is illustrated by the different distribution of 
transmembrane proteins in their plasma membrane (Gotz and Huttner, 2005).  These 
cells are considered the first NSC, as their progeny can originate both neurons and 
glia.  The time and location of their birth within the central nervous system (CNS) 
influences the number of divisions that NE cells undergo and the type of neural cells 
that they originate (Qian et al., 2000; Falk and Sommer, 2009; Okano and Temple, 
2009).  Indeed, NSC alter their properties over time, exhibiting a distinct order of cell 
type production; neuronal cells first, and glial cells latter. 
NSC and progenitor cells can divide symmetrically, generating two daughter 
cells with the same fate, or asymmetrically, generating two different cells in which 
one can be identical to the mother cell.  Depending on the types of cells generated, 
these divisions can either be proliferative or differentiative.  In an initial phase, 
neuroepithelial cells undergo symmetric proliferative divisions at the ventricular 
surface.  They subsequently switch to asymmetric divisions, generating more 
neuroepithelial cells and other progenitors.  These include basal progenitors, which 
upon division generate two neurons (Haubensak et al., 2004).  At the onset of 
neurogenesis, around E9-10 in mice, NE cells begin to acquire glial features and give 
rise to another type of NSC, the radial glia (RG), which along with a subpopulation of 
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adult astrocytes are the founder cells for most neurogenic lineages in the CNS 
(Kriegstein and Alvarez-Buylla, 2009).  The differentiation potential of RG is more 
restricted when compared with NE cells, and although some subsets of RG are 
tripotent, the majority seem to be bipotent or unipotent (Conti and Cattaneo, 2010).  
The name of RG was attributed due to several characteristics shared with astrocytes, 
including the presence of glycogen granules (Choi and Lapham, 1978) and the 
expression of glial fibrillary acidic protein (GFAP) (Choi and Lapham, 1978; Levitt 
and Rakic, 1980), astrocyte-specific glutamate transporter (GLAST) (Shibata et al., 
1997) and brain lipid binding protein (BLBP) (Feng et al., 1994).  Before their NSC 
nature was discovered, RG were most known for supporting radial migration of 
newborn neurons from the ventricular zone to the mantle regions, guiding them 
through their long radial processes (Campbell and Gotz, 2002).  RG divide 
asymmetrically to generate post-mitotic neurons, glial cells, more RG or intermediate 
progenitors.  The latter can divide symmetrically before differentiating into the 
neuronal or glial lineage, according to their restrictions (Haubensak et al., 2004; 
Miyata et al., 2004; Noctor et al., 2004).  While in many species RG persist into 
adulthood, in the mammalian brain they disappear soon after birth, giving rise to the 
adult astrocyte-like NSC (Merkle and Alvarez-Buylla, 2006). 
 
2.2. Adult NSC 
The long held idea that no new neurons were generated in the adult brain was 
first questioned by Altman and Das, who observed hippocampal neurogenesis in rats 
injected with thymidine-H3 (Altman and Das, 1965).  Although technical difficulties 
prevented further advances (Bergstrom and Forsberg-Nilsson, 2012), differentiation 
of adult brain cells into neurons and astrocytes was again demonstrated in the 90’s 
(Reynolds and Weiss, 1992; Richards et al., 1992), infusing the NSC field with a new 
breath.  Since then, many efforts have been undertaken to understand the nature of the 
adult neural progenitor cells and the mechanisms involved in their differentiation, as 
they could prove to be invaluable therapeutic tools. 
In the adult brain, the two main niches of neurogenesis are the subventricular 
zone (SVZ) of the lateral wall of the lateral ventricles, and the subgranular zone 
(SGZ) of the dentate gyrus of the hippocampus (Corotto et al., 1993; Luskin, 1993; 
Seki and Arai, 1993), although it may also occur in other parts of the brain (Rietze et 
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al., 2000; Bernier et al., 2002; Kokoeva et al., 2005).  Far from a merely restorative 
process, adult neurogenesis is an important part of the mechanisms conferring brain 
plasticity, along with molecular, synaptic or morphological alterations in individual 
cells, allowing the brain to make changes in its own functional circuitry in response to 
internal cues or environmental challenges (Lledo et al., 2006). 
In the SVZ, the NSC pool is larger than in the SGZ (Yao et al., 2012), and three 
types of progenitors can be found: type A, B and C cells.  Type B cells, also known as 
B1 cells, proliferate slowly and represent the NSC population.  They are thought to be 
derived from embryonic RG, retaining glial properties such as GFAP and GLAST 
expression (Alvarez-Buylla et al., 2001; Merkle et al., 2004).  Upon induction, type B 
cells generate type C cells, which are rapidly dividing, transit-amplifying progenitors 
(Mu et al., 2010).  Type C cells can give rise to type A cells, neuroblasts that migrate 
into to olfactory bulb through the rostral migratory stream, where they differentiate 
into several types of neurons, depending on their place of origin within the SVZ 
(Merkle et al., 2007). In addition, SVZ progenitors can also generate astrocytes and 
oligodendrocytes that migrate into the corpus callosum, septum, striatum, and fimbria 
fornix (Marshall and Goldman, 2002; Menn et al., 2006; Gonzalez-Perez et al., 2009). 
The resident NSC of the SGZ of the dentate gyrus of the hippocampus are radial 
astrocytes, also known as radial glia-like cells or type 1 progenitors.  They are 
characterized by the expression of nestin, GFAP, and Sox2, and generate non-radial 
intermediate progenitors termed type 2 or type D cells, which actively self-amplify 
and also express nestin and Sox2, but not GFAP (Fukuda et al., 2003; Garcia et al., 
2004; Suh et al., 2007; Yao et al., 2012).  Mature type 2 cells can differentiate into 
neuroblasts, which migrate into the nearby granule layer and differentiate into 
glutamatergic neurons.  Approximately half of these cells survive and integrate the 
pre-existing neuronal circuits (Markakis and Gage, 1999; van Praag et al., 2002; Toni 
et al., 2007).  Recently, type 1 cells from the DG were shown to be indeed multipotent 
NSC, as they are capable of undergoing self-renewing symmetric and asymmetric 
divisions and can differentiate into both neurons and astrocytes (Bonaguidi et al., 
2011). 
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2.3. In vitro culturing of NSC 
For the last 20 years, several protocols for the derivation, expansion and 
differentiation of NSC and neural progenitors have been described (Kokovay et al., 
2008).  The first studies on NSC identity revealed that, in the presence of mitogens 
such as epidermal growth factor (EGF) and fibroblast growth factor (FGF), 
multipotent NSC dissociated from adult brain and spinal cord could be propagated in 
culture as neurospheres, free-floating spheroid aggregates of tightly clustered cells 
that are clonally derived from a single cell (Reynolds and Weiss, 1992; Reynolds and 
Weiss, 1996).  Due to their three-dimensional structure, neurospheres are highly 
heterogeneous, consisting of a mixed population of progenitors, differentiated cells 
and a low proportion of NSC (Conti and Cattaneo, 2010).  As a result, neurosphere 
cultures are not particularly efficient in the generation of neurons.  As an alternative, 
adherent monolayer culturing systems have been developed in the last years (Conti et 
al., 2005).  These models present several advantages in comparison with 
neurospheres, including high purity and a higher neurogenic potential (Fig. 2.2) 
(Conti and Cattaneo, 2010). 
 
Figure 2.2.  Comparison of neurosphere and monolayer culture systems.  Both 
neurospheres and monolayer neural stem cell (NSC) lines can be derived from fetal and adult 
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brains and display multipotency, generating neurons, astrocytes and oligodendrocytes under 
appropriate culturing conditions.  Neurospheres are composed of different cell populations, 
including NSC, progenitors and differentiated cells, while monolayer NSC cultures are highly 
homogeneous.  This property of monolayer NSC lines results in higher reproducibility of 
differentiation protocols and in a higher neurogenic potential, when compared to 
neurospheres.  Adapted from Conti and Cattaneo, 2010. 
 
Sources of NSC for in vitro model systems include fetal and adult brain, spinal 
chord and non-neural cells as well (Reynolds and Weiss, 1992; Laywell et al., 1999; 
Louis and Reynolds, 2005; Pollard et al., 2006; Zhou and Tripathi, 2012).  Neural 
precursors have also been generated from mouse and human embryonic stem cells 
(ESC) (Ying et al., 2003; Pankratz et al., 2007).  Importantly, the generation of 
induced pluripotent stem cells (iPSC) using four factors described by Yamanaka in 
2006 opened a whole new field of possibilities in the stem cell area (Takahashi and 
Yamanaka, 2006).  iPSC are obtained by reprogramming adult somatic cells into an 
ESC state.  Much like ESC, iPSC can be converted into neural progenitors in vitro 
(Chambers et al., 2009).  However, the true novelty for NSC modeling is that the 
cellular reprogramming technology used for iPSC generation can be adapted to 
generate other cell types.  Latter, this technology was used to generate functional 
induced neuronal (iN) cells from fibroblasts and hepatocytes (Vierbuchen et al., 2010; 
Marro et al., 2011).  The disadvantage of iN cell generation, however, is their lack of 
self-renewal, resulting in a low neuronal yield.  This problem has been recently 
overcome through the generation of induced neural progenitor cells (iNPC) and 
induced NSC (iNSC) (Kim et al., 2011; Han et al., 2012; Lujan et al., 2012; Thier et 
al., 2012).  Reprogrammed cells can be useful tools for disease modeling, particularly 
in cell development-related pathologies or when tissue and cell samples are not 
readily available, as is the case of the nervous system (Marchetto and Gage, 2012).  In 
vitro neural models can hence be invaluable platforms for drug discovery and 
development of new diagnostic tools, as well as for generating desirable cells for 
clinical intervention. 
 
2.4. Cell cycle control of NSC fate 
NSC fate is intimately connected with cell cycle control, as several molecules 
involved in cell cycle progression have been shown to affect not only proliferation, 
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but also neuronal differentiation and proliferation.  In addition, other molecules 
known for their differentiation modulatory properties have latter been shown to affect 
the cell cycle (Ohnuma et al., 2001).  Indeed, tight cell cycle control is probably a 
fundamental property of NSC, as they show a major upregulation of genes involved in 
cell cycle progression and DNA synthesis, which cannot be simply explained by their 
higher rates of proliferation (Karsten et al., 2003).  Furthermore, it is generally 
accepted that, following expansion of progenitors, cell cycle exit must occur in order 
to allow differentiation (Hindley and Philpott, 2012). 
Cell cycle comprises four sequential phases: first gap phase (G1); S phase, 
where the DNA is replicated; second gap phase (G2); and mitosis (M), where the 
genetic material is divided into the two nascent cells.  Quiescent cells, which are not 
in a proliferative state and are considered out of the cell cycle, are in the G0 phase.  
The sequential nature of these processes is accomplished by the action of specific 
control mechanisms, cell cycle checkpoints, which ensure that the next phase does not 
begin until certain requirements are complete, including complete DNA synthesis and 
correct chromosome segregation for progression into the G2/M and G1 phases, 
respectively (Hartwell and Weinert, 1989).  Progression through different phases is 
mainly controlled by two sets of proteins: cyclins, whose expression oscillates 
throughout the cell cycle; and cyclin-dependent kinases (Cdk), which phosphorylate 
target proteins and drive cell cycle progression (Murray, 2004; Malumbres, 2011).  
During G1 phase, Cdk4/6-cyclin D and Cdk2-cyclin E complexes successively 
phosphorylate and inactivate the retinoblastoma protein (Rb), thereby derepressing 
critical regulatory proteins such as E2F transcription factors, responsible for the 
progression into the S phase (Lundberg and Weinberg, 1998).  Importantly, G1 
progression is additionally regulated by Cdk inhibitors (CKI), including 
p21CIP1/WAF1and p27KIP1, among others, which hinder cell cycle progression (Sherr and 
Roberts, 1995).  Cdk2-cyclin A control DNA replication and drive cells through S 
phase (Woo and Poon, 2003).  In the absence of unreplicated or damaged DNA, 
Cdk1, which binds cyclins A and B, is activated and drives G2/M progression.  
Mitotic exit, in turn, depends on Cdk1 inactivation through cyclin destruction (Nigg, 
2001).   
Interestingly, it has been shown that different neuronal fates are often 
determined during the final stage of cell cycle, depending on the integration of 
extracellular signals at specific cell cycle phases.  A good example is the 
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differentiation of cortical neurons, whose laminar fate is determined during S or G2 
phases. Here, M-phase progenitors retain their normal fate when transplanted into 
older host brains, while S-phase progenitors do not (McConnell and Kaznowski, 
1991).  Timing of cell cycle exit can also influence the relative rates of gliogenesis 
and neurogenesis.  Indeed, it has been shown that Xenopus hairy/Enhancer of split 2 
(XHes2) promotes retinal gliogenesis by repressing neurogenesis and by delaying cell 
cycle withdrawal of a subset of progenitors (Solter et al., 2006).  Another interesting 
observation is that G1 length plays a crucial role in controlling the balance between 
progenitor maintenance and neural differentiation (Salomoni and Calegari, 2010a).  
Indeed, during embryonic development, CKIs accumulate with each division of 
progenitor cells, resulting in a progressive increase in G1 length, decreased 
proliferation and increased differentiation (Fero et al., 1996; Kiyokawa et al., 1996; 
Durand et al., 1997).   
The observation that G1 length manipulation alters the balance between 
proliferative and differentiative divisions led to the formulation of the cell cycle 
length hypothesis.  This hypothesis states that longer cell cycles allow the 
accumulation of factors necessary for cell fate changes to occur (Lange et al., 2009; 
Salomoni and Calegari, 2010a).  Recently, Ali and colleagues have provided a 
mechanistic explanation for differentiation and cell cycling coordination.  They 
identified the proneural transcription factor neurogenin 2 (Ngn2) as a Cdk level 
sensor (Ali et al., 2011).  According to their model, in rapidly dividing progenitor 
cells, G1 is short and Cdks rapidly accumulate, phosphorylating Ngn2 at multiple 
sites and inhibiting its transcriptional activity.  However, when G1 phase is longer, 
Cdk activity remains low for longer periods of time, allowing unphosphorylated Ngn2 
to accumulate and drive differentiation through activation of downstream target 
genes.  These and other studies suggest that cell cycle components play major roles in 
the control of neural progenitor proliferation and differentiation, not only during 
embryonic development, but also in adulthood, where their specific contributions vary 
with cell type and age (Beukelaers et al., 2012). 
 
2.5. Apoptosis-associated factors in NSC proliferation and differentiation 
In biology there is room for few dogmas.  Indeed, while initial studies in a 
particular field may identify clear, defined functions for specific proteins and 
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pathways, a closer approach usually unravels a more complex, context-dependent 
reality.  A good example is provided by apoptosis-associated proteins and pathways.  
Although for years the activation of apoptosis regulators and executioners was 
regarded as a cellular death sentence, emerging evidence suggests that they mediate a 
wide-range of non-apoptotic processes as well, including cell cycle progression, 
differentiation, metabolism, autophagy and inflammation (Galluzzi et al., 2012a).  
Indeed, several conserved elements of apoptosis are also integral components of self-
renewal and differentiation programs, where their activity must be carefully regulated 
in order to avoid cell loss (Sola et al., 2012). 
 
2.5.1. Caspases 
Interestingly, a recent screening of the human proteome with a powerful new 
bioinformatics tool unexpectedly identified a large number of caspase-3 predicted 
substrates that are associated with development and neurogenesis (Ayyash et al., 
2012).  Indeed, apoptosis-independent caspase activity has been shown to drive 
differentiation of neural and glial progenitors and human Ntera2 (NT2) cells 
(Fernando et al., 2005; Oomman et al., 2006; Pistritto et al., 2012).  In neuronal tissue, 
non-apoptotic caspase functions include modulation of pruning, the process of 
eliminating excessive neuronal projections, including axons, dendrites and synaptic 
connections (Kuo et al., 2006); modulation of synaptic plasticity, learning and 
memory (Gulyaeva et al., 2003; Huesmann and Clayton, 2006; Li et al., 2010); 
regulation of chemotropic responses of retinal growth cones (Campbell and Holt, 
2003); and regulation of axonal projection, synaptic formation and maturation of 
olfactory sensory neurons (Ohsawa et al., 2010).  The obvious question that follows is 
how caspases are able to participate in all these processes without inducing cell death.  
Several mechanisms have been proposed, including focalized and restricted caspase 
activation and differential substrate availability (Weber and Menko, 2005; Fernando 
and Megeney, 2007; Ribeil et al., 2007).  In fact, during Drosophila neural precursor 
development, low caspase activation is required for regulation of Wingless signaling 
through Shaggy 46 cleaving, which contributes to the emergence of sensory organ 
precursor cells (Kanuka et al., 2005).  Sensory organ development, in turn, requires 
apoptotic and non-apoptotic caspase activities.  The balance between the two types of 
activity is regulated by precise temporal control of a Drosophila IAP, DIAP1 (Koto et 
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al., 2009).  Indeed, caspase activity during neural differentiation may be regulated by 
the relative levels of its activators and inhibitors.  In sympathetic neurons and rat 
pheochromocytoma (PC12) cells, levels of Apaf-1 are decreased and IAP proteins are 
more effective in differentiated, rather than in undifferentiated cells (Vyas et al., 
2004; Wright et al., 2004).  Remarkably, chicken lens epithelial cells could be 
induced to differentiate through short-term exposure to an apoptogen.  This elicited 
high expression of pro-apoptotic molecules, such as Bax and Bcl-XS, mitochondria-
mediated Cyt c release and caspase-3 activation, albeit at a far lower level than that 
associated with apoptosis, revealing that caspase activity is indeed crucial for cell fate 
decision (Weber and Menko, 2005).   
 
2.5.2. Calpains 
Developmental data also suggests a role for calpains in proliferation and 
differentiation.  Indeed, disruption of the Capn4 gene, which encodes the small 
subunit common to calpain 1 and 2, results in mouse embryonic lethality 
(Zimmerman et al., 2000).  While specific deletion of calpain 1 still produced viable, 
fertile mice, deletion of calpain 2 resulted in preimplantation embryonic lethality, 
suggesting different roles for the two proteins in development (Dutt et al., 2006).  
During Xenopus development, calpain expression is stronger between neurulation and 
growth period, with neural tube-forming cells being calpain 2-positive, which 
indicates that calpains may play a role during neural development.  A curious cross-
talk between the caspase and calpain systems in neuronal differentiation has been 
described in PC12 cells.  In this model, caspase-1 is activated following the initial 
stage of differentiation and promotes neurite outgrowth by decreasing calpastatin 
levels (Vaisid et al., 2005).  However, during early stages of PC12 neuronal 
differentiation, increased levels of calpastatin and decreased levels of calpain activity 
are observed.  In addition, further decreasing calpain activity stimulates neurite 
elongation (Oshima et al., 1989; Pinter et al., 1994; Vaisid et al., 2005).  In contrast, it 
has been reported that during differentiation of human neuroblastoma cells, 
calpastatin levels do not change while calpain 1 expression increases (Grynspan et al., 
1997).  Nevertheless, a decrease in calpain 2 levels was observed during neuronal 
differentiation of a bipotent human neuroblastoma line, while a new calpastatin 
species was detected during Schwannian differentiation (Saito et al., 1994).  The 
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discrepancies in the available data may reflect different experimental conditions and 
assaying methods, but also the action of different calpain proteins.  In addition, the 
majority of studies focus only on neuronal and not glial differentiation, probably due 
to the use of neuronal restricted models. 
Although the available literature on calpain activity in NSC is scarce, data 
from other models suggests it may be an important regulator of proliferation and 
differentiation.  In fact, calpain activity has been implicated in proliferation and 
differentiation of different cell types, including osteoblasts, chondrocytes, 
keratinocytes, adipocytes, monocytes, lens fiber cells and myoblasts (Nakamura et al., 
1992; Garach-Jehoshua et al., 1998; Patel and Lane, 1999; Grossi et al., 2008; Kook 
et al., 2008; Shimada et al., 2008; De Maria et al., 2009; Kashiwagi et al., 2010; 
Kashiwagi et al., 2011).  Calpains may regulate these processes through modulation 
of signaling pathways.  Indeed, p38 MAPK signaling disruption has been implicated 
in calpain inhibition-elicited suppression of myogenic differentiation (Kook et al., 
2008).  In addition, calpains may cleave a wide array of cellular substrates required 
for cell cycle progression and cytoplasmic remodeling.  In this respect, calpain 
mediated modulation of p27KIP1 expression regulates proliferation and differentiation 
of osteoblasts and chondrocytes (Kashiwagi et al., 2010; Kashiwagi et al., 2011).  
Furthermore, during myoblast differentiation, calpains cleave the transcription factor 
c-Myc, inactivating its transcriptional activity and converting it into Myc-nick, which 
promotes cytoskeletal rearrangements and accelerates muscle differentiation 
(Conacci-Sorrell and Eisenman, 2011).   
 
2.5.3. Bcl-2 family 
Bcl-2 family members have also been implicated in neural differentiation.  
Interestingly, Bcl-2 expression has been observed in neurogenic regions, both during 
embryonic development and in adulthood (Merry et al., 1994; Bernier and Parent, 
1998).  In addition, Bcl-XL expression increases throughout brain development, 
peaking during neurogenesis, and both Bcl-2 and Bcl-XL are expressed in post-mitotic 
neurons (Krajewska et al., 2002).  Bcl-2 is upregulated and promotes neuronal 
commitment, differentiation and neurite extension in several in vitro models, 
including human neural crest-derived tumor cells, NT2/D1 human neuronal 
precursors and PC12 cells (Sato et al., 1994; Suzuki and Tsutomi, 1998; Wang et al., 
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2001; Trouillas et al., 2008).  While some studies report that Bcl-2 increases neuronal 
differentiation by protecting differentiating cells from apoptosis (Sato et al., 1994), 
others ascribe it death-independent roles, such as activation of p38α and β-catenin 
signaling (Eom et al., 2004; Lei et al., 2012).  Bcl-XL, in turn, has been shown to 
enhance the survival and generation of dopaminergic neurons from human NSC and 
mouse ESC (Liste et al., 2004; Shim et al., 2004).  Another study has suggested that 
Bcl-XL enhances neurogenesis by increasing the proliferation of neuronal progenitors, 
while inhibiting differentiation of glial precursors (Liste et al., 2007). 
Interestingly, it has been suggested that the determination of neuronal versus 
glial lineages might be regulated by the balance of anti- and pro-apoptotic Bcl-2 
family proteins.  Indeed, while anti-apoptotic Bcl-XL is associated with neurogenesis, 
expression of the pro-apoptotic Bax peaks during the astrogenic period of mouse 
development, and modulation of its levels affects the astrocytic differentiation rate of 
embryonic cortical precursors (Chang et al., 2007).  Importantly, these results were 
not associated with Bcl-XL or Bax modulation of survival or apoptosis.  Others have 
shown that deficiency of pro-apoptotic Bim, but not Puma, accelerates neuronal 
differentiation of adult mouse hippocampus precursors (Bunk et al., 2010). 
 
2.5.4. p53 and p73 
p53, initially regarded as a tumor-suppressor, is a multi-function protein that 
regulates several cell signaling pathways and is capable of inducing cell cycle arrest, 
senescence or apoptosis in response to diverse stimuli.  In fact, in both the developing 
and mature nervous systems, p53 has been largely associated with induction of 
apoptosis in cells that do not differentiate properly or suffer injury by a variety of 
insults, including DNA damage, ischemia and excitotoxicity (Miller et al., 2000).  
However, an increasing body of evidence points to a role for p53 in neural progenitor 
proliferation and differentiation, independent of its apoptotic role (Tedeschi and Di 
Giovanni, 2009).  Indeed, although p53-deficient mice are viable, a fraction of the 
embryos exhibit defects in neural tube closure resulting in exencephaly, an 
overgrowth of neural tissue in the region of the mid-brain (Sah et al., 1995).  During 
mouse embryogenesis, p53 expression is high at early stages of neural development 
(E10.5-12.5), in proliferating neuroepithelial cells surrounding the ventricles of the 
cerebellum, the telencephalon and the mesencephalon (E16.5), and in post-mitotic 
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neuroblasts (E18.5) (Schmid et al., 1991).  Furthermore, p53 expression and activity 
were shown to mediate neural differentiation in several models, including PC12 cells, 
mouse E14-derived neurospheres and olfactory bulb progenitors (Poluha et al., 1997; 
Aranha et al., 2009; Armesilla-Diaz et al., 2009).  This appears to be accomplished 
through several mechanisms, such as p53 transcriptional regulation of wnt7b and 
tfcp2l4, involved in dendritic extension and ectodermal development, respectively 
(Brynczka et al., 2007), and p53-mediated regulation of tropomyosin-related kinase A 
(TrkA) expression, and consequent MAPK activation (Zhang et al., 2006).  In 
addition, targeting of p21 by p53 leads to cell cycle arrest, ceasing of proliferation and 
induction of differentiation (Hughes et al., 2000; Armesilla-Diaz et al., 2009).  p53 
can also promote neurogenesis through down-regulation of the Akt/p-
FOXO3A/inhibitor of differentiation 1 (Id1) pathway (Aranha et al., 2009) and 
through up-regulation and interaction with dual oxidase maturation factor 1 
(DUOXA1) (Ostrakhovitch and Semenikhin, 2011).  Interestingly, the p53-related 
protein p73, which is also involved in apoptosis regulation, has been implicated in 
neural differentiation.  Indeed, p73-deficient mice exhibit neurologic defects, 
including abnormal hippocampal development, cortical hypoplasia and 
hydrocephalus, and reduction of Sox2 and Notch expression in their NSC (Yang et 
al., 2000; Agostini et al., 2010; Talos et al., 2010).  p73 was shown to play a crucial 
role in both embryonic and adult neurogenesis, maintaining an adequate neurogenic 
pool by promoting self-renewal and proliferation and inhibiting premature senescence 
of NSC and early progenitors (Gonzalez-Cano et al., 2010; Talos et al., 2010).  In the 
adult organism, this appears to be accomplished through p73-mediated transcriptional 
regulation of Hey2, which itself promotes NSC maintenance by preventing premature 
differentiation (Fujitani et al., 2010).  However, p73 has been implicated in neural 
differentiation as well, as its levels increase after induction of differentiation in mouse 
E14.5 neurospheres (Agostini et al., 2010) and neurablastoma cells, inducing both 
morphological and biochemical markers of differentiation (De Laurenzi et al., 2000).  
Finally, both p73 and p53 are involved in oligodendrocyte precursor cell 
differentiation (Billon et al., 2004). 
The increasing evidence of roles for apoptosis-regulatory proteins and pathways 
in neural proliferation and differentiation opens exciting new research opportunities 
with potential relevance for therapeutic approaches, where an appropriate balance 
between proliferation, differentiation and survival of NSC must be achieved. 
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2.6. Modulation of neural differentiation by ROS 
ROS are often associated with oxidative stress in the CNS, having been 
implicated in degeneration and cell death in a number of disorders, including 
Parkinson’s disease, Alzheimer’s disease and schizophrenia (Alam et al., 1997; 
Markesbery, 1997; Bitanihirwe and Woo, 2011).  However, a growing body of 
evidence points to an interdependency between ROS production and signaling and 
NSC self-renewal and differentiation, both in the embryo and in adults (Fig. 2.3) 
(Vieira et al., 2011).  It has been suggested that NSC are more resistant to oxidative 
stress, based on the observation that adult SVZ-derived neurospheres have lower ROS 
levels than post-mitotic neurons due to a higher expression of antioxidant enzymes 
(Madhavan et al., 2006).  However, neurospheres are composed of a heterogeneous 
mix of different neural populations, including progenitors and differentiated cells, 
with only a fraction of the cells exhibiting NSC properties, which may lead to 
misleading interpretations (Conti and Cattaneo, 2010).  Indeed, analysis of NSC-
enriched populations of sorted primary adult SVZ cells revealed elevated ROS levels 
in these cells, when compared to the non-enriched populations (Le Belle et al., 2011).  
These differences may also arise from different proliferative states of the studied 
populations.  In fact, adult NSC are generally quiescent and, upon activation, generate 
highly proliferative intermediate progenitors, possibly with different ROS levels.  In 
line with this hypothesis, increased ROS levels have been observed and shown to be 
required for neural progenitor proliferation (Limoli et al., 2004; Le Belle et al., 2011; 
Walton et al., 2012).  This elevation of ROS in proliferative precursors may in turn 
play a part in the following neurogenic process.  Indeed, data from several models 
indicate that neuronal differentiation is accompanied by an increase in mitochondrial 
numbers and ROS production, as well as by upregulation of pathways related to 
mitochondrial function, oxygen consumption, oxidative stress and hypoxia 
(Suzukawa et al., 2000; Goldsmit et al., 2001; Tsatmali et al., 2005; Shinjyo and Kita, 
2007; Konopka et al., 2008; Moliner et al., 2008; Kennedy et al., 2010; Walton et al., 
2012).  Interestingly, hyperoxia and the resulting ROS production were sufficient to 
induce neuronal differentiation of PC12 cells (Katoh et al., 1997).  Other evidence for 
the role of ROS during neurogenesis comes from the discovery that several oxidation-
responsive genes are elevated in genetic- and exercise-induced models of hyperactive 
hippocampal neurogenesis (Walton et al., 2012).   
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Figure 2.3.  Redox status influences NSC proliferation and differentiation.  Depicted at 
the left is the adult neurogenic niche, composed of a cluster of neural progenitor cells (NPC), 
neuroblasts (N), astrocytes and microvasculature.  Lower levels of reactive oxygen species 
(ROS) are required for progenitor cell proliferation. Neural differentiation, in turn, is 
associated with an increase in ROS levels, with intermediate and higher ROS levels favoring 
neuronal and glial differentiation, respectively.  Adapted from Huang et al. 2012. 
 
ROS may also determine other aspects of neuronal differentiation.  It has been 
shown that ROS are produced early in rat cortical cultures by bipotent neuronal 
precursors, that latter differentiate into large pyramidal-like neurons or smaller 
nuclear calretinin-expressing neurons (Tsatmali et al., 2006).  In these conditions, 
antioxidant treatment did not alter the number of neurons, but rather the final ratio of 
large versus small neurons.  Proteins and pathways that have been associated with 
ROS function in NSC proliferation and differentiation include PI3K/Akt, Ras and Erk 
(Goldsmit et al., 2001; Le Belle et al., 2011). 
ROS have been shown to modulate glial differentiation as well.  Interestingly, 
it has been suggested that intracellular redox state modulates the balance between 
self-renewal and differentiation of oligodendrocyte-type-2 astrocyte progenitor cells. 
These cells become more reduced in response to proliferative signals, such as growth 
factors, and more oxidized in response to differentiation signals (Smith et al., 2000).  
More recently, it has been shown that glutamate-induced oligodendrocytic 
differentiation of rat SVZ NSC involves production of ROS, which in turn seems to 
promote maturation of oligodendrocytes and favor myelination (Cavaliere et al., 
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2012).  Other authors demonstrated that cellular redox environment also modulates 
the choice between neuronal and astroglial differentiation (Prozorovski et al., 2008).  
Specifically, under reducing conditions, the transcription factor Hes1 drives pro-
neural Mash1 expression in neural progenitors, thus favoring neurogenesis.  On the 
other hand, induction of mild oxidation activates Sirt1, which binds Hes1 and inhibits 
Mash1 transcription, leading to increased astrogenesis. 
The fact that NSC fate choice is regulated by redox dynamics opens new 
possibilities for exogenous modulation of these decisions.  Notably, the 
naphthoquinone-derivative plumbagin was recently shown to induce proliferation and 
differentiation of rat spinal chord glial progenitors (Luo et al., 2010).  Interestingly, 
the two effects were elicited by different concentrations of the naphthoquinone 
derivative.  While lower concentrations promoted astrocyte differentiation through 
Stat3 activation, higher concentrations promoted proliferation, possibly through 
plumbagin’s redox-cycling properties. 
It is clear that modulation of NSC and neural progenitor self-renewal and 
differentiation by ROS is a very complex and highly context-dependent mechanism.  
The discovery that oxidative environment regulates these processes has a huge 
importance, specially when we consider that antioxidant-treatment has been regarded 
as a promising strategy for treatment of neurodegenerative disorders associated with 
elevated levels of ROS.  Like other apoptosis-related factors, ROS too must be 
regarded as multifunctional signaling molecules that play different roles under 
different cellular contexts. 
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Objectives 
 
The studies presented in this thesis were driven by the hypothesis that 
apoptosis-associated factors and pathways modulate NSC proliferation and 
differentiation.  Based on that, we defined two broad objectives: 1) to identify and 
characterize new roles for apoptosis-associated proteins in NSC fate decision; and 2) 
to modulate both apoptotic and differentiation pathways using novel inhibitors of 
apoptosis.  First, our goal was to test novel synthetic naphthoquinone derivatives for 
their antiapoptotic potential.  Second, we aimed to investigate the potential 
involvement of calpains in the regulation of NSC proliferation and differentiation.  
Finally, we sought to bring these two areas together by evaluating whether the 
previously studied anti-apoptotic naphthoquinone derivatives could modulate NSC 
differentiation. 
The specific questions addressed in this thesis are: 
1. Can synthetic naphthoquinone derivatives modulate apoptosis and 
prevent cell death in response to toxic stimuli? 
2. Are calpain 1 and 2 involved in NSC proliferation and/or 
differentiation?  If so, how are calpains regulated in this context and 
which pathways do they modulate? 
3. Can synthetic naphthoquinone derivatives also regulate NSC 
differentiation?  What are the pathways involved? 
 
The overarching goal of the research presented in this thesis is to increase our 
understanding on the role of apoptosis-related factors in NSC fate decision and to take 
advantage of this knowledge to manipulate cell fate using novel strategies.  The 
results may have broad implications in advancing our understanding of neural 
proliferation, differentiation, and their interplay with the apoptosis machinery.  
Ultimately, our findings may prove useful in the development of stem cell-based 
therapeutic strategies. 
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3.1 Abstract 
Compounds containing a quinone moiety represent an important class of 
biologically active molecules that are widespread in nature, displaying anticancer, 
antibacterial, antimalarial, and fungicidal activities.  In the course of designing 2,3-
disubstituted-1,4-naphthoquinones derivatives as potential cysteine protease 
inhibitors, two naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylates, 1a and 1b, were 
obtained.  The antiapoptotic potential of 1a and 1b was then evaluated and compared 
to that of naphthoquinone 4.  Primary rat hepatocytes were incubated with synthesized 
naphthoquinone derivatives and then exposed to the apoptotic stimulus camptothecin.  
Our results indicate that naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylates 1a and 1b 
exerted a potent protective role in camptothecin-induced apoptosis in primary rat 
hepatocytes.  Both 1a and 1b significantly increased cell viability, while reducing 
nuclear fragmentation, caspase-3, -8 and -9 activation, and cytochrome c release 
induced by camptothecin.  In addition, 1a and 1b were shown to up-regulate Bcl-XL, 
a pro-survival member of the Bcl-2 family of proteins, which modulates the 
mitochondrial pathway of apoptosis.  Similar protective effects of quinone derivatives 
were seen in HuH-7 and PC12 cells incubated with distinct apoptotic stimuli, such as 
camptothecin, TGF-β1, or rotenone.  Our results suggest that naphtho[2,3-
d]isoxazole-4,9-dione-3-carboxylates 1a and 1b may act as potent, cytoprotective 
agents, through modulation of apoptotic pathways.  
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3.2 Introduction 
Apoptosis represents a universal and exquisitely efficient cellular suicide 
pathway essential for a variety of normal biological processes, ranging from 
embryonic development to ageing.  The “intrinsic” mitochondrial pathway and the 
“extrinsic” death receptor pathway of apoptosis act largely independently of each 
other, although there is cross-talk and integration between the two signaling 
mechanims (Hengartner, 2000; Sola et al., 2007).  In mammals, the intrinsic 
mitochondrial pathway of apoptosis is triggered by intracellular stress signals, which 
converge on mitochondria, leading to membrane permeabilization, and release of 
apoptogenic proteins to the cytosol.  Finally, the release of cytochrome c is a highly 
regulated event, with members of the Bcl-2 family of proteins playing an essential 
role in this process (Youle and Strasser, 2008). 
Quinone compounds represent an important class of biologically active 
molecules that are widespread in nature.  They display anticancer, antibacterial, 
antimalarial and fungicidal activities (Dewick, 2002).  In particular, the anticancer 
activity of quinones has received increased attention as a result of quinone interaction 
with targets that are overexpressed in various human malignancies, including protein 
phosphatases Cdc25A and Cdc25B (Kar et al., 2003; Ham et al., 2004; Brisson et al., 
2005) and the two-electron reductase NQO1 (also known as DT-diaphorase) (Tudor et 
al., 2003).  Interaction with these targets might involve alkylation of cysteine residues 
by Michael addition of the cysteine thiolate to the quinone system (Li et al., 2005; 
Santos and Moreira, 2007), or alternatively, redox cycling, generating reactive oxygen 
species that can lead to oxidation of the catalytic cysteine to sulfonic acid (O'Brien, 
1991; Brisson et al., 2005).  Quinones have also been reported as inducers of 
apoptosis, by increasing the expression of caspase-8 and -3, decreasing the expression 
of Bcl-2 and lowering the mitochondrial transmembrane potential (Calviello et al., 
2003; Li et al., 2007).  In contrast, only few quinones have been reported to have the 
potential to inhibit apoptosis.  For example, 1,4-benzoquinone is known to suppress 
apoptosis by inactivation of executioner	  caspase-3 (Kokel and Xue, 2006).  Similarly, 
several naphthoquinones were also shown to be good inhibitors of caspase-3 
(Graczyk, 1999). 
Here, we evaluated the potential of synthesized naphtho[2,3-d]isoxazole-4,9-
dione-3-carboxylates 1a and 1b to modulate apoptosis, and compared it to that of 
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simple naphthoquinone 4.  Our results indicate that 1a and 1b, but not 4, exert a 
general potent protective role against apoptotic cell death. 
 
3.3 Methods 
3.3.1 Chemical synthesis of naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylates 
1a and 1b, and naphthoquinone 4 
In the course of designing naphthoquinones as cysteine protease inhibitors 
(Valente et al., 2007), we unexpectedly obtained naphtho[2,3-d]isoxazole-4,9-dione-
3-carboxylates 1 as the major product of the reaction of 2,3-dichloro-1,4-
naphthoquinone and nitroacetate esters.  Chemical formulas of naphtho[2,3-
d]isoxazole-4,9-dione-3-carboxylates 1a and 1b and naphthoquinone 4 are shown in 
Fig. 3.1.  Pure compounds were used in all experiments. 
 
 
Figure 3.1.  Chemical formula of naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylates 1a and 
1b, and naphthoquinone 4. 
 
3.3.2 Cell culture and preparation of rat primary hepatocytes 
Rat primary hepatocytes were isolated from male Sprague-Dawley rats (100–
150 g) by collagenase perfusion as described previously (Mariash et al., 1986).  In 
brief, rats were anesthetized with phenobarbital, and the livers were perfused with 
0.05% collagenase.  Hepatocyte suspensions were obtained by passing collagenase-
digested livers though 125-µm gauze and washing cells in William’s E medium 
supplemented with 26 mM sodium bicarbonate, 23 mM HEPES, 0.01 units/ml insulin, 
2mM L-glutamine, 10 nM dexamethasone, 100 units/ml penicillin, 100 units/ml 
Chapter	  3	  
44 
streptomycin (Sigma-Aldrich, St. Louis, MO), and 20% heat-inactivated fetal bovine 
serum (FBS; Invitrogen, Carlsbad, CA).  Cell viability was determined by trypan blue 
exclusion and was typically 80–85%.  After isolation, hepatocytes were resuspended 
in William’s E medium and plated on PrimariaTM tissue culture dishes (BD 
Biosciences, San Jose, CA) at either 2.5x105 cells/cm2 for protein extraction, or 5x104 
cells/cm2 for all other experiments.  The cells were maintained at 37°C in a 
humidified atmosphere of 5% CO2 for 4 h to allow attachment.  Plates were then 
washed with medium to remove dead cells and incubated in William’s E medium 
containing 10% heat-inactivated FBS.  In addition, aliquots of 1 x 105 cells/cm2 
human hepatoma HuH-7 cells were plated and maintained at 37ºC in a humidified 
atmosphere of 5% CO2 using DME (Invitrogen) supplemented with 10% FBS, 100 
U/ml penicillin, and 100 U/ml streptomycin for 24 h before treatments.  Rat 
pheochromocytoma PC12 cells were grown in RPMI-1640 medium supplemented 
with 10% heat-inactivated horse serum (Sigma-Aldrich), 5% FBS, and 1% 
penicillin/streptomycin and maintained at 37ºC in a humidified atmosphere of 5% 
CO2.  Cells were plated at 2 x 105 cells/cm2 for 24 h before treatments. 
 
3.3.3 Treatments with quinone derivatives and induction of apoptosis 
In cytoxicity assays, hepatocytes were incubated with either 0.01-500 µM of 
1a, 1b or 4 for 36 h.  In apoptosis protection assays, PC12 cells, hepatocytes or HuH-
7 cells were pretreated with quinone derivatives for 1 h and then exposed to the 
cytotoxic insult for 12, 36, and 48 h, respectively.  Hepatocytes were incubated with 
either 10 or 20 µM of camptothecin (Sigma-Aldrich), or 1 nM recombinant human 
TGF-β1 (R&D Systems Inc., Minneapolis, MN).  HuH-7 cells were also exposed to 
TGF-β1 and PC12 cells were exposed to 1 nM rotenone (Sigma-Aldrich).  In 
coincubation studies, quinone derivatives remained in the incubation medium 
throughout the experiment.  Cell viability assays were performed.  Cytosolic and total 
proteins were extracted for caspase activity assays and immunoblot analysis.  In 
parallel experiments, cells were fixed for morphological evaluation of apoptosis or 
cytochrome c immunostaining. 
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3.3.4 Cell viability assays 
Cell viability was measured by the lactate dehydrogenase (Sigma-Aldrich) 
viability assay according to the manufacturer’s instructions and by the trypan blue 
exclusion method.  Mean values were expressed as fold change from control. 
 
3.3.5 Morphologic evaluation of apoptosis 
Hoechst labeling of cells was used to detect apoptotic nuclei.  Briefly, the 
medium was gently removed to prevent detachment of cells.  Attached cells were 
fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS), pH 7.4, for 10 
min at room temperature, incubated with Hoechst dye 33258 (Sigma-Aldrich) at 5 
µg/ml in PBS for 5 min, washed with PBS, and mounted using PBS:glycerol (3:1, 
v/v).  Fluorescent nuclei were scored blindly and categorized according to the 
condensation and staining characteristics of chromatin.  Normal nuclei showed non-
condensed chromatin dispersed over the entire nucleus.  Apoptotic nuclei were 
identified by condensed chromatin, contiguous to the nuclear membrane, as well as 
nuclear fragmentation of condensed chromatin.  Five random microscopic fields per 
sample of ~ 500 nuclei were counted, and mean values were expressed as the 
percentage of apoptotic nuclei. 
 
3.3.6 Caspase activity assays 
Caspase activity was determined in cytosolic protein extracts after harvesting 
and homogenization of cells in isolation buffer containing 10 mM Tris-HCl buffer, 
pH 7.6, 5 mM MgCl2, 1.5mM potassium acetate, 2mM dithiothreitol, and protease 
inhibitor mixture tablets (Complete; Roche Applied Science, Indianapolis, IN). 
General caspase-3-, caspase-8-, and caspase-9-like activities were determined by 
enzymatic cleavage of chromophore p-nitroanilide (pNA) from the substrates N-
acetyl-Asp-Glu-Val-Asp-pNA (DEVD-pNA), N-acetyl-Ile-Glu-Thr-Asp-pNA (IETD-
pNA) and N-acetyl-Leu-Glu-His-Asp-pNA (LEHD-pNA) (Sigma-Aldrich), 
respectively.  The proteolytic reaction was carried out in isolation buffer containing 
50 µg of cytosolic protein extracts and 50 µM DEVD-p-nitroanilide, IETD-p-
nitroanilide or LEHD-p-nitroanilide.  The reaction mixtures were incubated at 37°C 
for 1 h, and the formation of pNA was measured at 405 nm using a 96-well plate 
reader.  In addition, caspase-3 cleavage was determined by immunoblotting. 
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3.3.7 Immunoblotting 
Levels of Bcl-XL, IkB, and caspase-3 processing were determined by Western 
blot analysis.  Briefly, 60-100 µg of total or cytosolic protein extracts were separated 
on 12% SDS-polyacrylamide electrophoresis gels.  Following electrophoretic transfer 
onto nitrocellulose membranes, immunoblots were incubated with 15% H2O2 for 15 
min at room temperature.  After being blocked with a 5% milk solution, the blots 
were incubated overnight at 4°C with primary mouse monoclonal antibodies reactive 
to caspase-3 (H-227; Santa Cruz Biotechnology, Santa Cruz, CA) or primary rabbit 
polyclonal antibodies reactive to Bcl-XS/L (L-19; Santa Cruz Biotechnology) or IkB-α 
(sc-371; Santa Cruz Biotechnology) and finally with secondary antibodies conjugated 
with horseradish peroxidase (Bio-Rad Laboratories, Hercules, CA) for 3 h at room 
temperature.  The membranes were processed for protein detection using the 
SuperSignal substrate (Thermo Fisher Scientific Inc., Waltham, MA).  β-actin (AC-
15, Sigma-Aldrich) was used as loading control.  Protein concentrations were 
determined using the Bio-Rad protein assay kit according to the manufacturer’s 
specifications. 
 
3.3.8 Immunocytochemistry 
Cytochrome c release was detected by immunostaining of cells fixed in 4% 
paraformaldehyde in PBS.  Fixed cells were incubated for 1 h with PBS containing 
0.3% Triton X-100 (PBST) and 20 mg/ml bovine serum albumin (BSA).  This was 
followed by 2 h incubation with monoclonal antibody anti-cytochrome c (BD 
Biosciences, Franklin Lakes, NJ; 1:200 in PBST containing 5 mg/ml BSA) and 1 h 
reaction with Cy2-conjugated anti-mouse secondary antibody (Jackson 
ImmunoResearch; 1:200 in PBST with 5 mg/ml BSA).  Slides were mounted with 
Fluoromount-G (Beckman Coulter, Fullerton, CA) and visualized using an Axioscop 
fluorescence microscope (Carl Zeiss, Jena, Germany). 
 
3.3.9 Densitometry and statistical analysis 
The relative intensities of protein bands were analyzed using the Quantity One 
Version 4.6 densitometric analysis program (Bio-Rad) and normalized to the 
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respective loading controls.  Statistical analysis was performed using GraphPad InStat 
Version 3.00 (GraphPad Software, San Diego, CA) for the analysis of variance and 
Bonferroni’s multiple comparison tests.  Values of p < 0.05 were considered 
significant. 
 
3.4 Results 
3.4.1 Synthesis of naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylates 1a and 1b, 
and naphthoquinone 4 
Naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylates 1a and 1b were prepared 
from readily available 2,3-dichloro-1,4-naphthoquinone 2 and 1 eq. of nitroacetate 
ester 3a-b in the presence of triethylamine.  These syntheses gave 1a and newly 
synthesized 1b in yields of 19-35%.  The structural assignment of the products 1 was 
based on spectroscopic analyses, which in the case of 1a accorded with the literature 
(Chuang et al., 1999).  Naphthoquinone 4 was prepared from readily available 2-
bromo-1,4-naphthoquinone 5 and an excess of aqueous methylamine solution.  
Naphthoquinone 4 was isolated with 78% yield (Valente et al., 2007). 
 
3.4.2 1a and 1b, but not 4, act as potent inhibitors of cell death 
The biological effects of quinone derivatives were tested in cell culture 
studies.  Different concentrations were used, ranging from 0.01 to 500 µM, in 
cultured primary rat hepatocytes.  The compounds were non-cytotoxic in 
concentrations up to 50 µM and cytotoxic at higher concentrations, with an IC50 of ca. 
100 µM.  Concentrations higher than 100 µM increased general cell death by ~ 4-fold 
(p < 0.001).  However, the percentage of apoptotic cells remained similar to controls 
even at concentrations of 100 µM, which indicates that the cytotoxicity observed at 
higher concentrations is associated with forms of cell death other than apoptosis.  The 
quinone derivatives were also tested for their ability to prevent cell death.  
Camptothecin, a topoisomerase I inhibitor that induces DNA damage (Hsiang et al., 
1985), was used as a cell death stimulus in cultured primary rat hepayocytes.  Cell 
viability was accessed by trypan blue exclusion (Fig. 3.2).  Camptothecin exposure 
for 36 h resulted in a ~ 4-fold decrease in cell viability (p < 0.01), which was partially 
rescued by preincubation with 0.1 or 1 µM of 1a or 1b (p < 0.05).  This effect 
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represents a 60-70% protection against cell death.  In contrast, pretreatment of 
hepatocytes with 4 had no significant effects on cell viability.  Incubation with 1a, 1b 
or 4 alone resulted in levels of cell death similar to untreated controls, with the 
exception of 1 µM of 1a, which significantly increased cell viability (p < 0.05).  
Similar results were obtained with lactate dehydrogenase viability assays (data not 
shown). 
 
 
Figure 3.2.  1a and 1b, but not 4, modulate camptothecin-induced decrease in cell 
viability in primary rat hepatocytes.  Cells were incubated with 0.1 µM (grey bars) or 1 µM 
(black bars) of either 1a, 1b, 4, or no addition (white bars).  In addition, cells were 
coincubated with 10 µM camptothecin 1 h later, when indicated.  Thirty six hours after 
incubation, total and trypan-blue stained cells were counted and the viability calculated as the 
number of surviving cells per total number of cells.  The results are expressed as the mean ± 
S.E. fold change for at least three different experiments.  *p < 0.05 and **p < 0.01 from 
untreated control; †p < 0.05 from camptothecin alone. 
 
As naphthoquinone 4 showed no evident protection against camptothecin-
induced cell death, the remaining experiments were conducted with 1a and 1b only.  
Primary rat hepatocytes were treated as before and apoptosis was assessed by changes 
in nuclear morphology, detected after Hoechst labeling of cells.  Several 
concentrations and time points were tested to determine the adequate model system to 
specifically evaluate the modulation of apoptosis by naphthoquinone derivatives.  
Apoptosis increased from ~ 9% in control cells to 22 and 30% in cells exposed to 10 
and 20 µM camptothecin, respectively, for 36 h (p < 0.01) (Fig. 3.3).  Earlier time 
points of incubation with camptothecin resulted in significantly less apoptosis (data 
not shown).  The protective effects of 1a and 1b on camptothecin-induced apoptosis 
were tested in a dose-dependent manner (Fig. 3.3).  Both 0.1 and 1 µM concentrations 
of 1a and 1b acted as potent inhibitors of apoptosis, protecting against 10 and 20 mM 
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camptothecin-induced nuclear fragmentation by 76-98% and 70-88%, respectively (p 
< 0.05).  1a and 1b 10 µM concentrations were still effective at modulating apoptosis; 
however, 100 µM further increased camptothecin-induced nuclear fragmentation.  
Subsequent experiments evaluating the cytoprotective potential of quinone derivatives 
were performed using 10 mM camptothecin for 36 h that yielded moderate but 
significant levels of apoptosis, which in turn were significantly modulated by both 1a 
and 1b. 
 
Figure 3.3.  1a and 1b reduce camptothecin-induced nuclear fragmentation in primary 
rat hepatocytes.  Cells were incubated with either 0.1 (light grey bars), 1 (medium grey 
bars), 10 (dark grey bars) or 100 µM (black bars) of either 1a or 1b, or no addition (white 
bars).  In addition, cells were coincubated with either 10 or 20 µM camptothecin 1 h later, 
when indicated.  Thirty six hours after incubation, cells were fixed and stained for 
morphological assessment of apoptosis, as described under “Methods”.  (A) Fluorescent 
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microscopy of Hoechst staining in either untreated control cells (a) or cells treated with 10 
µM camptothecin (b), 0.1 µM of 1a (c) or 1b (e), and camptothecin plus 1a (d) and 1b (f).  
Apoptotic nuclei were identified by condensed chromatin as well as nuclear fragmentation 
(arrows).  Scale bar, 10 µm.  (B) Percentage of apoptosis in control hepatocytes and in cells 
treated with 10 or 20 µM camptothecin, in the presence or absence of 1a or 1b (bottom).  The 
results are expressed as the mean ± S.E. arbitrary units for at least four different experiments.  
**p < 0.01 from untreated control; †p < 0.05 from camptothecin alone. 
 	  
Figure 3.4.  1a and 1b reduce TGF-β1- and 
rotenone-induced nuclear fragmentation, in 
different cell types.  (A) Primary rat hepatocytes 
were incubated with 1 nM TGF-β1 for 36 h and 
coincubated with 1 µM of either 1a or 1b, when 
indicated.  (B) HuH-7 cells were incubated with 1 
nM TGF-β1 for 36 h and coincubated with 10 µM 
of either 1a or 1b, when indicated.  (C) PC12 cells 
were incubated with 1 nM rotenone for 24 h and 
coincubated with 1 µM of either 1a or 1b, when 
indicated.  Cells were fixed and stained for 
morphological assessment of apoptosis, as 
described under “Methods”.  Percentage of 
apoptosis was calculated and the results are 
expressed as the mean ± S.E. arbitrary units for at 
least four different experiments.  **p < 0.01 from 
untreated control; ††p < 0.01 from apoptotic insult 
alone. 
 
 
 
The ability of quinone derivatives to inhibit apoptosis was further investigated 
using other cell types and different apoptotic stimuli.  Recombinant human TGF-β1 (1 
nM), a multifunctional cytokine that triggers apoptosis (Lawrence, 1996; Sola et al., 
2006), resulted in ~ 20% of apoptosis in cultured primary rat hepatocytes and 30% in 
HuH-7 cells (p < 0.01) (Fig. 3.4A and B).  1a and 1b were equally protective in both 
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cell systems, significantly reducing apoptosis in hepatocytes and HuH-7 cells 
compared with cells incubated with TGF-β1 alone.  In addition, the quinone 
derivatives were highly effective against rotenone-induced cell death in PC12 cells 
(Fig. 3.4C).  Rotenone increased apoptosis from 13% in controls to 30% after 24 h of 
exposure (p < 0.01), while pretreatment with either 1a or 1b reduced apoptosis to 
almost control values (p < 0.01). 
 
3.4.3 1a and 1b reduce camptothecin-induced caspase activation in primary rat 
hepatocytes 
We further addressed 1a and 1b antiapoptotic potential by measuring caspase-
3-like enzymatic activity and caspase-3 processing, 36 h after the toxic insult.  
Incubation of hepatocytes with camptothecin alone resulted in a significant increase in 
caspase-3-like activity (p < 0.01) (Fig. 3.5A).  However, caspase-3 activity was 
reduced by 60-90% when cells were pre-incubated with different concentrations of 
1a, and to control levels when cells were pre-incubated with 1b (p < 0.05).  In fact, 
compared with untreated controls, cells pre-incubated with both naphtho[2,3-
d]isoxazole-4,9-dione-3-carboxylates alone at 0.1 µM presented significantly lower 
levels of caspase-3-like activity (p < 0.01).  Caspase-3 processing data from western 
blot analysis of cytosolic protein extracts corroborated these results (Fig. 3.5B). 
 
 
Figure 3.5.  1a and 1b reduce camptothecin-induced caspase-3 activation in primary rat 
hepatocytes.  Cells were incubated with 0.1 µM (grey bars) or 1 µM (black bars) of either 1a 
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or 1b, or no addition (white bars).  In addition, cells were coincubated with 10 µM 
camptothecin 1 h later, when indicated.  Thirty six hours after incubation, cytosolic proteins 
were extracted for caspase activity and processing assays as described under “Methods”.  (A) 
DEVD-specific caspase activity.  (B) and representative immunoblot of active caspase-3.  The 
results are expressed as the mean ± S.E. arbitrary units for at least three different experiments.  
**p < 0.01 from untreated control; †p < 0.05 from camptothecin alone. 
 
Next, caspase-8- and -9-like activities were measured, as the activation of each 
initiator caspase is generally linked to either the extrinsic or the mitochondrial 
pathways of apoptosis, respectively.  Treatment of primary rat hepatocytes with 
camptothecin was responsible for a small but significant increase in caspase-8-like 
activity (p < 0.05) (Fig. 3.6A).  Pre-incubation with 1a protected against 
camptothecin-induced caspase-8 activity at the highest concentration, leading to a 
78% decrease in caspase 8-like activity (p < 0.05).  Pre-incubation with 1b was 
protective against camptothecin-induced caspase-8-like activation (p < 0.05).  In 
addition, camptothecin treatment of primary rat hepatocytes resulted in a 20% 
increase in caspase-9-like activity (p < 0.05), which was restored to untreated control 
levels when cells were pre-incubated with 1a or 1b, at both concentrations (p < 0.05) 
(Fig. 3.6B).  The time course activation of apoptotic parameters, such as caspases, is 
expected to show an effect of camptothecin, in the presence or absence of 
naphthoquinones, that confirms time course data of endpoint measures such as cell 
death and nuclear fragmentation. 
 
3.4.4 1a and 1b prevent camptothecin-induced cytochrome c release in primary 
rat hepatocytes 
To further investigate the effect of 1a and 1b at the mitochondrial level, we 
performed cytochrome c immunostaining in hepatocytes treated with the quinone 
derivatives and exposed to camptothecin.  Incubation with camptothecin resulted in 
cytochrome c release from mitochondria to the cytosol, as illustrated by a strong 
cytoplasmic staining, which was mostly abolished by 1a or 1b pretreatment (Fig. 3.7). 
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Figure 3.6.  1a and 1b reduce camptothecin-induced caspase-8 and -9 activities in 
primary rat hepatocytes.  Cells were incubated with 0.1 µM (grey bars) or 1 µM (black 
bars) of either 1a or 1b, or no addition (white bars).  In addition, cells were coincubated with 
10 µM camptothecin 1 h later, when indicated.  Thirty six hours after incubation, cytosolic 
proteins were extracted for caspase activity assays as described under “Methods”.  IETD- (A) 
and LEHD-specific (B) caspase activities in cytosolic protein extracts.  The results are 
expressed as the mean ± S.E. arbitrary units for at least four different experiments.  *p < 0.05 
and **p < 0.01 from untreated control; †p < 0.05 and ††p < 0.01 from camptothecin alone. 
 
Figure 3.7.  1a and 1b modulate 
camptothecin-induced cytochrome c release 
in primary rat hepatocytes.  Cells were 
incubated with 0.1 µM of either 1a or 1b and 
coincubated with 10 µM camptothecin 1 h 
later.  Thirty six hours after incubation, cells 
were fixed and immunostained for cytochrome 
c visualization, as described under “Methods”.  
Fluorescent microscopy shows mitochondrial 
localization of cytochrome c in control cells (a) 
and in cells exposed solely to either 1a (c) or 
1b (e).  Strong cytoplasmic staining was 
evident in cells incubated with camptothecin  
Chapter	  3	  
54 
(b).  Notably, pretreatment of camptothecin exposed hepatocytes with either 1a (d) or 1b (f) 
abolished this effect.  Scale bar, 10 µm 
3.4.5 1a and 1b modulate Bcl-XL expression in primary rat hepatocytes 
We next evaluated the levels of several Bcl-2 family members.  Although 
immunoblot analysis of Bcl-2 and Bax was inconclusive (data not shown), significant 
changes in Bcl-XL were observed when cells were incubated with either 1a or 1b 
(Fig. 3.8A).  Exposure of cells to camptothecin consistently increased Bcl-XL (p < 
0.05), which may reflect a survival attempt in response to the toxic insult.  However, 
pretreatment of hepatocytes with 1a resulted in a further increase in Bcl-XL protein 
levels.  In fact, incubation with either 1a alone or in combination with camptothecin 
increased Bcl-XL by ~ 2.5-fold (p < 0.05).  This effect was less significant when 1b 
was used.  We next evaluated whether NF-κB derepression could explain Bcl-XL 
increased protein expression (Fig. 3.8B).  Quinone derivatives did not decrease 
protein levels of the NF-kB inhibitor, IkB, from 12 to 36 h after camptothecin 
incubation, suggesting that NF-kB is not activated. 
 
Figure 3.8. 1a and 1b modulate Bcl-XL expression in primary rat hepatocytes.  Cells  
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were incubated with 0.1 µM (grey bars) or 1 µM (black bars) of either 1a or 1b, or no 
addition (white bars). In addition, cells were coincubated with 10 µM camptothecin 1 h later, 
when indicated. Proteins were extracted and processed for immunoblot analysis as described 
under “Methods”. (A) Representative immunoblot (top) and histogram (bottom) of Bcl-XL 
expression at 36 h of camptothecin incubation. (B) Histogram of IκB expression at 12 (light 
grey), 24 (dark grey) and 36 (black) h of camptothecin incubation. All densitometry values 
for Bcl-XL and IκB were normalized to respective β-actin expression, and the results are 
expressed as the mean ± S.E. arbitrary units for at least three to five different experiments. *p 
< 0.05 from untreated control; †p < 0.05 from camptothecin alone. 
 
3.5 Discussion 
Apoptosis or programmed cell death is a highly regulated process of selective 
cell deletion involved in a variety of processes, including embryonic development, 
normal cell turnover, hormone-induced tissue atrophy, cell mediated immunity, tumor 
regression and a growing number of pathological disorders, typified by AIDS and 
Alzheimer’s diseases (Hengartner, 2000).  The possibility to modulate this process 
represents a major interest for therapeutic development.  In this study, we investigated 
whether two synthesized naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylates, 1a and 
1b, and a naphthoquinone 4 modulate the apoptotic threshold and evaluated their 
effect on apoptotic signaling.  Our results indicate that 1a and 1b, but not the simple 
naphthoquinone 4, are potent antiapoptotic agents.  Both naphtho[2,3-d]isoxazole-4,9-
dione-3-carboxylates 1a and 1b significantly increased cell viability, reduced nuclear 
fragmentation, and inhibited caspase-3, -8 and -9 activation induced by camptothecin 
in primary rat hepatocytes.  Similar protective effects were seen in human hepatoma 
HuH-7 cells and rat pheochromocytoma PC12 cells challenged with distinct apoptotic 
stimuli, such as camptothecin, TGF-β1 or rotenone.  Finally, our results also indicate 
that the protective effects may be associated with modulation of Bcl-2 family 
proteins, namely through the up-regulation of Bcl-XL. 
Quinone derivatives 1a and 1b inhibited caspase-3 processing and activation 
in camptothecin-treated cells.  In previous studies, we have shown proof of principle 
that naphthoquinones are time-dependent inhibitors of papain, a cysteine protease 
with a broad range of specificity, which shares sequence and structural homology 
with other mammalian cysteine proteases (Iley et al., 2006; Valente et al., 2007).  The 
naphthoquinones react by Michael-type reaction with the active site SH group.  
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Whether this is also true for quinone derivatives 1a and 1b needs to be further 
investigated. 
Quinone derivatives 1a and 1b were also effective at preventing activation of 
both caspase-8 and -9; however, the effect was more evident in caspase-9.  This is 
consistent with modulation of the mitochondrial pathway of apoptosis, as apoptosome 
formation and subsequent caspase-9 and -3 activation are key events in the intrinsic 
pathway.  This hypothesis was further confirmed by the fact that release of 
cytochrome c from mitochondria to the cytoplasm during apoptosis was inhibited by 
1a or 1b pretreatment.  Furthermore, both 1a and 1b were shown to up-regulate Bcl-
XL, a pro-survival member of the Bcl-2 family of proteins, which modulates the 
mitochondrial pathway of apoptosis.  It is unclear how 1a and 1b exert this function, 
but it seems to be independent of NF-kB activation.  Although Bcl-XL is 
transcriptionally regulated by NF-kB (Kucharczak et al., 2003), we did not observe 
any decrease in protein levels of IkB, the inhibitor of NF-kB, suggesting that NF-kB 
is not activated. 
In summary, three quinones were synthesized and their ability to inhibit 
apoptosis was evaluated.  Our data showed that the naphtho[2,3-d]isoxazole-4,9-
dione-3-carboxylates 1a and 1b significantly reduce cell death.  1a and 1b appear to 
specifically prevent apoptosis by inhibiting caspase activation and cytochrome c 
release.  In addition, the naphtho[2,3-d]isoxazole-4,9-dione containing an ethyl group 
1a is particularly efficient in up-regulating anti-apoptotic Bcl-XL. 
To the best of our knowledge, most of the quinones act as inducers of 
apoptosis.  In addition to redox cycling, naphthoquinones can undergo Michael 
addition to form adducts with sulfhydryls and primary amines, leading to cell injury 
and cell death.  Here, we describe two synthesized quinone derivatives that are strong 
inhibitors of caspase-dependent cell death.  Since the synthetic pathways currently 
available for naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylates do not allow 
extensive introduction of chemical diversity, we are now developing alternative 
efficient synthetic methods to determine useful structure-activity relationships.  The 
marked antiapoptotic properties of the naphtho[2,3-d]isoxazole-4,9-dione-3-
carboxylates 1a and 1b, together with their lack of cytotoxicity, makes them attractive 
candidates for future development of antiapoptotic molecules. 
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4.1 Abstract 
Calpains are calcium regulated cysteine proteases that have been described in 
a wide range of cellular processes, including apoptosis, migration and cell cycle 
regulation.  In addition, calpains have been implicated in differentiation, but their 
impact on neural differentiation requires further investigation.  Here, we addressed the 
role of calpain 1 and calpain 2 in neural stem cell (NSC) self-renewal and 
differentiation.  We found that calpain inhibition using either the chemical inhibitor 
calpeptin or the endogenous calpain inhibitor calpastatin favored differentiation of 
NSCs.  This effect was associated with significant changes on cell cycle-related 
proteins and may be regulated by calcium.  Interestingly, calpain 1 and calpain 2 were 
found to play distinct roles in NSC fate decision.  Calpain 1 expression levels were 
higher in self-renewing NSC and decreased with differentiation, while calpain 2 
increased throughout differentiation.  In addition, calpain 1 silencing resulted in 
increased levels of both neuronal and glial markers, β-III Tubulin and glial fibrillary 
acidic protein (GFAP).  Calpain 2 silencing elicited decreased levels of GFAP.  These 
results support a role for calpain 1 in repressing differentiation, thus maintaining a 
proliferative NSC pool, and suggest that calpain 2 is involved in glial differentiation. 
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4.2 Introduction 
Differentiation is the process by which stem cells give rise to committed and 
specialized cells (Murry and Keller, 2008).  Stem cells have been successfully used in 
regenerative medicine (Leeb et al., 2011; Wu and Hochedlinger, 2011).  Nevertheless, 
the potential of stem cells is yet far from being fully explored and requires a better 
understanding of stem cell biology.  Neural stem cells (NSC) have the ability to 
proliferate and self-renew, as well as to differentiate, following induction, into several 
neural cell types, including neurons, oligodendrocytes and glial cells (Gage, 2000; 
Gotz and Huttner, 2005; Ahmed, 2009).  Although thoroughly studied, the molecular 
pathways regulating differentiation of stem cells are still not fully defined, and may 
implicate cell cycle, apoptosis and migration, among other processes. 
Calpains are a large conserved family of cysteine proteases regulated by 
calcium which cleave many different substrates, modulating protein activity (Goll et 
al., 2003).  Calpains have been implicated in the regulation of a wide range of cellular 
processes, including cell cycle, migration, apoptosis, autophagy and synaptic 
plasticity (Santella et al., 1998; Franco and Huttenlocher, 2005; Mazeres et al., 2006; 
Raynaud and Marcilhac, 2006; Demarchi and Schneider, 2007; Liu et al., 2008; 
Zadran et al., 2010a).  Calpain activity can be modulated by calcium and phospholipid 
binding, phosphorylation, autolysis and subcellular localization (Goll et al., 2003; 
Leloup et al., 2010; Zadran et al., 2010b).  Additionally, calpains are regulated by the 
specific endogenous inhibitor calpastatin (Wendt et al., 2004).  Unlike other 
proteases, calpains do not have a consensus substrate-binding or cleavage site, making 
it difficult to predict their possible substrates.  In fact, substrates cleaved by different 
calpains vary depending on the context, probably as a consequence of the complex 
regulatory network affecting these proteases.  Calpain 1 and calpain 2 are the most 
studied and abundant calpain molecules in the brain (Liu et al., 2008).  
Although calpains have several important physiological functions, most of the 
studies involving these proteases in the central nervous system are disease-related.  In 
fact, calpains have been implicated in several brain pathologies, such as Parkinson’s 
disease, Alzheimer’s disease, Huntington’s disease, stroke and brain trauma (Zatz and 
Starling, 2005; Liu et al., 2008; Ferreira and Bigio, 2011).  The importance of 
calpains in synaptic function and memory formation has also been studied (Liu et al., 
2008; Zadran et al., 2010a). 
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Several studies have implicated calpains in differentiation mechanisms, 
including differentiation of mesenchimal stem cells, such as myoblasts, osteoblasts, 
chondrocytes and adipocytes (Yajima and Kawashima, 2002).  A role for cysteine 
proteases in differentiation of embryonic stem cells into neural cells has also been 
reported, although the involvement of calpains in embryonic stem cell differentiation 
was argued against (de Azevedo-Pereira et al., 2011).  Nevertheless, neural progenitor 
cells exhibit calcium transients during cell cycle progression that are required for 
proliferation in cellular models (Resende et al., 2010).  In addition, mitogen-activated 
protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K)/Akt are major 
signaling pathways implicated in a wide range of cellular processes (Krasilnikov, 
2000; Roux and Blenis, 2004), including neural stem cell proliferation and 
differentiation (Singh et al., 2003; Li et al., 2006; Wang et al., 2009; Sato et al., 2010; 
Ojeda et al., 2011).  These pathways have previously been implicated in regulation of 
calpain activity (Leloup et al., 2010; Qin et al., 2010; Su et al., 2010; Zadran et al., 
2010b).  Interestingly, calpain and calpastatin activities are modulated during neural 
differentiation of rat pheochromocytoma (PC12) cells (Oshima et al., 1989; Pinter et 
al., 1994; Vaisid et al., 2005).  Altered expressions levels for both calpain and 
calpastatin proteins were also described during human neuroblastoma cell 
differentiation to Schwannian and neuronal cells (Saito et al., 1994).  Nevertheless, 
the potential function of calpains during neural differentiation is still poorly 
understood and requires further investigation. 
In the present study, we elucidated the role of calpain 1 and 2 during NSC 
self-renewal and differentiation.  Our results suggest that calpain 1 maintains 
stemness and represses neural differentiation.  In addition, calpain 2 acts as potential 
modulator of gliogenesis.  These results underscore the distinct regulatory functions 
of calpain 1 and 2 in NSC fate decision. 
 
4.3 Methods 
4.3.1 Ethics 
The tau-green fluorescent protein mouse NSC line (NS-TGFP) was obtained 
from Dr. Smith’s Laboratory, University of Cambridge, Cambridge, UK (Silva et al., 
2006), and provided by Dr. Henrique, University of Lisbon, Lisbon, Portugal.  
Neurospheres of MNSC were obtained from Dr. Reynold’s Laboratory, University of 
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Queensland, Brisbane, Australia, and provided by Dr. Low, University of Minnesota, 
Minneapolis, MN, USA.  The Animal Ethical Committee at the Faculty of Pharmacy, 
University of Lisbon, Portugal waived the need for approval.  
 
4.3.2 Cell culture and treatments 
NS-TGFP cells were derived from 14.5- days post coitum mouse fetal 
forebrain, and constitutively express the fusion protein Tau-GFP (Pratt et al., 2000; 
Silva et al., 2006).  This cell line was established using a method that produces pure 
cultures of adherent NSC, which continuously expand by symmetrical division and 
are capable of tripotential differentiation (Conti et al., 2005; Pollard et al., 2006; 
Glaser et al., 2007). NS-TGFP cells were grown in monolayer as previously described 
(Spiliotopoulos et al., 2009) and routinely maintained in undifferentiation medium, 
Euromed-N medium (EuroClone S.p.A., Pavia, Italy), supplemented with 1% N-2 
supplement (Invitrogen Corp., Grand Island, NY), 20 ng/mL epidermal growth factor 
(EGF; PeproTech EC, London, UK), 20 ng/mL basic fibroblast growth factor (bFGF; 
PeproTech EC) and 1% penicillin-streptomycin (Invitrogen Corp.), in uncoated tissue 
culture plastic flasks at 37°C in a humidified atmosphere of 5% CO2.  Medium was 
changed every 3 days and cells collected with accutase (Sigma-Aldrich Co., St. Louis, 
MO) when confluent.  Permissive conditions were obtained by platting NSC in tissue 
culture plates pre-coated with 0.1% gelatin (Sigma-Aldrich Co.) at 3x104 cells/cm2 in 
N2B27 medium, 1:1 mixture of DMEM/F12 (Invitrogen Corp.) and Neurobasal 
(Invitrogen Corp.), supplemented with 0.5% N-2 supplement, 1% B27 supplement 
(Invitrogen Corp.) and 2 mM L-Glutamine (Invitrogen Corp.).  N2B27 medium was 
further supplemented with 10 ng/mL EGF, 10 ng/mL bFGF and 1% penicillin-
streptomycin.  After 24 h in permissive conditions, 50 µM calpeptin (Tocris 
Bioscience, Bristol, UK), 10 µM SB203580 (Tocris Bioscience), 25 µM PD98059, 
250 nM wortmannin, 20 µM nifedipine, 10 µM dantrolene, 1 µM xestospongin C or 
DMSO (all from Sigma-Aldrich Co.) were added to the culture medium for 6, 9, 24 or 
27 h. After collection with accutase, cells were counted and processed for flow 
cytometry analysis, BrdU staining or immunoblotting.  Differentiation of NS-TGFP 
cells was performed by first platting cells in undifferentiation medium onto uncoated 
tissue culture plastic dishes at 3x104 cells/cm2 for 24 h, and changing the culture 
medium to differentiation medium, Euromed-N medium supplemented with 10 ng/mL 
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bFGF, 0.5% N-2 supplement, 1% B27 supplement and 1% penicillin-streptomycin.  
Cells were collected before medium change (time 0), or cultured for additional 3, 6, 
24 or 48 h, and then collected for cell death analysis and protein extraction.  For 
microscopic detection of neuronal and astrocytic morphology and for 
immunocytochemical co-labeling of β-III Tubulin and GFAP, cells were fixed at 2 
days of differentiation or 4 days of differentiation in the presence of 1% fetal bovine 
serum (FBS) (Invitrogen Corp.) for the last 2 days in culture, and then processed as 
described below.  
Primary MNSC containing a constitutively expressed marker for GFP were 
also used in selected experiments.  MNSC were obtained from central nervous system 
tissue of embryonic mice (Reynolds and Weiss, 1992; Reynolds and Weiss, 1996; 
Rietze and Reynolds, 2006), maintained as neurospheres and induced to differentiate 
as previously described (Aranha et al., 2009; Aranha et al., 2010).  Cells were 
collected at 1, 2, 3, 6 or 8 days after induction of differentiation and processed for 
flow cytometry analysis or immunobloting assays. 
 
4.3.3 siRNA and plasmid transfections 
For short interference RNA (siRNA) transfections, two pools of 4 siRNA 
nucleotides designed to knockdown mouse calpain 1 (L-062006-00-0005) and calpain 
2 (L-043027-00-0005) expression were purchased from Dharmacon (Waltham, MA).  
A control siRNA containing a scrambled sequence that does not lead to the specific 
degradation of any known cellular mRNA was used as control.  Briefly, cells were 
first cultured in uncoated dishes in undifferentiation medium without penicillin-
streptomycin.  Twenty four hours after plating, cells were transfected with 100 nM 
siRNA in the presence of 10% FBS using Lipofectamine 2000 (Invitrogen Corp.), 
according to the manufacturer’s instructions.  Six hours later, the medium was 
changed to differentiation medium and cells were cultured for additional 24 and 48 h.  
Efficiencies of calpain 1 and calpain 2 silencing were assessed by immunoblotting.  
Calpain inhibition was also achieved by overexpressing the endogenous inhibitor 
calpastatin.  Briefly, cells were transfected with ∼ 2 µg pcDNA-Flag-mCAST 
construct, kindly provided by Dr. Duarte (Center for Neuroscience and Cell Biology, 
Coimbra, Portugal), or with pcDNA empty vector.  The Flag-mCAST construct was 
prepared by cloning full-length mouse calpastatin cDNA with N-terminal Flag into 
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pcDNA vector (Invitrogen Corp.).  Cells were cultured in uncoated dishes in N2B27 
medium supplemented with 10 ng/mL EGF and 10 ng/mL bFGF for 24 h, transfected 
for 6 h using Lipofectamine 2000 and then the medium was changed to differentiation 
medium.  Calpastatin overexpression was evaluated by immunoblotting against the 
Flag tag. 
 
4.3.4 Flow cytometry analysis 
NS-TGFP cells were washed twice with Ca2+- and Mg2+-free PBS (Invitrogen 
Corp.), treated with accutase and harvested with PBS.  MNSC were trypsinized 
(0.025% trypsin/EDTA) (Invitrogen Corp.) and harvested in Ca2+-free and Mg2+-free 
PBS and 2% FBS.  For cell death analysis, cells were stained with the vital dye PI (5 
µg/mL; Sigma-Aldrich Co.) and Annexin-V-APC (eBioscience, Inc., San Diego, CA), 
according to manufacturer's instructions, to determine phosphatidylserine exposure.  
Proliferation levels were determined by BrdU incorporation analysis using the APC 
BrdU Flow Kit (BD Biosciences Pharmingen, San Diego, CA).  BrdU was added to 
the culture medium 3 h after cell treatments, and cells were re-incubated for 
additional 6 h for flow cytometry analysis.  
For detection of Nestin and β-III Tubulin expression levels, cells were fixed 
with paraformaldehyde (4% w/v) in PBS for 20 min at 4oC, washed twice with 
washing solution 0.1% saponin (Fluka, Biochemika, Switzerland) in PBS, and 
blocked for 20 min in blocking solution 0.25% saponin and 5% FBS in PBS.  
Subsequently, cells were washed and incubated with antibodies reactive to Nestin 
(MAB 353; Chemicon International, Temecula, CA) or β-III Tubulin (Tuj1; Covance, 
Princeton, New Jersey) at a dilution of 1:300 and 1:500, respectively, in antibody 
blocking solution (0.1% saponin and 5% FBS in PBS), for 30 min.  Cells were then 
washed twice and incubated with anti-mouse antibody conjugated to Dylight 649 
(Jackson ImmunoResearch Laboratories, Inc., West Grove, PA), at a dilution of 
1:5000 for 30 min.  Cells were washed twice, resuspended in PBS with 2% FBS and 
analyzed using the FACSCalibur (Becton Dickinson, Mountain View, CA).  Data 
were statistically evaluated using FlowJo software (Tree Star, Inc, Ashland, OR). 
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4.3.5 Immunoblotting 
Steady-state levels of cyclin E, p21, p27, β-III Tubulin, GFAP, calpain 1, 
calpain 2, Flag-calpastatin and β-actin were determined by immunoblotting.  Cells 
were collected and lysed for isolation of total protein extracts with lysis buffer (50 
mM KCl, 50 mM PIPES, 10 mM EGTA, 2 mM MgCl2, 0.5% Triton X-100, pH 7.4) 
supplemented with 100 µM PMSF, 1 mM DTT and Halt Protease and Phosphatase 
Inhibitor Cocktail (Thermo Fisher Scientific Inc., Rockford, IL), followed by 
centrifugation at 200g at 4oC for 20 min.  Protein content was measured by the Bio-
Rad protein assay kit (Bio-Rad Laboratories, Hercules, CA, USA) according to the 
manufacturer's specifications, using bovine serum albumin as standard.  Fifty to one 
hundred µg of total protein extracts were separated on 8% sodium dodecyl sulphate-
polyacrylamide electrophoresis gel, and then subjected to immunoblotting using 
primary mouse monoclonal antibodies reactive to p27 (Santa Cruz Biotechnology, 
Santa Cruz, CA), β-III Tubulin (Tuj1; Covance), GFAP (MAB360; Chemicon 
International), Flag (M2; Sigma-Aldrich Co.) or β-actin (A5441; Sigma-Aldrich Co.), 
or primary rabbit polyclonal antibodies reactive to cyclin E (Santa Cruz 
Biotechnology), calpain 1 (sc-7531-R; Santa Cruz Biotechnology) or calpain 2 (2539; 
Cell Signaling Technology, Inc., Beverly, MA), or primary goat polyclonal antibodies 
reactive to p21 (Santa Cruz Biotechnology).  Blots were subsequently incubated with 
secondary antibodies conjugated with horseradish peroxidase (Bio-Rad Laboratories).  
Finally, membranes were processed for protein detection using Immobilon (Millipore 
Corporation, Billerica, MA) or SuperSignal reagent (Pierce, Rockford, IL).  Ponceau 
S staining was also used to assess equal gel loading. 
 
4.3.6 Immunocytochemistry 
For detection of proliferating cells, S-phase nuclei were stained using the 
BrdU In-Situ Detection Kit (BD Biosciences Pharmingen).  BrdU was added to the 
culture medium 3 h after cell treatments, and cells were re-incubated for additional 6 
h and processed according to manufacturer’s instructions.  For fluorescence 
microscopy, NS-TGFP cells were fixed with paraformaldehyde (4%, w/v) in PBS and 
blocked for 1 h at room temperature in PBS, containing 0.1% Triton-X-100, 1% FBS, 
and 10% normal donkey serum (Jackson ImmunoResearch Laboratories, Inc.).  For 
single staining, cells were incubated with either anti-β-III Tubulin or anti-GFAP 
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antibodies at a dilution of 1:1000 in blocking solution, overnight at 4°C.  Cells were 
then incubated with an Alexa 568-conjugated anti-mouse antibody (Life Technologies 
Ltd, Paisley, UK) at a dilution of 1:200 in blocking solution, for 2 h at room 
temperature.  Mouse NS cell nuclei were then stained with Hoechst 33258 (Sigma-
Aldrich Co.) at 50 µg/ml in PBS, for 5 min at room temperature. For co-labeling of β-
III Tubulin and GAFP, cells were incubated with mouse anti-β-III Tubulin and rabbit 
anti-GFAP (Sigma-Aldrich Co.) antibodies at a dilution of 1:500 and 1:250, 
respectively, in blocking solution, overnight at 4°C.  Cells were then incubated with 
Alexa 405-conjugated anti-mouse and Alexa 594-conjugated anti-rabbit antibodies 
(Life Technologies Ltd) at a dilution of 1:200 each, for 2 h at room temperature.  
Samples were mounted using Fluoromount-G™ (Beckman Coulter, Inc., Brea, CA).  
Fluorescence microscopy assessments were performed with a Zeizz AX10 
microscope (Carl Zeiss, Jena, Germany) equipped with a Leica DFC490 camera 
(Leica Weitzlar, Germany) or with a Zeiss LSM 510 META confocal microscope 
(Carl Zeiss). 
 
4.3.7 Densitometry and statistical analysis 
The relative intensities of protein bands were analyzed using the Quantity One 
Version 4.6.3 densitometric analysis program (Bio-Rad Laboratories).  Results from 
different groups were compared using the Student’s t test, two-way ANOVA or one-
way ANOVA followed by Bonferroni’s or Dunnett’s multiple comparison tests.  
Values of p < 0.05 were considered statistically significant.  All statistical analysis 
was performed with GraphPad Prism 5 software (GraphPad Software, Inc., San 
Diego, CA). 
 
4.4 Results 
4.4.1 Calpain inhibition decreases proliferation of neural stem cells 
Although calpains have already been implicated in several differentiation 
systems (Oshima et al., 1989; Pinter et al., 1994; Yajima and Kawashima, 2002; 
Vaisid et al., 2005), their involvement during neural differentiation has not yet been 
fully explored.  We have previously shown that cysteine proteases, such as caspases, 
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regulate mouse NSC differentiation by interfering with the FOXO3A/Id1 signaling 
pathway (Aranha et al., 2009).  
To address the role of calpains in NSC self-renewal and differentiation, we 
first incubated NS-TGFP cells with the calpain chemical inhibitor calpeptin in 
permissive condition medium.  This specific condition maintains cells in a 
proliferative status, although low levels of differentiation can be observed after a few 
days in culture.  After 24 h, cells were treated with 50 µM calpeptin or dimethyl 
sulfoxyde (DMSO; control) and incubated for additional 6, 9 or 27 h.  Our results 
show that calpeptin treatment resulted in a marked decrease in cell number, eliciting 
almost 50% reduction in cell density at 27 h (p < 0.01) (Fig. 4.1A).  
 
 
Figure 4.1.  Calpeptin treatment decreases cell density and proliferation.  NS-TGFP cells 
were cultured in permissive conditions and treated with either 50 µM calpeptin or DMSO 
(control), and BrdU was added 3 h later as described in Materials and Methods.  (A) Cell 
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density was accessed at different times after treatment and calculated as the number of live 
cells per cm2 dish surface area. (B) Cell viability was determined by flow cytometry after 24 h 
and expressed as the percentage of PI and Annexin-V double-negative cells.  (C) 
Immunocytochemistry detection of BrdU-positive nuclei (brown).  (D) Representative 
histogram of BrdU positive cells assessed by flow cytometry (left), and respective 
quantification data (right).  Data represent mean ± SEM of three independent experiments. §p 
< 0.05 and *p < 0.01 from respective control. 
 
 However, this did not correlate with increased cell death, as measured by 
propidium iodide (PI) and Annexin-V staining, indicating low levels of toxicity (Fig. 
4.1B).  Bromodeoxyuridine (BrdU) incorporation, in turn, revealed a 25% decrease in 
proliferation after calpeptin treatment, as assessed by immunocytochemistry (Fig. 
4.1C) and flow cytometry (Fig. 4.1D) analysis (p < 0.01). 
To investigate whether inhibition of proliferation by calpains was due to 
altered cell cycle dynamics, we investigated the expression levels of several cell cycle 
markers.  Interestingly, truncated p27 was decreased after calpeptin treatment of NS-
TGFP cells (Fig. 4.2).  Truncation of cyclin-dependent kinase inhibitor p27 results in 
a substantial reduction in its inhibitory activity (Levkau et al., 1998; Schiappacassi et 
al., 2008).  In addition, calpain inhibition increased p21 and decreased cyclin E levels, 
indicative of impaired G1 progression in these conditions (Salomoni and Calegari, 
2010a).  Our results suggest that calpain activity is involved in cell cycle progression 
and proliferation of NSC. 
 
 
Figure 4.2.  Calpeptin treatment modulates cell cycle proteins.  NS-TGFP cells were 
cultured in permissive conditions, treated with either 50 µM calpeptin or DMSO (control) for 
24 h and processed for immunoblotting as described in Materials and Methods.  
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Representative immunoblots (top) and corresponding densitometry analysis (bottom) of 
cyclin E, p21 and p27 levels after calpeptin treatment.  Two distinct p27 bands were detected, 
corresponding to full length (~ 27 kDa) and truncated (marked with *) forms.  Data represent 
mean ± SEM of three independent experiments.  §p < 0.05 and †p < 0.001 from respective 
control. 
 
4.4.2 Calpain inhibition increases differentiation of NSC 
Cell cycle dynamics can influence differentiation, including neurogenesis 
(Ohnuma and Harris, 2003; Salomoni and Calegari, 2010a). We next investigated the 
differentiation status of calpeptin-treated NS-TGFP cells.  Interestingly, calpeptin 
treatment decreased the proportion of Nestin-positive cells by ~ 35% (p < 0.05) (Fig. 
4.3A), while increasing the percentage of β-III Tubulin-positive by almost 90% (p < 
0.001) (Fig. 4.3B), indicating loss of stemness and induction of neural differentiation, 
respectively.  Similar results were obtained in a mouse neurosphere model (MNSC).  
Calpeptin-treated MNSC showed a 15% decrease in the proportion of Nestin-positive 
cells (p < 0.05) and a 45% increase in the percentage of β-III Tubulin-positive cells (p 
< 0.05) (Fig. 4.3C). 
We next sought to determine if any of the MAPK and PI3K/Akt pathways 
regulated calpain activity in NSC and if their inhibition mimicked the effects 
observed after calpain inhibition by calpeptin. NS-TGFP cells were treated with p38, 
mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK/ERK) 
and PI3K/Akt chemical inhibitors (SB203580, PD98059 and wortmannin, 
respectively), and the differentiation status was evaluated after 24 h (Fig. 4.4A and 
B).  Surprisingly, no significant differences were seen in the percentage of Nestin- or 
β-III Tubulin-positive cells, as compared to the control, indicating that, in these 
conditions, neither the MAPK p38 or MEK/ERK pathways, nor the PI3K/Akt 
pathway are involved in the calpain-mediated regulation of self-renewal and 
differentiation of NSC. 
We have also treated NS-TGFP cells with several inhibitors for calcium 
receptor/channels, previously shown to maintain calcium oscillations in NSC 
(Resende et al., 2010), namely nifedipine, an L-type channel blocker; dantrolene, a 
ryanodine receptor channel antagonist; and xestospongin C, an inositol trisphosphate 
receptor (IP3R) inhibitor.  Interestingly, while dantrolene elicited no significant 
Chapter	  4	  
72 
alterations, both nifedipine and xestospongin C treatment resulted in differences 
similar to calpeptin treatment (Fig. 4.4A and B).  In fact, nifedipine and xestospongin 
C induced a small, but significant decrease in the percentage of Nestin-positive cells 
(p < 0.01 and p < 0.001, respectively), and a marked increase in the proportion of β-
III Tubulin-positive cells (p < 0.001 and p < 0.05, respectively).   
 
 
Figure 4.3.  Calpeptin treatment decreases Nestin- and increases β-III Tubulin-positive 
cells.  NS-TGFP cells and MNSC were cultured in permissive or differentiation conditions, 
respectively, treated with either 50 µM calpeptin or DMSO (control), and collected after 24 or 
48 h as described in Materials and Methods.  Cells were subsequently labeled for Nestin and 
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β-III Tubulin detection by flow cytometry as described in Materials and Methods.  (A) 
Representative histogram of Nestin-positive cells (left) and respective quantification data 
(right) in NS-TGFP cells after 24 h.  (B) Representative histogram of β-III Tubulin-positive 
cells (left) and respective quantification data (right) in NS-TGFP cells after 24 h.  (C) 
Quantification of Nestin- and β-III Tubulin-positive cells in MNSC after 24 or 48 h, 
respectively. Data represent mean ± SEM of at least three independent experiments. §p < 0.05 
and †p < 0.001 from respective control. 
 
Figure 4.4. Inhibition of calcium flux decreases 
Nestin- and increases β-III Tubulin-positive 
cells.  NS-TGFP cells were cultured in permissive 
conditions and treated with either 10 µM 
SB203580, 20 µM PD98059, 250 nM wortmannin, 
20 µM nifedipine, 10 µM dantrolene, 1 µM 
xestospongin C or DMSO (control), and collected 
after 24 h. Cells were subsequently labeled for 
Nestin and β-III Tubulin detection by flow 
cytometry as described in Materials and Methods. 
(A) Quantification of Nestin-positive cells in NS-
TGFP cells after different treatments. (B) 
Quantification of β-III Tubulin-positice cells. Data 
represent mean ± SEM of at least three independent 
experiments. §p < 0.05, *p < 0.01 and †p < 0.001 
from respective control. 
 
Thus, our results suggest that calcium oscillations mediated by IP3R and L-
type channels are responsible for calpain activation, maintenance of self-renewal and 
repression of differentiation of NSC. 
 
4.4.3 Calpain inhibition throughout neural differentiation increases 
neurogenesis 
To further explore the mechanism by which calpains regulate neural 
differentiation, we transfected NS-TGFP cells with calpastatin, an endogenous 
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specific calpain inhibitor (Wendt et al., 2004), and then induced neural differentiation.  
Cells were grown under differentiation conditions for 48 h and the expression of 
neuronal and glial differentiation markers β-III Tubulin and glial fibrillary acidic 
protein (GFAP) was accessed at several time-points. As expected, both neural 
markers increased throughout differentiation, starting at 24 h and peaking at 48 h (Fig. 
4.5A).  
 
 
Figure 4.5. Neuronal and astrocytic phenotypes after induction of neural differentiation. 
β-III Tubulin and GFAP expression was evaluated in NS-TGFP cells at different times of 
differentiation as described in Materials and Methods. (A) Representative immunoblots (top) 
and corresponding densitometry analysis (bottom) showing an increase in β-III Tubulin and 
GFAP protein levels throughout neural differentiation. Results are expressed as mean ± SEM 
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arbitrary units for at least three independent experiments. §p < 0.05 and †p < 0.001 from 
undifferentiated cells. (B) Immunofluorescence detection of neuronal and astrocytic 
morphology in cells co-stained with anti-β-III Tubulin and anti-GFAP antibodies after 4 days 
of neural differentiation. Scale bar, 20 µm. 
 
Cells developed typical neuronal and astrocytic morphologies, accompanied 
by the expression of β-III Tubulin and GFAP, respectively, at 2 days (data not shown) 
and 4 days in culture (Fig. 4.5B).  
Following transfection, the Flag-calpastatin construct was easily detected by 
Western blot 24 h after induction of differentiation (Fig. 4.6A).  More importantly, 
calpastatin overexpression increased β-III Tubulin expression by 40% (p < 0.05) (Fig. 
4.6B), corroborating our previous observation in calpeptin-treated NSC.  However, no 
differences in GFAP levels were detected.  Thus, our results reinforce the role of 
calpains in NSC fate and indicate that calpains may differently modulate neurogenesis 
and gliogenesis. 
 
 
Figure 4.6. Calpastatin overexpression increases neuronal but not glial differentiation. 
β-III Tubulin and GFAP expression levels were evaluated by immunoblotting in NS-TGFP 
cells. Cells were transfected with either pcDNA-Flag-mCAST or pcDNA empty vector 
(control), differentiated and collected after 24 h, as described in Materials and Methods. (A) 
Representative immunoblots of Flag expression and β-actin in control and calpastatin 
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overexpressing cells. (B) Representative immunoblots (top) and corresponding densitometry 
analysis (bottom) showing increased β-III Tubulin expression (left) and unchanged GFAP 
(right) protein levels in pcDNA-Flag-mCAST transfected cells. β-actin was used as loading 
control. Results are expressed as mean ± SEM arbitrary units for six independent 
experiments. *p < 0.01 from control. 
 
4.4.4 Calpain 1 and 2 are differentially expressed throughout neural 
differentiation and do not correlate with cell death 
Calpain 1 and 2 are the most abundant calpain molecules in the brain (Liu et 
al., 2008), and calpastatin inhibits the activity of both proteins (Wendt et al., 2004).  
We next addressed their specific contributions to neural differentiation.  Curiously, 
expression levels of calpain 1 were markedly higher in self-renewing NSC, and 
decreased significantly during differentiation of NS-TGFP cells (Fig. 4.7A).  In 
contrast, calpain 2 increased throughout differentiation in a similar manner as β-III 
Tubulin and GFAP.  In MNSC, β-III Tubulin- and GFAP-positive cells have 
previously been detected at 3 and 8 days of differentiation, respectively (Aranha et al., 
2009).  Accordingly, the expression patterns of both calpain 1 and 2 were similar to 
those found in NS-TGFP undergoing differentiation, with levels of calpain 1 
decreasing as calpain 2 increased throughout neural differentiation (Fig. 4.7B).  Thus, 
our results suggest that calpain 1 and 2 have distinct functions throughout NSC 
differentiation.  Finally, as calpains are apoptosis-associated proteases, we searched 
for a correlation between calpain expression and cell death throughout differentiation.  
We have previously shown that differentiation of MNSC was not associated with an 
increase in cell death (Aranha et al., 2010).  Similarly, our results reveal no significant 
differences in viability and cell death of differentiating NS-TGFP cells, as measured 
by PI and Annexin-V staining (Fig. 4.7C).  These results indicate that calpains may be 
important for the regulation of neural differentiation in a cell death-independent 
manner. 
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Figure 4.7. Calpain expression levels are altered throughout differentiation of NSC.  NS-
TGFP and MNSC were grown under differentiation conditions and collected for calpain 1 and 
2 immunoblotting or stained with Annexin-V-APC/PI to evaluate cell death as described in 
Materials and Methods. (A) Representative immunoblots (top) and corresponding 
densitometry analysis (bottom) of calpain 1 and calpain 2 protein levels throughout NS-TGFP 
differentiation. β-actin was used as loading control. Results are expressed as the mean ± SEM 
arbitrary units for four independent experiments. §p < 0.05, *p < 0.01 and †p < 0.001 from 
undifferentiated cells. (B) Representative immunoblots of calpain 1 and 2 expression 
throughout MNSC differentiation. Ponceau staining was used as loading control. (C) 
Representative Annexin-V-APC/PI data plot (left) and quantification data of viable (PI-
negative, Annexin-V-negative) cells (right), showing absence of cell death throughout NS-
TGFP differentiation. Data represent mean ± SEM of three independent experiments.  
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4.4.5 Calpain 1 represses neural differentiation, while calpain 2 increases glial 
differentiation 
To further investigate the precise roles of calpain 1 and 2 during neural 
differentiation, we transfected NS-TGPF cells with siRNA specific for calpain 1 
(siCAPN1) or calpain 2 (siCAPN2), or unspecific control, and then induced 
differentiation.  Reduced expression of calpain 1 and 2 was observed by Western blot 
in cells treated with siCAPN1 and siCAPN2, respectively (Fig. 4.8A).  Both β-III 
Tubulin and GFAP expression levels were ~ 25% (p < 0.05) and 50% (p < 0.01) 
increased after calpain 1 silencing (Fig. 4.8B).  Calpain 2 knockdown, in turn, elicited 
a significant decrease in GFAP expression (p < 0.05), but no differences in β-III 
Tubulin expression.  These results were corroborated by immunocytochemistry 
analysis (Fig. 4.8C). The opposing actions of calpain 1 and 2 on GFAP expression 
may explain the absence of difference found earlier in GFAP upon calpastatin 
overexpression.  Thus, our results suggest that calpain 1 plays a role in cell cycle 
progression of NSC, delaying differentiation and maintaining a proliferative neural 
stem cell pool, while calpain 2 may be important for glial differentiation. 
 
4.5 Discussion 
The present study identifies a distinct regulatory function of calpains during 
NSC proliferation and differentiation in vitro.  Calpain 1 represses both neuronal and 
glial differentiation, while calpain 2 is associated with glial differentiation.   
Transplantation of stem cells may provide a more permanent remedy than 
present drug treatments for cell replacement in various neurodegenerative diseases.  
However, stem cells survive and differentiate poorly after transplantation (Bakshi et 
al., 2005; Hodges et al., 2007).  Curiously, it has been shown that several conserved 
elements of apoptosis are also integral components of terminal differentiation 
(Fernando et al., 2005; Fujita et al., 2008), suggesting that apoptosis-related proteins 
might be important players of cell fate decisions.  We have recently demonstrated the 
involvement of specific apoptosis-associated molecules in mouse NSC differentiation.  
In fact, apoptosis-associated miRNAs were involved in neural differentiation (Aranha 
et al., 2010), and caspase inhibition and p53 silencing synergistically delayed neural 
differentiation, with no evidence of apoptosis (Aranha et al., 2009).  Here, we 
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investigated the potential role of proteases such as calpains in the regulation of NSC 
self-renewal and differentiation.  
 
 
 
Figure 4.8. Calpain 1 and 2 silencing regulates the expression of neural differentiation 
markers.  NS-TGFP cells were transfected with siRNAs for either calpain 1 (siCAPN1), 
calpain 2 (siCAPN2) or control siRNA, and then differentiated. Cells were fixed for 
immunocytochemistry or collected for Western blot analysis as described in Materials and 
Methods. (A) Representative immunoblots showing a reduction of calpain 1 (left) and calpain 
2 (right) protein levels after siRNA-induced silencing. (B) Representative immunoblots (top) 
and corresponding densitometry analysis (bottom) showing altered β-III Tubulin (left) and 
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GFAP (right) protein levels following calpain 1 or calpain 2 silencing. Results are expressed 
as mean ± SEM arbitrary units for at least three independent experiments. β-actin was used as 
loading control. §p < 0.05 and *p < 0.01 from control. (C) Confocal immunofluorescence 
detection of cells labeled with anti-β-III Tubulin and anti-GFAP antibodies shows increased 
expression of β-III Tubulin and GFAP following calpain 1 knockdown and decreased 
expression of GFAP following calpain 2 knockdown in differentiating NS-TGFP cells. 
Hoechst 33258 staining was used to visualize cell nuclei. Scale bar, 10 µm.  
 
Much like caspases, calpains are cysteine proteinases that once activated 
cleave a wide range of cellular substrates (Goll et al., 2003).  Calpains are regulated 
by calcium and several studies have already demonstrated calpain involvement in 
differentiation systems, supporting the idea that apoptosis-associated factors are 
involved in regulation of the differentiation process.  In fact, it has been demonstrated 
that during muscle cell differentiation, calpains relocate to the cell membrane of 
myoblasts in response to calcium flux and participate in fusion associated protein 
degradation (Schollmeyer, 1986; Dourdin et al., 1997).  Calpains have also been 
implicated in osteoblast and chondrocyte differentiation (Yajima and Kawashima, 
2002), as well as in the turnover of transcriptional nuclear proteins driving 
differentiation of 3T3-L1 preadipocytes (Watt and Molloy, 1993; Patel and Lane, 
1999).  However, calpain activation has not always been associated with promotion of 
cellular differentiation.  The conversion of ST-13 preadipocytes into adipocytes was 
shown to be enhanced by calpain inhibition (Yajima and Kawashima, 2002).  The 
specific role of calpains during neural differentiation remains largely unknown and 
requires further investigation, as only a few studies were performed in appropriate cell 
models (Oshima et al., 1989; Pinter et al., 1994; Saito et al., 1994; Vaisid et al., 2005). 
In the present study, we first demonstrated that treatment of NS-TGFP mouse 
NSC with the calpain chemical inhibitor calpeptin decreases both cell number and 
proliferation.  Our data is in accordance with other studies highlighting the 
importance of calpain activity in cell cycle progression, particularly in the transition 
from G1 to S phase (Patel and Lane, 2000; Akashiba et al., 2006; Kashiwagi et al., 
2010; Kashiwagi et al., 2011).  We show that inhibition of calpain activity in NSC by 
calpeptin leads to a significant decrease in cyclin E levels, responsible for the G1/S 
transition.  The impairment of cell cycle progression induced by calpeptin was also 
detected by p21 accumulation and decreased p27 degradation, evidenced by the 
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presence of a lower molecular weight truncated fragment (Levkau et al., 1998).  In 
fact, it has already been shown that deletion of calpain regulatory small subunit 
Capn4 results in impaired cell cycle progression in chondrocytes.  This specific 
deletion led to an accumulation of certain cell cycle proteins known as calpain 
substrates, such as cyclin D, cyclin E, and p27, as well as reduced phosphorylation of 
retinoblastoma protein and p27 (Kashiwagi et al., 2010).  p27 transcription and 
degradation, in turn, was also shown to be mediated by calpains in other models, 
including osteoblasts, cortical neurons and preadipocytes (Patel and Lane, 2000; 
Akashiba et al., 2006; Kashiwagi et al., 2011).  Further, p21 accumulation induced by 
calpain inhibition has also been observed in other studies, where in vitro incubation 
with calpain 1 and 2 resulted in rapid degradation of p21 (Chen et al., 2001; Khan et 
al., 2002).  It has been demonstrated that calcium oscillations occurring in G1 to S 
transition are required for cell cycle progression in both neural progenitor and 
undifferentiated cells, correlating with G1 shortening and increased proliferation 
(Lenos and Tsaniklidou, 2010; Resende et al., 2010).  Furthermore, calcium 
oscillations increase the levels of several proliferation-associated proteins and 
decrease p27-mediated inhibition (Resende et al., 2010).  Curiously, it was recently 
proposed that the length of G1 directly influences the differentiation rate of neural 
precursors (Lenos and Tsaniklidou, 2010; Salomoni and Calegari, 2010a; Salomoni 
and Calegari, 2010b).  In this respect, it appears that G1 phase prolongation is both 
necessary and sufficient to induce switching from proliferation to differentiation in 
neural progenitors (Salomoni and Calegari, 2010a).  Therefore, it is not surprising that 
calpains accelerate G1 to S transition and that calpain inhibition is necessary to 
increase G1 length and promote neural stem cell differentiation.  Consistent with this 
hypothesis, our results revealed that treatment of neural stem cells with calpeptin 
induces a significant decrease in the proportion of Nestin-positive neural progenitors, 
while increasing the proportion of neuronal cells positive for β-III Tubulin.  These 
results were also obtained in MNSC cultures, revealing that NSC differentiation 
induced by calpain inhibition was not restricted to the NS-TGFP cell line.  To clarify 
the specific signaling pathway that regulate calpain activity in NSC, NS-TGFP cells 
were treated with different chemical inhibitors of major signaling pathways.  Our 
results showed that, similarly to calpeptin treatment, inhibition of calcium flux 
strongly influences NSC fate decision.  We tested the IP3R, L-type channel and 
ryanodine receptor inhibitors xestospongin C, nifedipine, and dantrolene, 
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respectively, and observed that the first two had a significant effect in NSC 
differentiation, decreasing Nestin and increasing β-III Tubulin positive cells in the 
population.  In fact, it has already been shown that calcium oscillations in neural 
progenitor cells are restricted to the G1/S transition and require calcium influx only 
through IP3Rs, L-type channels and ryanodine receptors (Resende et al., 2010).  Since 
calpains are calcium-activated proteases, it is possible that calpains are regulated by 
calcium oscillations in G1, thereby promoting cell cycle progression through 
modulation of cell cycle proteins. 
To further address the role of calpains during neural differentiation, the 
expression levels of specific calpain 1 and 2 were investigated and found to be 
strikingly different throughout NSC differentiation.  In fact, while calpain 1 
expression was higher during self-renewal and decreased throughout differentiation, 
expression of calpain 2 markedly increased during neural differentiation in both NS-
TGFP and MNSC.  More importantly, fluctuations in calpain expression are not 
associated with cell-death signaling pathways, as no difference was detected in cell 
viability throughout differentiation in both cell models.  Thus, our observation raises 
the possibility that calpain 1 and 2 differentially regulate NSC biology.  The fact that 
calpain 1 is mostly expressed in self-renewing NSC suggests its involvement in 
regulation of proliferation mechanisms.  Indeed, distinct functions for both calpains 
have already been reported.  Calpain 1, but not calpain 2, was shown to be present in 
the nucleus and cytoplasm of cultured cortical neurons, being capable of degrading 
p27 in cell lysates (Akashiba et al., 2006). In addition, calpain 1 degraded the G1 
cyclin dependent kinase inhibitor p19INK4d in vitro (Joy et al., 2006), consistent with a 
role in the regulation of cellular self-renewal.  Notably, our data validates this 
hypothesis by showing that calpain 1 silencing increases both neuronal and glial 
differentiation.  
In this study, calpain 2 levels increased throughout neural differentiation, 
suggesting that this specific calpain plays a role later in differentiation.  Accordingly, 
studies on PC12 neuronal differentiation have demonstrated that although calpain 
inhibition is important in early events of the differentiation process, calpains may be 
required in later stages as well (Pinter et al., 1994; Vaisid et al., 2005).  In fact, 
calpastatin levels declined later during differentiation in a caspase-1 dependent 
manner, allowing calpain-mediated cleavage of fodrin (Vaisid et al., 2005).  Our 
results showed that calpain 2 silencing elicited a significant decrease in GFAP 
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expression during neural differentiation, while no significant differences were 
detected in β-III Tubulin expression.  This finding, coupled with others showing that 
calpain 2 is mostly localized in glial cells, while calpain 1 is located primarily in 
neurons (Hamakubo et al., 1986; Ray et al., 2002; Akashiba et al., 2006), suggests 
that calpain 2 activity is important for glial, but not neuronal differentiation.  In fact, 
the inhibition of both calpains during neural differentiation by calpastatin resulted in a 
marked increase in β-III Tubulin expression and no differences in GFAP levels.  If 
calpain 1 is indeed responsible for maintaining NSC self-renewal, it would be 
expected that its inhibition would induce a significant increase in both β-III Tubulin 
and GFAP, as detected after calpain 1 silencing. However, it is not surprising that 
GFAP levels remained unchanged after calpastatin treatment if we consider that 
inhibition of calpain 2 leads to decreased GFAP expression.  Thus, calpain regulation 
of neural stem cell fate choices is apparently a complex process that may involve a 
tightly coordinated action of different calpains during self-renewal and differentiation 
stages.  
Collectively, our results support a role for calpain 1 in the maintenance of a 
proliferative neural stem cell pool, and suggest that calpain 2 is involved in the onset 
of glial differentiation.  Further insight into the factors regulating calpain 1 and 2 
activities and their specific substrates during neural differentiation is necessary to 
understand the complexity of calpain function in NSC fate decision. 
 
Acknowledgments 
We are grateful to Dr. Elsa Abranches and Dr. Evguenia Bekman (Instituto de 
Medicina Molecular, University of Lisbon, Lisbon, Portugal) for skillful technical 
assistance in establishing NS-TGFP cell line culture conditions.  The authors also 
wish to thank Dr. João Barata (Instituto de Medicina Molecular) for the cyclin E, p21 
and p27 antibodies, Dr. Dora Brites (iMed.UL, University of Lisbon, Lisbon, 
Portugal) for the rabbit anti-GFAP antibody and Dr. Carlos Duarte (Center for 
Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal) for the 
pcDNA-Flag-mCAST plasmid. 
This work was supported by grants PTDC/SAU-NMC/117877/2010 and Pest-
OE/SAU/UI4013/2011 from Fundação para a Ciência e a Tecnologia (FCT), Lisbon, 
Portugal. D.M.S, J.M.X., and A.L.M. were recipients of Ph.D. fellowships 
SFRH/BD/42008/2007, SFRH/BD/68368/2010, and SFRH/BD/80060/2011, 
Chapter	  4	  
84 
respectively, from FCT. The funders had no role in study design, data collection and 
analysis, decision to publish, or preparation of the manuscript. 
 
 
 
  
	  	  
	  	  	  	  	  	  	  	  	  	  
Synthetic condensed 1,4-naphthoquinone 
derivative shifts neural stem cell differentiation 
by regulating redox state 	  	  	  	  
Daniela M. Santos1, Maria M. M. Santos1, Rui Moreira1, Susana Solá1,2, 
Cecília M. P. Rodrigues1,2 
 
1Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL), Faculty of 
Pharmacy, University of Lisbon, Lisbon, Portugal 
2Department of Biochemistry and Human Biology, Faculty of Pharmacy, University 
of Lisbon, Lisbon, Portugal 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Molecular Neurobiology 2012, DOI: 10.1007/s12035-012-8353-y 
	  	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reprinted from Molecular Neurobiology, DOI: 10.1007/s12035-012-8353-y, Daniela 
M. Santos, Maria M. M. M. Santos, Rui Moreira, Susana Solá, Cecília M. P. 
Rodrigues.  Synthetic Condensed 1,4-naphthoquinone Derivative Shifts Neural Stem 
Cell Differentiation by Regulating Redox State, Copyright 2012, with permission 
from Springer Science plus Business Media. All rights reserved. 
 
Results	  
 
5.1 Abstract 
Naphthoquinones are bioactive compounds widespread in nature that impact 
on several cellular pathways, including cell proliferation and survival, by acting as 
prooxidants and electrophiles.  We have previously described the role of the synthetic 
isoxazole condensed 1,4-naphthoquinone derivative 1a in preventing apoptosis 
induced by distinct stimuli in several cell models.  In addition, apoptosis regulators 
and executioners may control neural stem cell (NSC) fate, without involving cell 
death per se.  Here, we hypothesize that 1a might also play a role in NSC fate 
decision.  We found that exposure to 1a shifts NSC differentiation potential from 
neurogenic to gliogenic lineage and involves the generation of reactive oxygen 
species, without increasing cell death.  Modulation of caspases and calpains, using 
cysteine protease inhibitors, failed to mimic 1a effects.  In addition, incubation with 
the naphthoquinone derivative resulted in upregulation and nuclear translocation of 
antioxidant responsive proteins, Nrf2 and Sirt1, which in turn may mediate 1a-
directed shift in NSC differentiation.  In fact, antioxidants halted the shift in NSC 
differentiation potential from neurogenic to gliogenic lineage, while strongly reducing 
reactive oxygen species generation and Nrf2 and Sirt1 nuclear translocation in NSC 
exposed to 1a.  Collectively, these data support a new role for a specific 
naphthoquinone derivative in NSC fate decision and underline the importance of 
redox environment control. 
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5.2 Introduction 
Stem cells are uncommitted cells with the ability to self-renew and to 
differentiate into specialized, functional cells (Murry and Keller, 2008).  They reside 
in different tissues, both in the embryo and in the adult organism and display different 
differentiation capacities. The ability of neural stem cells (NSC) to differentiate is 
restricted to the neural lineage, thus differentiating into neuronal and glial cells (Gage, 
2000).  NSC hold great promise for neuro-replacement therapies; however, many 
challenges need to be overcome before clinical application of NSC-based therapy is 
successfully adopted in patients with neurological diseases (Daadi, 2011).  The 
characterization of signaling pathways that regulate neural differentiation is a step in 
the right direction, as it paves the way for molecular manipulation of cellular 
processes to obtain desirable cell types, both in vitro and following transplantation in 
vivo (Lyssiotis et al., 2011).  
Quinones are bioactive compounds widespread in nature that display 
inflammatory, anti-inflammatory, cytotoxic and anticancer properties, among others 
(Bolton et al., 2000; Kumagai et al., 2012).  These compounds may function as 
prooxidants, leading to the production of reactive oxygen species (ROS), and as 
electrophiles, forming covalent bonds with tissue nucleophiles, particularly with the 
cysteine thiol groups present in numerous molecules (Kumagai et al., 2012).  ROS are 
important signaling molecules that impact several cellular pathways, including cell 
proliferation and survival (Ray et al., 2012).  In fact, several molecules are activated 
in response to alterations in the redox state, including nuclear factor erythroid 2-
related factor 2 (Nrf2), which translocates to the nucleus in oxidative conditions and 
binds to anti-oxidant response elements (ARE), driving transcription of cytoprotective 
genes (Baird and Dinkova-Kostova, 2011).  Another example is Sirtuin 1 (Sirt1), a 
nicotinamide adenine dinucleotide (NAD+)-dependent protein deacetylase, which 
responds to energetic and redox status, regulating many different processes, such as 
cell cycle, apoptosis and lifespan (Rajendran et al., 2011). 
We have previously shown that synthetic naphtho[2,3-d]isoxazole-4,9-dione-
3-carboxylates 1a and 1b are capable of protecting primary rat hepatocytes, human 
hepatocarcinoma (HuH-7) and rat pheochromocytoma (PC12) cells from apoptosis 
induced by distinct stimuli (Santos et al., 2009).  These naphthoquinone derivatives 
were able to modulate apoptotic pathways at several levels, preventing cytochrome c 
release from the mitochondria, reducing the activity of caspases-3, -8 and -9, and up-
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regulating pro-survival Bcl-XL (Santos et al., 2009; Castro et al., 2010).  Interestingly, 
it has recently been recognized that cell death-relevant proteins, notably those that 
operate in the core of the executing apoptosis machinery are functionally involved in 
differentiation of a wide range of cell types, including neural cells (Fernando et al., 
2002; Fernando et al., 2005; Fernando and Megeney, 2007; Stiewe, 2007).  We have 
previously shown that caspase inhibition and p53 silencing synergistically delay 
neural differentiation (Aranha et al., 2009), and that calpain 1 promotes self renewal 
of NSC and inhibits general neural differentiation, while calpain 2 is associated with 
glial differentiation (Santos et al., 2012).  In addition, we observed a cell death-
independent modulation of several apoptosis associated microRNAs during 
differentiation of mouse embryonic stem cells, PC12 and human teratocarcinoma-
derived Ntera2/D1 neuron-like (NT2N) cells (Aranha et al., 2010), and showed that 
miR-34a is required for neuronal differentiation (Aranha et al., 2011).  Therefore, we 
hypothesized that naphthoquinone derivatives might also have the ability to modulate 
NSC fate decision, in addition to their cell death modulating properties.  
In the present study, we elucidated the role of the naphtho[2,3-d]isoxazole-4,9-
dione-3-carboxylate 1a during NSC differentiation.  Our results suggest that this 
specific naphthoquinone influences NSC fate switch, facilitating glial versus neuronal 
fate decision. In addition, the quinone-directed effect appears to involve production of 
ROS and upregulation of antioxidant response proteins, such as Nrf2 and Sirt1.  These 
results underscore the distinct regulatory functions of naphthoquinone derivatives in 
NSC fate decision. 
 
5.3 Materials and methods 
5.3.1 Ethics 
The NS-TGFP cell line was obtained from Dr. Smith’s Laboratory, University 
of Cambridge, Cambridge, UK (Silva et al., 2006), and provided by Dr. Henrique, 
University of Lisbon, Lisbon, Portugal.  The Animal Ethical Committee at the Faculty 
of Pharmacy, University of Lisbon, Portugal waived the need for approval.  
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5.3.2 Chemical synthesis of naphtho[2,3-d]isoxazole-4, 9-dione-3-carboxylate 1a 
Naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylate 1a (Fig. 3.1) was 
synthesized using previously reported methods (Santos et al., 2009; Santos et al., 
2010). The compound was recrystallized in AcOEt/n-hexane and then used in all 
experiments.  
 
5.3.3 Cell culture 
NS-TGFP cells were derived from 14.5-dpc mouse fetal forebrain, and 
constitutively express the fusion protein Tau-GFP (Pratt et al., 2000; Silva et al., 
2006).  This cell line was established using a method that produces pure cultures of 
adherent NSC, which continuously expand by symmetrical division and are capable 
of tripotential differentiation (Conti et al., 2005; Pollard et al., 2006; Glaser et al., 
2007). NS-TGFP cells were grown in monolayer as previously described 
(Spiliotopoulos et al., 2009; Santos et al., 2012) and routinely maintained in 
undifferentiation medium, Euromed-N medium (EuroClone S.p.A., Pavia, Italy), 
supplemented with 1% N-2 supplement (Invitrogen Corp., Grand Island, NY), 20 
ng/mL epidermal growth factor (EGF; PeproTech EC, London, UK), 20 ng/mL basic 
fibroblast growth factor (bFGF; PeproTech EC) and 1% penicillin-streptomycin 
(Invitrogen Corp.), in uncoated tissue culture plastic flasks at 37°C in a humidified 
atmosphere of 5% CO2.  Medium was changed every 3 days and cells collected with 
accutase (Sigma-Aldrich Co., St. Louis, MO) when confluent.  Neural differentiation 
of NS-TGFP cells was performed by first platting cells in undifferentiation medium 
onto uncoated tissue culture plastic dishes at 3x104 cells/cm2 for 24 h, and changing 
the culture medium to differentiation medium, Euromed-N medium supplemented 
with 10 ng/mL bFGF, 0.5% N-2 supplement, 1% B27 supplement and 1% penicillin-
streptomycin. 
 
5.3.4 Cell treatments 
Cells were treated with chemical compounds upon medium change, allowed to 
differentiate for different time periods up to 72 h and then collected for 
immunoblotting, flow cytometry or immunocytochemical analysis.  25 µM or 50 µM 
naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylate 1a, solubilized  in DMSO (Sigma-
Aldrich Co.), was added to NSC.  To inhibit calpains and caspases, 50 µM calpeptin 
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(Tocris Bioscience, Bristol, UK) and 50 µM Z-VAD-FMK (Sigma-Aldrich Co.), 
respectively, were added to cells for 48 h.  For redox studies, known antioxidants such 
as 0.5 µM N-acetylcysteine (NAC) and 50 µM lipoic acid (LA) (Sigma-Aldrich Co.) 
were used. When cells were differentiated for 1 day or more, NAC and LA were only 
added 20 h after induction of differentiation.  For ROS quantification, 10 µM 2',7'-
dichlorodihydrofluorescein diacetate (H2DCFDA) (Molecular Probes, Invitrogen, 
Eugene, OR, USA) was added to the culture medium 30 min prior to cell collection 
and posterior flow cytometry analysis.  DMSO was routinely added as a negative 
control. 
 
5.3.5 Cell flow cytometry analysis 
NS-TGFP cells were washed twice with Ca2+- and Mg2+-free phosphate buffer 
saline (PBS) (Invitrogen Corp.), treated with accutase and harvested with PBS.  For 
cell death analysis, cells were stained with the vital dye PI (5 µg/mL; Sigma-Aldrich 
Co.) and Annexin-V-APC (eBioscience, Inc., San Diego, CA), according to 
manufacturer's instructions, to determine phosphatidylserine exposure.  For ROS 
quantification, cells pre-treated with H2DCFDA were resuspended in PBS with 2% 
fetal bovine serum (FBS) (Invitrogen Corp.) and emission of green fluorescence was 
analyzed after 20 min.  For detection of nestin, β-III tubulin and GFAP expression 
levels, cells were fixed with paraformaldehyde (4% w/v) in PBS for 20 min at 4oC, 
washed twice with washing solution 0.1% saponin (Fluka, Biochemika, Switzerland) 
in PBS, and blocked for 20 min in blocking solution 0.25% saponin and 5% FBS in 
PBS.  Subsequently, cells were washed and incubated for 30 min with mouse primary 
antibodies reactive to β-III tubulin (Tuj1; Covance, Princeton, New Jersey) or GFAP 
(MAB360; Chemicon International) at a dilution of 1:500 and 1:200, respectively, or 
with an Alexa Fluor 647-conjugated mouse antibody reactive to nestin (560393; BD 
Biosciences Pharmingen, San Diego, CA) at a dilution of 1:5.  All antibodies were 
diluted in antibody blocking solution (0.1% saponin and 5% FBS in PBS).  Cells were 
then washed twice and for β-III tubulin and GFAP detection, further incubated with 
anti-mouse antibodies conjugated to Dylight 649 or Dylight 488 (Jackson 
ImmunoResearch Laboratories, Inc., West Grove, PA) at a dilution of 1:5000 or 
1:100, respectively, for 30 min.  Cells were washed twice, resuspended in PBS with 
2% FBS and analyzed using the FACS Calibur (Becton Dickinson, Mountain View, 
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CA).  Data were statistically evaluated using FlowJo software (Tree Star, Inc, 
Ashland, OR). 
 
5.3.6 Immunoblotting 
Steady-state levels of β-III tubulin, GFAP, Sirt1, Nrf2 and β-actin were 
determined by immunoblotting.  Cells were collected and lysed for isolation of total 
protein extracts with lysis buffer (50 mM KCl, 50 mM PIPES, 10 mM EGTA, 2 mM 
MgCl2, 0.5% Triton X-100, pH 7.4) supplemented with 100 µM PMSF, 1 mM DTT 
and Halt Protease and Phosphatase Inhibitor Cocktail (Thermo Fisher Scientific Inc., 
Rockford, IL), followed by centrifugation at 200g at 4oC for 20 min.  Protein content 
was measured by the Bio-Rad protein assay kit (Bio-Rad Laboratories, Hercules, CA, 
USA) according to the manufacturer's specifications, using bovine serum albumin as 
standard. Eighty to twenty µg of total protein extracts were separated on 8% sodium 
dodecyl sulphate-polyacrylamide electrophoresis gel, and then subjected to 
immunoblotting using primary mouse monoclonal antibodies reactive to β-III tubulin 
(Tuj1; Covance), GFAP (MAB360; Chemicon International), Nrf2 (R&D Systems, 
Minneapolis, MN, USA) or β-actin (A5441; Sigma-Aldrich Co.) or rabbit polyclonal 
antibodies reactive to Sirt1 (Millipore Corporation, Billerica, MA).  Blots were 
subsequently incubated with secondary antibodies conjugated with horseradish 
peroxidase (Bio-Rad Laboratories).  Finally, membranes were processed for protein 
detection using Immobilon (Millipore Co.) or SuperSignal reagent (Pierce, Rockford, 
IL).  Ponceau S staining was also used to assess equal gel loading. 
 
5.3.7 Immunocytochemistry 
For fluorescence microscopy, NS-TGFP cells were fixed with 
paraformaldehyde (4%, w/v) in PBS and blocked for 1 h at room temperature in PBS, 
containing 0.1% Triton-X-100, 1% FBS, and 10% normal donkey serum (Jackson 
ImmunoResearch Laboratories, Inc.).  Cells were incubated with primary mouse 
monoclonal antibodies reactive to β-III tubulin (Tuj1; Covance) or GFAP (MAB360; 
Chemicon International) at a dilution of 1:500 or with primary rabbit policlonal 
antibodies reactive to Sirt1 (Millipore Corporation) or Nrf2 (ab31163; Abcam, 
Cambridge, MA) at a dilution of 1:250 or 1:50, respectively, overnight at 4°C.  For β-
III tubulin and GFAP detection, cells were incubated with an Alexa 568 conjugated 
Results	  
93 
anti-mouse antibody (Life Technologies Ltd, Paisley, UK) and for Sirt1 and Nrf2 
detection, R-PE-conjugated (Jackson ImmunoResearch Laboratories, Inc.) and Alexa 
488-conjugated (Life Technologies Ltd) anti-rabbit antibodies were used, 
respectively. Secondary antibodies were diluted 1:200 and incubated for 2 h at room 
temperature.  All antibodies were diluted in blocking solution.  Mouse NSC nuclei 
were stained with Hoechst 33258 (Sigma-Aldrich Co.) at 50 µg/ml in PBS, for 10 min 
at room temperature.  Samples were mounted using Fluoromount-G™ (Beckman 
Coulter, Inc., Brea, CA).  Fluorescence microscopy assessments were performed with 
a Zeizz AX10 microscope (Carl Zeiss, Jena, Germany) equipped with a Leica 
DFC490 camera (Leica Weitzlar, Germany).  Total and nuclear fluorescence was 
measured by manual tracing of the nucleus and corresponding cells using ImageJ 
software (National Institutes of Health).  Cytoplasmic fluorescence and corresponding 
area were determined by subtracting nuclear from total fluorescence and nuclear from 
total cellular area.  Results were expressed as mean fluorescence intensity per µm2 or 
ratio between nuclear and cytoplasmic values. 
 
5.3.8 Densitometry and statistical analysis 
The relative intensities of protein bands were analyzed using the Quantity One 
Version 4.6.3 densitometric analysis program (Bio-Rad Laboratories).  Results from 
different groups were compared using the Student’s t test, two-way ANOVA or one-
way ANOVA followed by Bonferroni’s or Dunnett’s multiple comparison tests.  
Values of p < 0.05 were considered statistically significant.  All statistical analysis 
was performed with GraphPad Prism 5 software (GraphPad Software, Inc., San 
Diego, CA). 
 
5.4 Results 
5.4.1 Naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylate 1a induces a shift from 
neuronal to glial differentiation of NSC 
Recent studies identified a strong correlation between apoptosis-regulatory 
proteins and regulation of cellular differentiation (Sola et al., 2012).  In addition, it 
has been previously shown that naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylate 1a 
is a potent inhibitor of apoptosis (Santos et al., 2009).  Although naphthoquinones 
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influence a wide range of well-established cellular events, the potential of 1a to 
modulate NSC differentiation has not yet been explored.  
To address the impact of the quinone derivative 1a in NSC differentiation, we 
first incubated NS-TGFP cells with this specific compound under differentiation 
conditions.  We have previously characterized the differentiation of adherent mouse 
NSC, NS-TGFP (Santos et al., 2012).  In the present study, differentiation of NS-
TGFP was induced by changing the culture medium, as described in Materials and 
Methods, and 25 or 50 µM 1a or control DMSO were added at the same time.  Cells 
were allowed to differentiate for 72 h and the expression of stemness marker nestin 
and differentiation markers β-III tubulin and glial fibrillary acidic protein (GFAP) was 
analyzed throughout time.  Flow cytometry analysis revealed that 1a exposure did not 
change the percentage of nestin-expressing cells (Fig. 5.1A), indicating that it neither 
promotes nor inhibits differentiation of NSC in these conditions.  However, 50 µM 1a 
treatment promoted variations in the expression of differentiation markers, decreasing 
the percentage of β-III tubulin-positive neuronal cells and increasing the proportion of 
GFAP-positive glial cells (Fig. 5.1B).  These results were further confirmed by 
Western blot analysis (Fig. 5.1C).  Importantly, 1a treatment did not affect the 
viability of cells throughout the time of differentiation, as determined by PI/Annexin 
V staining (Fig. 5.1D).  Our data suggest that 1a may be responsible for a shift in the 
differentiation potential of NSC from the neuronal to the glial lineage. 
 
5.4.2 The 1a-directed NSC fate switch is independent of cysteine protease 
inhibition 
We have previously shown that 1a inhibits apoptosis pathways in cells 
stimulated with different toxic insults (Santos et al., 2009).  In addition, non-radical 
oxidants such as quinones have the ability to directly alter active site cysteines, thus 
regulating protein activity (Jones, 2008).  Caspases and calpains are well known 
apoptotic cysteine proteases that are also involved in NSC differentiation (Aranha et 
al., 2009; Santos et al., 2012).  Therefore, we tested if these apoptosis-associated 
proteases are responsible for 1a-induced shift in NSC fate.  NSC were incubated with 
calpain and caspase inhibitors, either separately or combined, and the ability of 
protease inhibitors in mimicking the 1a effect in NSC fate was evaluated.   
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Figure 5.1. 1a decreases neuronal and increases glial differentiation of mouse NSC.  NS-
TGFP cells were grown in differentiation medium, incubated with 25 or 50 µM 1a or DMSO 
(control) and collected after 24, 48 or 72 h as described in Materials and Methods. (A) Flow 
cytometry analysis of nestin expression throughout differentiation revealed no significant 
differences in progenitor percentage with 1a treatment. (B) Flow cytometry analysis of β-III 
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tubulin (left) and GFAP (right) expression throughout differentiation showed that 50 µM 1a 
elicited a significant decrease in neuronal cells and an increase in glial cells, respectively. (C) 
Representative immunoblots (top) and corresponding densitometry analysis (bottom) showing 
decreased β-III tubulin and increased GFAP protein levels after 48 h treatment. β-actin was 
used as loading control. (D) Flow cytometry analysis of PI and Annexin V double-negative 
(viable) cells showing no significant changes in viability after 1a treatment. Data represent 
mean ± SEM of at least three independent experiments. §p < 0.05, *p < 0.01 and †p < 0.001 
from respective control. 
 
Flow cytometry analysis of nestin, β-III tubulin and GFAP revealed that Z-
VAD-FMK, a pan caspase inhibitor, did not significantly affect NSC differentiation in 
these conditions (Fig. 5.2).   
 
 
 
 
 
Figure 5.2. 1a-directed NSC fate switch is 
independent of caspase and calpain inhibition.  NS-
TGFP cells were grown in differentiation medium and 
treated for 48 h with 50 µM 1a and/or calpeptin or Z-
VAD-FMK or DMSO (control), as described in 
Materials and Methods. Flow cytometry analysis of 
stemness marker nestin (top), neuronal marker β-III 
tubulin (middle) and glial marker GFAP (bottom) 
showed that neither caspase nor calpain inhibition with 
Z-VAD-FMK or calpeptin elicited changes in the 
expression patterns of these markers similar to 1a 
treatment. Data represent mean ± SEM of at least three 
independent experiments. §p < 0.05, *p < 0.01 and †p < 
0.001 from respective control. 
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Calpeptin, a calpain chemical inhibitor, on the other hand, was responsible for 
a significant decrease in the proportion of nestin-positive cells, even when cells where 
co-incubated with 1a.  This reduction in nestin expression is in accordance with our 
previous observations regarding the role of calpain 1 in maintaining proliferation and 
inhibiting differentiation of NSC (Santos et al., 2012).  It thus appears that calpeptin 
acts at an earlier stage, inhibiting self-renewal of NSC.  Nevertheless, calpain 
inhibition elicited a decrease in β-III tubulin and an increase in GFAP proportion, 
similar to 1a treatment.  While we cannot exclude that calpains are part of the 
mechanism of action of 1a in NSC fate decision, the differences found in nestin 
expression indicate that other mechanisms may be involved. 
 
5.4.3 1a increases intracellular levels of reactive oxygen species (ROS) and 
antioxidant response proteins  
Quinones are known for their pro-oxidant activity, as they can generate ROS 
by electron transfer reactions (Kumagai et al., 2012).  ROS, in turn, control several 
signaling pathways and have the ability to modulate NSC differentiation (Vieira et al., 
2011).  To investigate whether 1a treatment increased ROS activity in differentiating 
NSC, we incubated cells with 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA), 
which upon oxidation is converted into the fluorescent 2',7'-dichlorofluorescein 
(DCF), allowing the detection and quantification of intracellular ROS.  We measured 
the resulting fluorescence by flow cytometry and observed that 1a elicited a 
significant increase in intracellular ROS, compared to control (Fig. 5.3A).  This early 
increase in ROS was maintained throughout time, up to 72 h.  The antioxidant N-
acetylcysteine (NAC) effectively reduced 1a-induced increase in ROS activity (Fig. 
5.3B). 
To better understand the impact of 1a-mediated increase in intracellular ROS, 
we investigated Sirt1 and Nrf2, two redox responsive proteins that during oxidative 
conditions are translocated to the nucleus and control gene expression (Baird and 
Dinkova-Kostova, 2011; Rajendran et al., 2011).  In fact, a significant increase in 
both Sirt1 and Nrf2 expression levels was observed after 2 h of 1a treatment (Fig. 
5.4A).  We did not observe consistent differences in latter time-points (data not 
shown), suggesting that Sirt1 and Nrf2 expression is tightly regulated and restricted in 
time.  Since the subcellular distribution of the two proteins is a better indicative of 
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their activity, we then investigated the impact of 1a in Sirt1 and Nrf2 nuclear 
translocation.   
 
 
Figure 5.3. 1a increases intracellular levels of ROS during NSC differentiation.  NS-
TGFP cells were grown in differentiation medium, treated with 50 µM 1a or DMSO (control) 
and incubated for 5, 24, 48 and 72 h. The antioxidant NAC was added at induction of 
differentiation. ROS levels were detected by incubating cells with H2DCFDA for 30 min, 
prior to collection. The resultant, oxidized, fluorescent DCF was detected by flow cytometry 
as described in Materials and Methods. (A) Representative histograms of intracellular ROS 
(left) and respective quantification at 5 h (right). (B) Co-treatment with 0.5 µM NAC partially 
prevented the increase in ROS elicited by 1a at 5 h. Data represent mean ± SEM of three 
independent experiments. §p < 0.05 
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Figure 5.4. Antioxidant response pathways are activated by 1a treatment during NSC 
differentiation.  NS-TGFP cells were grown in self-renewal conditions (Undiff) or in 
differentiation medium, treated with 50 µM 1a or DMSO (control) for 0.5, 1, 2 or 24 h, as 
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described in Materials and Methods. (A) Representative immunoblots showing an increase in 
Sirt1 and Nrf2 expression levels after 2 h of 1a treatment. β-actin was used as loading control. 
Immunofluorescence detection of cells labeled with anti-Sirt1 (B) and anti-Nrf2 (C) 
antibodies showing translocation of antioxidant response proteins to the nucleus following 
induction of differentiation and a further increase in this response in 1a treated cells. Hoechst 
33258 staining was used to visualize cell nuclei. Scale bar, 10 µm 
 
Our results showed that induction of differentiation per se is enough to 
promote Sirt1 translocation to the nucleus after 30 min, where it could still be 
detected after 2 h (Fig. 5.4B).  Notably, 1a treatment was responsible for an even 
more pronounced nuclear versus cytoplasmic localization at these differentiation 
times.  However, after 24 h of differentiation, the expression of Sirt1 returned to 
lower levels, both in control and in 1a-treated cells.  In addition, Nrf2 was more 
concentrated in the nucleus after 2 h of differentiation and had a lower expression 
after 24 h (Fig. 5.4C).  Similarly, 1a-treated cells showed a more sustained Nrf2 
activation pattern, with nuclear Nrf2 localization more evident after 24 h of NSC 
differentiation and 1a treatment.  To evaluate whether Sirt1 and Nrf2 activation by 1a 
was due to increased ROS production, we co-treated cells with two known 
antioxidants, NAC and lipoic acid (LA).  Antioxidants alone elicited no significant 
changes in Sirt1 and Nrf2 expression or nuclear localization (Fig. 5.5A and B).  
Western blot data confirmed these negative results (data not shown).  Nevertheless, 
both NAC and LA decreased nuclear localization of Sirt1 and Nrf2 after 1a exposure 
for 2 and 24 h, respectively (Fig. 5.5A and B).  Sirt1 total fluorescence was also 
reverted to control levels by antioxidant treatment (Fig 5.5B).  These data indicate 
that 1a activates antioxidant response pathways in differentiating NSC, through ROS 
production. 
 
5.4.4 ROS mediate the 1a-directed shift in the differentiation potential of NSC 
Recently, the interdependence between oxidative defense and NSC 
differentiation fate has been demonstrated, and it has been suggested that ROS 
production and mtDNA damage is the primary signal for the elevated astrogliosis and 
lack of neurogenesis seen during repair of neuronal injury (Wang et al., 2010; Wang 
et al., 2011). Thus, we aimed to investigate whether 1a-mediated ROS production was 
Results	  
101 
responsible for the observed shift in NSC differentiation potential by co-treating 
differentiating NSC with 1a and antioxidants.   
 
 
 
Figure 5.5. Antioxidants revert Sirt1 and Nrf2 activation in response to 1a treatment. 
NS-TGFP cells were grown in differentiation medium and treated with 50 µM 1a or DMSO 
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(control). The antioxidants NAC or LA were added at the same time or 20 h after induction of 
differentiation, as described in Materials and Methods. Immunofluorescence detection (A) 
and respective quantification (B) of cells labeled with anti-Sirt1 and anti-Nrf2 antibodies at 2 
and 24 h, respectively, showing reversion of 1a-elicited nuclear translocation in cells co-
treated with antioxidants. Hoechst 33258 staining was used to visualize cell nuclei. Scale bar, 
10 µm. Fluorescence is expressed as mean fluorescence intensity per µm2 per cell and as ratio 
between nuclear and cytoplasmic fluorescence levels per cell. 
 
Flow cytometry analysis showed that addition of NAC at the time of 
differentiation induction inhibited the differentiation process itself (data not shown). 
In fact, low levels of ROS must be required for the induction of differentiation, as 
suggested by the early activation of Sirt1 and Nrf2 previously observed (Fig. 5.4B and 
C).  For this reason, NSC were incubated with NAC 20 h after induction of 
differentiation and 1a supplementation.  Interestingly, flow cytometry analysis 
showed that the reduction in the proportion of β-III tubulin positive cells elicited by 
1a was reverted by ~ 55 % upon co-treatment with NAC (Fig. 5.6A).  Similarly, the 
increase in GFAP expressing cells observed after 1a incubation was prevented by ~ 
80 % with the addition of NAC (Fig. 5.6A).  The results were corroborated by 
immunocytochemistry analysis (Fig. 5.6B).  In addition, LA induced similar effects 
(Fig. 5.6B).  Thus, our results suggest that 1a shifts the differentiation potential of 
NSC from neurogenic to gliogenic lineage via ROS production. 
 
5.5 Discussion 
The present study identifies the quinone derivative naphtho[2,3-d]isoxazole-
4,9-dione-3-carboxylate 1a as a modulator of NSC fate.  We observed that treatment 
of differentiating NSC with 50 µM 1a resulted in increased proportion of GFAP 
expressing glial cells, in detriment of β-III tubulin expressing neuronal cells, without 
inducing cell death.  Importantly, this was not accompanied by significant changes in 
the proportion of nestin expressing progenitor cells, indicating that 1a does not delay 
nor accelerates differentiation, but rather shifts the potential of NSC to the gliogenic 
lineage.  Interestingly, consistent with these findings, the naphthoquinone plumbagin 
has been shown to stimulate astrocyte proliferation and differentiation via Stat3 
activation in a model of rat spinal cord neural progenitors (Luo et al., 2010).  
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Figure 5.6. 1a shifts NSC differentiation to glia through ROS production.  NS-TGFP 
cells were grown in differentiation medium, treated with 50 µM 1a or DMSO (control) and 
incubated for 48 and 72 h. The antioxidants NAC or LA were added 20 h after induction of 
differentiation, as described in Materials and Methods. (A) Representative histograms of β-III 
tubulin and GFAP-positive cells (top) and respective quantification data (bottom) at 48 and 
72 h, respectively. Data represent mean ± SEM of at least three independent experiments. *p 
< 0.01 and †p < 0.001 from DMSO. (B) Immunofluorescence detection of cells labeled with 
anti-β-III tubulin and anti-GFAP antibodies at 48 h and 72 h, respectively, showing partial 
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reversion of 1a effects in cells co-treated with antioxidants. Hoechst 33258 staining was used 
to visualize cell nuclei. Scale bar, 10 µm. 
 
Since we have previously described a role for apoptosis-associated proteases 
in several models of NSC differentiation (Aranha et al., 2009; Santos et al., 2012), we 
tested whether 1a acted through calpain or caspase inhibition.  In fact, both calpains 
and caspases have cysteine thiols in their active sites, redox-active and nucleophilic 
functional groups that can be modified by quinone derivatives, rendering the enzyme 
inactive (Kumagai et al., 2012).  In accordance, several authors have reported the 
reversible inactivation of calpains and caspases through oxidation of the active site 
cysteines (Borutaite and Brown, 2001; Carlin et al., 2006; Barbouti et al., 2007; 
Lametsch et al., 2008).  However, when we inhibited caspases in differentiating NSC 
by adding Z-VAD-FMK, we observed no significant differences in nestin, β-III 
tubulin or GFAP proportion in the population, compared to control.  Calpain 
inhibition by calpeptin, in turn, resulted in a decrease in β-III tubulin and an increase 
in GFAP proportion, similar to those observed in 1a-treated cells.  However, unlike 
1a exposure, calpain inhibition induced a significant decrease in the proportion of 
progenitor cells, marked with nestin.  This was probably due to a calpeptin-induced 
inhibition of differentiation (Santos et al., 2012).  Moreover, it has been shown that 
while oxidation inhibits the activity of calpains, it can also decrease the activity of the 
endogenous calpain inhibitor calpastatin, with the overall effect depending on 
environmental conditions, such as pH and ionic strength (Carlin et al., 2006).  Thus, 
while calpain inhibition cannot solely explain the 1a-mediated effects in 
differentiating NSC, possible interference of 1a with the calpain-calpastatin system 
cannot be excluded. 
To further address the role of 1a during neural differentiation, intracellular 
levels of ROS were investigated throughout NSC differentiation in the presence and 
absence of this compound, and were found to be strikingly different.  1a increased the 
intracellular levels of ROS in a sustained manner.  It is not surprising that 1a should 
act preferentially via ROS production since 1a is less electrophilic than simple 1,4-
naphthoquinones, such as plumbagin, due to the condensed isoxazole ring.  Indeed, it 
has been shown that differences in ring size of other condensed 1,4-naphthoquinones 
influenced the excited state properties and thus affected the efficiency of singlet 
oxygen generation (de Lucas et al., 2012).  We additionally observed that expression 
Results	  
105 
levels of Nrf2 were increased after 2 h of 1a incubation.  Activation of Nrf2 is one of 
the first cellular responses to redox imbalance, resulting in transcription of several 
stress-responsive and cytoprotective genes (Baird and Dinkova-Kostova, 2011).  In 
fact, it has been shown that several quinone derivatives can target specific cysteine 
residues of the Nrf2 repressor, Keap1 (Kobayashi et al., 2009), thus leading to Nrf2 
accumulation and nuclear translocation (Surh et al., 2008; Bock, 2012).  Our 
immunocytochemistry experiments showed that 1a-treated differentiating NSC had 
more Nrf2 in the nucleus after 30 min; the effect was particularly striking after 24 h 
treatment, when the levels of nuclear Nrf2 in control cells were lowest.  Importantly, 
we observed that addition of antioxidants after 1a treatment and induction of NSC 
differentiation reverted Nrf2 translocation to the nucleus, indicating that the 
mechanism of 1a-induced Nrf2 nuclear translocation is ROS-dependent.  It has been 
reported that induction of neuronal differentiation is accompanied by an increase in 
Nrf2 protein levels and that inhibition or activation of Nrf2 in PC12 and SH-SY5Y 
cells results in decreased or increased neuronal differentiation, respectively (Zhao et 
al., 2009; Kosaka et al., 2010).  Accordingly, we also observed a transient increase in 
Nrf2 in the nucleus upon induction of NSC differentiation.  However, 1a treatment in 
our model did not result in increased neurogenesis, but rather in increased gliogenesis.  
This difference could be attributed to limitations of the model systems, as PC12 and 
SH-SY5Y cells are neuronal restricted and cannot generate glial cells, or to different 
levels of Nrf2 activation. 
Additionally, 1a treatment resulted in increased expression of Sirt1 after 2 h, 
which was prevented by antioxidant treatment.  Sirt1 belongs to a large family of 
NAD-dependent protein deacetylases that have been linked to energy homeostasis and 
lifespan and is capable of sensing cellular redox status through fluctuations in the 
NAD+/NADH ratio (Yu and Auwerx, 2010; Rajendran et al., 2011; Houtkooper et al., 
2012).  Upon induction of NSC differentiation, we observed an increase in Sirt1 in the 
nuclear compartment.  This increase was detectable after 30 min and 2 h of 
differentiation, but was no longer present after 24 h.  Indeed, others have already 
described a transient translocation of Sirt1 to the nucleus upon induction of neural 
precursor cell differentiation (Hisahara et al., 2008).  We found that 1a increased 
nuclear Sirt1 at the beginning of differentiation, but not after 24 h, and that this 
increase was prevented by co-treatment with antioxidants, indicating a role for 
cellular redox state.  Others have shown decreased neuronal and oligodendrocytic, but 
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not astrocytic, differentiation of neural precursor cells upon Sirt1 inhibition, as well as 
increased neurogenesis after Sirt1 overexpression and nuclear translocation (Hisahara 
et al., 2008).  In contrast, we observed a decrease in the proportion of β-III tubulin-
expressing neuronal cells after 1a treatment.  This is in line with observations by 
others, showing that induction of mild oxidation in neural progenitors leads to 
suppression of neurogenesis and astrocyte expansion through Sirt1 activation 
(Prozorovski et al., 2008).  In addition, it has been reported that abnormal 
accumulation of mitochondrial DNA damage in differentiating neural cells leads to 
Sirt1 activation and shifts differentiation toward an astrocytic lineage, which can be 
prevented by antioxidant treatments (Wang et al., 2011).  Accordingly, we also 
observed an increase in GFAP-expressing glial cells paired with decreased neuronal 
cell numbers in 1a treated differentiating NSC.  We then investigated whether this 
shift in differentiation was indeed caused by ROS generation by co-treating cells with 
antioxidants.  While we initially added NAC and 1a to NSC at the same time, after 
inducing differentiation, we observed decreased levels of both β-III tubulin and GFAP 
expressing cells in cultures treated with the antioxidant (data not shown), indicating 
that blocking oxidation at early stages of differentiation inhibits the process itself.  
Indeed, it is known that high endogenous levels of ROS in NSC are crucial for the 
regulation of self-renewal and neuronal differentiation (Le Belle et al., 2011; Vieira et 
al., 2011).  Therefore, to allow proper induction of differentiation, we only added 
NAC and LA 20 h after changing the culture medium and adding 1a.  Importantly, we 
observed a partial reduction of the 1a effects in NSC differentiation potential, 
indicating that ROS generation by the napthoquinone derivative is an important part 
of its mode of action.  Moreover, this data indicate that while Sirt1 activation may 
play a role in the 1a-mediated shift in differentiation potential, other pathways are 
surely involved, as we only detected a transient activation of Sirt1 at the beginning of 
differentiation, several hours before antioxidant addition to the cultures.  Nrf2 
activation by 1a, however, was more evident at 24 h and was prevented by addition of 
antioxidants at 20 h, making this pathway a more likely candidate for ROS mediated-
1a regulation. 
Collectively, our results identify a new role for the quinone derivative 
naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylate 1a in driving NSC to a glial, rather 
than neuronal fate. This could be particularly relevant in the treatment of neurological 
disorders associated with a significant decrease in astrocyte density, such as 
Results	  
107 
schizophrenia, bipolar disorder and major depressive disorders (Webster et al., 2005; 
Williams et al., 2012).  However, further insights into the mechanism by which 1a-
induced ROS production switches NSC fate, namely the identification of relevant 
Nrf2 downstream targets, are necessary to fully understand the complexity of this 
specific naphthoquinone derivate in mediating NSC fate decision. 
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Cell fate decision results from the integration of multiple environmental and 
intrinsic signals by the cell. Although we tend to compartmentalize cellular processes 
to facilitate experimental studies and development of paradigms, these barriers and 
static definitions are artificial, often detrimental to scientific progress. The studies 
presented in this thesis contribute to an integrated view of neural differentiation, 
proliferation and apoptotic processes in cell fate decision. 
We started by evaluating the ability of two synthetic naphthoquinone 
derivatives, naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylates 1a and 1b, to prevent 
cell death induced by different stimuli. These naphthoquinone derivatives were 
designed as cysteine protease inhibitors and, thus, expected to prevent apoptosis 
through caspase inhibition (Iley et al., 2006; Valente et al., 2007).  Experiments were 
conducted in primary rat hepatocytes treated with the topoisomerase I inhibitor 
camptothecin, which induces DNA double-strand breaks, leading to apoptosis (Morris 
and Geller, 1996).  In addition, human hepatoma (HuH-7) and rat pheochromocytoma 
(PC12) cell lines, treated with the apoptogens TGF-β1 and rotenone, respectively, 
were also used. TGF-β1 is a multifunctional cytokine that activates both the extrinsic 
and the intrinsic pathways of apoptosis (Sola et al., 2006), whereas rotenone is an 
inhibitor of mitochondrial complex I that induces apoptosis by enhancing 
mitochondrial ROS production (Li et al., 2003a).  The use of different apoptogens 
would potentially provide additional information on the preferential apoptotic 
pathways modulated by these specific naphthoquinone derivatives. Our results 
showed that both 1a and 1b prevent cell death elicited by three different apoptotic 
stimuli in three different cellular models. Both naphthoquinone derivatives increased 
cell viability and reduced nuclear fragmentation and caspase-3, -8 and -9 activation. It 
remained to be addressed whether 1a and 1b directly modulate caspase activity, either 
by alkylation or by oxidation of catalytic site Cys residues; and, if so, whether they 
inhibit all caspases equally or show preference for any particular caspase. In fact, our 
data indicate that 1a and 1b can prevent both caspase-8 and caspase-9-like activities, 
associated with the extrinsic and the intrinsic pathways of apoptosis, respectively. 
However, the results were more striking in the latter, which could be due to a 
preferential activation of the intrinsic pathway by the apoptogens utilized. This 
question could be answered by including stimuli that preferentially activate the 
extrinsic pathway. Alternatively, 1a and 1b might differentially modulate the two 
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pathways of apoptosis. Consistent with modulation of the intrinsic pathway, we 
observed decreased Cyt c release to the cytoplasm upon 1a and 1b-pretreatment, and 
up-regulation of Bcl-XL in cells co-treated with 1a, although the specific mechanisms 
remained elusive.  
Interestingly, it has been shown that low doses of stressful stimuli often 
activate adaptive responses that increase cellular resistance to moderate or severe 
levels of stress (Calabrese et al., 2007).  In fact, the naphthoquinone derivative 
plumbagin has been shown to protect neuroblastoma and primary cortical neurons 
from subsequent oxidative and metabolic insults through activation of the Nrf2 
antioxidant response pathway (Son et al., 2010).  In addition, several pro-oxidants, 
including 1,4-naphthoquinone, were shown to protect lymphocytes against radiation-
induced cell death by activating the calcium-Erk1/2-Nrf2 pathway (Khan et al., 2011).  
In this respect, it would be interesting to investigate whether 1a and 1b also modulate 
these pathways in our cellular models. Indeed, the observation that the two 
naphthoquinone derivatives were particularly effective in preventing apoptosis in 
rotenone-treated PC12 cells suggests they may play a role in the activation of 
antioxidant response pathways as well. However, oxidant-responsive mechanisms are 
probably not solely responsible for the anti-apoptotic properties of 1a and 1b. In fact, 
our initial observation that naphthoquinone 4 could not prevent camptothecin-induced 
apoptosis of primary rat hepatocytes indicates that specific structural properties of 
naphthoquinone derivatives 1a and 1b must be required for apoptosis prevention. 
Driven by our interest in integrating different cellular processes, we next 
focused on alternative roles for apoptotic cysteine proteases, the putative targets of 1a 
and 1b, in regulating NSC proliferation and differentiation potential. Recently, several 
studies have demonstrated non-apoptotic roles for apoptosis-related factors, including 
modulation of stem cell fate decision (Galluzzi et al., 2012a; Sola et al., 2012).  
Furthermore, previous results from our group, among others, established a role for 
caspases in NSC differentiation. Indeed, non-apoptotic caspase-3 processing was 
observed during neural differentiation of mouse E14 neurospheres, whereas caspase 
inhibition elicited a decrease in neurogenesis and gliogenesis, associated with de-
repression of the p-FOXO3A/Id1 signaling pathway (Aranha et al., 2009).  In 
addition, a consistent increase of apoptosis-related miRNAs was also observed in 
different models of neural differentiation (Aranha et al., 2010).  We next chose to 
study another family of cysteine proteases largely known for participating in neuronal 
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apoptosis under pathological conditions, calpains. Notably, we found that calpain 
inhibition in self-renewing NSC leads to decreased proliferation, associated with 
altered levels of cell cycle regulators cyclin E, p21 and p27. This was in agreement 
with calpain-mediated cyclin E up-regulation and p21 and p27 degradation already 
described in other models (Chen et al., 2001; Akashiba et al., 2006; Hou et al., 2012).  
In the future, it would be interesting to test whether calpains also target these and 
other cell cycle proteins directly in our cellular model. Although this could be 
answered in part by in vitro proteolytic assays, those experiments are set in artificial 
environments and often do not reflect real in vivo interactions. For instance, calpain 
protein availability and activity may not be accounted for. We found that calpain 1 
was mostly expressed in self-renewing NSC and that its levels declined upon 
induction of neural differentiation. By contrast, calpain 2 levels were lower in self-
renewing NSC. This results led us to hypothesize that calpain 1 is the one responsible 
for NSC proliferation. We further observed that inhibiting calpain activity in 
proliferating NSC induced differentiation. Coincident with a role for calpain 1 in NSC 
self-renewal, specific calpain 1 silencing during NSC differentiation accelerated 
neural differentiation, characterized by increased expression of neuronal and glial 
markers. Calpain 2 levels, on the other hand, increased during differentiation, 
particularly at the onset of gliogenesis. Moreover, specific calpain 2 silencing during 
NSC differentiation resulted in decreased expression of a glial marker, suggesting that 
calpain 2 may play a role in gliogenesis. Therefore, it would be interesting to also 
clarify whether calpain 2 can modulate gliogenesis regulators, such as STAT and 
Notch signaling pathways (Oda et al., 2002; Sauvageot and Stiles, 2002).   
Given the involvement of calpains in apoptotic cell death during 
neurodegenerative diseases (Vosler et al., 2008), it is crucial to understand the 
regulatory network controlling calpain activation in NSC proliferation and 
differentiation. Calpain 1 and 2 differ in their Ca2+ requirements, with calpain 1 being 
activated by micromolar and calpain 2 by milimolar Ca2+ concentrations (Goll et al., 
2003).  Since intracellular Ca2+ concentrations are usually low, around 100 nM 
(Laude and Simpson, 2009), calpain activation depends on transient or localized 
increases in intracellular Ca2+ concentration, as well as on post-translational 
modifications or interaction with factors that lower Ca2+ requirements.  We 
hypothesize that calpain 1 is activated by Ca2+ transients in cycling NSC.  This is 
based on the previous observation that Ca2+ oscillations during the G1/S transition 
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promote neural progenitor proliferation (Resende et al., 2010), and on our own 
results.  Indeed, we showed that inhibition of Ca2+ flux in self-renewing NSC results 
in a switch to differentiation similar to the one observed upon calpain inhibition.  
Besides Ca2+ binding, several other factors regulate calpain activity.  In fact, future 
studies on the regulation of calpain activity in proliferating and differentiating NSC 
should include the expression pattern of calpastatin, the endogenous calpain inhibitor, 
and the subcellular localization of calpain proteins.  The latter could, on the one hand, 
be indicative of calpain activation status, as interaction with membrane phospholipids, 
for instance, facilitates calpain activation (Leloup et al., 2010); and, on the other hand, 
provide insight into calpain function and putative targets, if specific association with 
particular organelles, such as mitochondria and the nucleus, were to be detected (Kar 
et al., 2008; Raynaud et al., 2008). 
 Finally, we investigated whether the aforementioned anti-apoptotic 
naphthoquinone derivatives could modulate NSC proliferation and differentiation. 
Following our observations on the role of caspases and calpains in these processes, 
and given 1a and 1b putative cysteine protease modulatory properties, these 
molecules presented themselves as promising candidates.  Interestingly, we observed 
that treatment of differentiating NSC with 1a elicited a shift from neuronal to glial 
fate without affecting the rate of differentiation.  Preliminary experiments with 1b 
suggested that it elicited similar effects (data not shown).  However, these results 
appeared to be independent of caspase or calpain modulation.  In fact, NSC fate 
modulation occurred under 50 µM 1a-treatment, contrasting with the 0.1-1 µM used 
in apoptosis-prevention experiments.  It is not surprising that different concentrations 
of 1a treatment elicit different cellular outcomes through activation of different 
signaling pathways.  In fact, the effects of the naphthoquinone plumbagin in spinal 
cord neural progenitors were shown to be biphasic, with very low concentrations 
promoting astrocyte differentiation and high concentrations enhancing proliferation 
(Luo et al., 2010).  This led us to hypothesize that 1a modulated NSC fate decision 
through its quinone redox cycling and alkylating properties.  In accordance, we 
observed a sustained increase in intracellular ROS levels following 1a treatment.  
This was accompanied by activation of the antioxidant-response proteins Nrf2 and 
Sirt1, which could be prevented by antioxidant treatment.  Importantly, subsequent 
antioxidant treatment was able to partially reduce 1a-mediated shift in differentiation 
potential of NSC, suggesting that 1a acts through alteration of intracellular redox 
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environment.  In fact, Nrf2 and Sirt1 have previously been implicated in the 
regulation of neural differentiation (Prozorovski et al., 2008; Zhao et al., 2009).  	  It is 
tempting to	   test whether direct modulation of Nrf2 and Sirt1 expression or activity 
would be able to revert 1a-ellicited effects.  In addition, 1a may modulate NSC 
differentiation through regulation of other signaling pathways.  Indeed, the 
observation that plumbagin stimulates astrocytic proliferation and differentiation of 
rat spinal cord neural progenitors through Stat3 activation makes this pathway a 
strong candidate for 1a modulation (Luo et al., 2010).  Other candidates worth 
investigating include MAPK pathways, such as p38, which can be modulated by ROS 
and has been implicated in regulation of NSC proliferation and neuronal 
differentiation (Morooka and Nishida, 1998; Sato et al., 2008; Choi et al., 2011). 
 The main conclusions of the work presented in this thesis are illustrated 
below, where suggested cellular interactions are depicted (Fig. 6.1). 
 
 
Figure 6.1. Graphical abstract.	   	   Cellular interactions described in this thesis are depicted.  
Interactions that were suggested or shown indirectly are represented by dashed lines.  A 
neural stem cell (NSC; in orange), neuronal cell (blue), glial cell (green) and unspecified 
mammal cell (brown) are illustrated.  Distinct cellular effects of high and low concentrations 
of naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylate 1a (represented by its chemical formula) 
are shown.  ROS, reactive oxygen species. 
 
To further clarify the effect of ROS during NSC differentiation, we are 
currently investigating apoptotic mitochondrial events and key checkpoints 
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responsible for neural differentiation, as an alternative to cell death.  Interestingly, 
ongoing experiments suggest that mitochondria are depolarized and Cyt c is released 
at early stages of neural differentiation without increased cell death.  Curiously, a 
marked reduction in mitochondrial number has also been observed during 
differentiation, possibly as a cellular survival strategy to control excessive ROS 
production.  In fact, it has been shown that ROS can induce autophagy, a protective 
mechanism that promotes turnover of cell constituents, including dysfunctional or 
damaged mitochondria, which might explain this decrease in mitochondrial number 
(Green et al., 2011; Bhogal et al., 2012).  This issue deserves further investigation 
since autophagy might be one of the mechanisms responsible for limiting the 
activation of apoptotic pathways during differentiation, allowing apoptosis-associated 
factors to perform non-death functions. 
Another level of regulation that may control this decision is presented by 
miRNAs.  These nuclei acids function as a fine-tuning mechanism, rapidly controlling 
the expression of several genes (Tsang et al., 2007).  Our previous finding that 
apoptosis-associated miRNAs can modulate neural differentiation is another example 
of the crosstalk between the two pathways (Aranha et al., 2010).  It would be 
interesting to evaluate in the future whether these miRNAs control the mitochondrial 
alterations observed during neural differentiation. 
 It is increasingly clear that activation of apoptosis-related factors does not 
always result in cell death and must be interpreted according to the specific cellular 
context.  Investigating the strategies used by NSC to escape apoptosis and to re-direct 
these factors to the regulation of other cellular processes, such as proliferation and 
differentiation, may prove to be invaluable for the advance of both fields.  In addition, 
the emergence of this cross-talking network may have major implications for drug 
design and therapeutic interventions. 
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